var title_f40_2_40992="AC joint compression test - Part 2";
var content_f40_2_40992=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F58296&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F58296&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    AC joint compression test: Part 2",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 301px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In part two of the acromioclavicular compression test, the patient's arm is fully supinated.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Scott Koehler, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_2_40992=[""].join("\n");
var outline_f40_2_40992=null;
var title_f40_2_40993="CDC BMI for age girls 2 to 20 years";
var content_f40_2_40993=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F68478&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F68478&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 569px\">",
"   <div class=\"ttl\">",
"    Body mass index-for-age percentiles, girls, 2 to 20 years, CDC growth charts: United States",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 549px; height: 669px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Developed by the National Center for Health Statistics in collaboration with the National Center for Chronic Disease Prevention and Health Promotion (2000).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_2_40993=[""].join("\n");
var outline_f40_2_40993=null;
var title_f40_2_40994="Patient guidelines for weight-resistance training in osteoarthritis";
var content_f40_2_40994=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Patient guidelines for weight-resistance training in osteoarthritis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/2/40994/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/2/40994/contributors\">",
"     Kenneth C Kalunian, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/2/40994/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/2/40994/contributors\">",
"     Peter Tugwell, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/2/40994/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/2/40994/contributors\">",
"     Paul L Romain, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?40/2/40994/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 7, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Weight-resistance exercises can be used as part of the therapeutic regimen in patients with osteoarthritis (OA). General guidelines for patients with OA who are performing such training are reviewed here. An overview of the approach to weight-resistance training in patients with OA and the weight-resistance exercises that can be used as part of the therapeutic regimen in such patients are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/19/5427?source=see_link\">",
"     \"Weight-resistance training in patients with osteoarthritis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/28/7621?source=see_link\">",
"     \"Weight-resistance exercises in patients with osteoarthritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H384946\">",
"    <span class=\"h1\">",
"     GUIDELINES FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients should be given general guidelines to follow when weight-resistance exercises are prescribed for the treatment of osteoarthritis (OA). These include general considerations for planning an exercise program and strategies for performing exercises effectively and for avoiding injury.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H385036\">",
"    <span class=\"h2\">",
"     General considerations",
"    </span>",
"    &nbsp;&mdash;&nbsp;General considerations for the patient in planning weight-resistance training for OA include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Before starting any weight-resistance program, consult with a medical specialist experienced in arthritis care to learn what response you might expect from exercise and to discuss limitations. Some forms of arthritis do not respond well to weight-resistance training, and there may be some contraindications.",
"     </li>",
"     <li>",
"      Consult with a qualified physical therapist",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      personal trainer to find out which exercises are best for your particular type of arthritis. Some exercise and stretching routines are contraindicated and can aggravate a preexisting condition.",
"     </li>",
"     <li>",
"      A supervised exercise program in a gym is more desirable than an individual home-based program. People tend to be more likely to adhere to a program and to be motivated if they are being supervised. A gym has a greater diversity of equipment and classes.",
"     </li>",
"     <li>",
"      Find a training partner. Training partners are great for maintaining interest and motivation. A partner can also provide constructive criticism and can act as a spotter.",
"     </li>",
"     <li>",
"      If you are taking medication for arthritis, be aware of the possible side effects and the implications it could have for exercise. The benefits of some medications could give you a false sense of well-being and may allow you to push beyond your limits, which could lead to injury or exacerbation of your condition. The same guidelines should be followed with over-the-counter medications. They should not be overused. If you find little or no relief from the recommended dose, it could be a sign of a more serious condition. The use of ointments is another commonly used method of relief for the symptoms of arthritis. Ointments work by activating heat receptors in the skin. Whether or not they promote circulation is unclear. There are no scientific data that suggest how much relief is actually obtained by their use or whether they are effective in the treatment of arthritis.",
"     </li>",
"     <li>",
"      Exercise at times of the day when you feel most energetic and when you are not in a hurry.",
"     </li>",
"     <li>",
"      If you are overweight, incorporate a weight-loss program through diet and cardiovascular exercise. This will reduce the weightbearing loads placed on the joints.",
"     </li>",
"     <li>",
"      Keep yourself educated on the latest trends in exercise. Try different exercises. Try free weights as well as machines, as they have different benefits. Ask a lot of questions of personal trainers and other fitness experts; do not take anything for granted.",
"     </li>",
"     <li>",
"      Incorporate recreational activities of your choice into a fitness program such as golf, bicycling, hiking, or swimming.",
"     </li>",
"     <li>",
"      Have fun! You will not continue doing any activity if you do not enjoy it.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H385045\">",
"    <span class=\"h2\">",
"     Guidelines for performing exercise",
"    </span>",
"    &nbsp;&mdash;&nbsp;Guidelines for patients in performing exercises effectively and in avoiding injury include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Always warm up before starting your workout routine. This promotes circulation and prepares joints for activity.",
"     </li>",
"     <li>",
"      Once you have warmed up, do some light stretching exercises. This promotes greater flexibility and range of motion. Stretching can also provide some relief from the stiffness associated with arthritis. Do static stretches rather than ballistic stretches (static stretches are stretches that are held without bouncing for 20 to 30 seconds while ballistic stretches are stretches that are done with bouncing involved). Do not go beyond your range of motion. Overstretching can place excessive strain on muscles and joints.",
"     </li>",
"     <li>",
"      Become familiar with your limitations. There is a tendency to become overanxious to get back into shape, especially after being sedentary for a long time. Start out with light weights. This will put less strain on your joints. You will gain greater results from using proper technique, good body alignment, full muscle contractions, and a slow, steady pace. Heavy weights do not always promote muscle strength and growth.",
"     </li>",
"     <li>",
"      Always maintain proper body alignment. When standing, keep your knees bent to reduce stress on the lower back, keep abdominal muscles tight, keep your head positioned forward and not off to one side, and always stay focused when you are working out with weights.",
"     </li>",
"     <li>",
"      Use the mirrors in the gym to check your form and body alignment.",
"     </li>",
"     <li>",
"      Move the weights in a smooth steady motion without any sudden or jerky movements.",
"     </li>",
"     <li>",
"      Do not &ldquo;lock-out&rdquo; your joints at the end phase of an exercise. Always try to keep a small amount of flexion to reduce strain on the joints.",
"     </li>",
"     <li>",
"      Make sure you are breathing; do not hold your breath while you are lifting weights or stretching. Exhale while you are in the concentric contraction phase of lifting. Breathing while you are involved in a forceful contraction will reduce intrathoracic pressure. Reducing intrathoracic pressure is particularly important to those people with hypertension.",
"     </li>",
"     <li>",
"      Try to achieve a balance in opposing muscle groups. If you can do a biceps curl with 20 pounds, you should be able to do a tricep extension with the same amount of weight. This type of balance in muscle groups provides greater stability in joints.",
"     </li>",
"     <li>",
"      Orthopedic braces prescribed by a clinician should be worn during exercise unless otherwise prescribed. Cloth or neoprene braces provide inadequate support to joints and, at most, provide warmth and some proprioceptive stimulation. Wraps function in the same way that cloth and neoprene braces work. Gloves are critical for providing padding to the hands and for assisting in improving gripping power. Straps are excellent for relieving strain on the fingers and wrists. Taping can provide adequate support if done by a qualified trainer. Taping also provides adequate proprioceptive stimulation. Contrary to popular belief, weight belts provide inadequate support and should be used only for their proprioceptive benefits. Weightlifting belts may provide a false sense of support and may lead people to believe that they can lift excessive loads, especially during squats or dead-lifts.",
"     </li>",
"     <li>",
"      Hot packs can be applied to joints and muscles prior to exercising to reduce pain and to promote circulation. Cold packs can be applied after exercising to reduce inflammation; they should be applied for 20 minutes on and 20 minutes off.",
"     </li>",
"     <li>",
"      Wear proper shoes while exercising. Try on as many pairs as possible, and pick the most comfortable pair. Try out all the various types of shoes: cross trainers, mid-tops, high-tops, tennis shoes, basketball shoes, weightlifting shoes, running shoes, walking shoes, and hiking shoes. If you wear orthoses, try the shoes on with the orthoses in place.",
"     </li>",
"     <li>",
"      Pick cushioned surfaces, such as carpet, grass, exercise mats, or sand, on which to exercise. Cushioned surfaces reduce the shock impact off of the joints of the lower extremities.",
"     </li>",
"     <li>",
"      Stop exercising if you experience any of the following: increased pain or swelling in muscles or joints; popping; locking; giving-way; or new onset of musculoskeletal pain, abdominal pain, groin pain, chest pain, or shortness of breath.",
"     </li>",
"     <li>",
"      Alternate between weightbearing and non-weightbearing exercises.",
"     </li>",
"     <li>",
"      Always end an exercise session with an active cool-down. An active cool-down will reduce the onset of delayed muscle soreness, will slowly decrease an elevated heart rate, and will prevent blood from pooling in lower extremities, which can lead to dizziness. Stretching at the end of a workout session is also advisable.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H385021\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      General considerations that should be included in guidelines for patients planning to perform weight-resistance exercises for osteoarthritis (OA) include consultation with a medical specialist and a therapist or trainer; selection of a facility with appropriate supervision and equipment; attention to other health issues that may affect exercise safety and performance, including medications, time of day, and overweight and other medical conditions; and identification of a training partner, when possible. (See",
"      <a class=\"local\" href=\"#H385036\">",
"       'General considerations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Guidelines for patients in performing exercises effectively and in avoiding injury include warming up before starting the workout; cooling down afterward; proper stretching; use of proper technique during exercises; and continued use of prescribed braces or orthoses and of proper shoes during exercise. (See",
"      <a class=\"local\" href=\"#H385045\">",
"       'Guidelines for performing exercise'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Exercise should be stopped if increased pain or swelling in muscles or joints; popping; locking; giving-way; or new onset of musculoskeletal pain, abdominal pain, groin pain, chest pain, or shortness of breath is experienced while exercising. (See",
"      <a class=\"local\" href=\"#H385045\">",
"       'Guidelines for performing exercise'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5500 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-183.1.191.153-09F22AFDA5-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_2_40994=[""].join("\n");
var outline_f40_2_40994=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H385021\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H384946\">",
"      GUIDELINES FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H385036\">",
"      General considerations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H385045\">",
"      Guidelines for performing exercise",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H385021\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/28/7621?source=related_link\">",
"      Weight-resistance exercises in patients with osteoarthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/19/5427?source=related_link\">",
"      Weight-resistance training in patients with osteoarthritis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_2_40995="Lateral neck flexion PI";
var content_f40_2_40995=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F79565&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F79565&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Lateral neck flexion",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 443px; height: 442px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Sit or stand. Look straight ahead. Slowly tilt the head toward the right shoulder until you feel a stretch along the left side of the neck. Hold for 5 seconds. Straighten the neck then tilt the head towards the left shoulder. Hold for a count of 5. Repeat this sequence 10 times.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_2_40995=[""].join("\n");
var outline_f40_2_40995=null;
var title_f40_2_40996="Cyproheptadine: Pediatric drug information";
var content_f40_2_40996=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Cyproheptadine: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?19/25/19862?source=see_link\">",
"    see \"Cyproheptadine: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?34/28/35268?source=see_link\">",
"    see \"Cyproheptadine: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F14959840\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Euro-Cyproheptadine;",
"     </li>",
"     <li>",
"      PMS-Cyproheptadine",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1057570\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antihistamine",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1057564\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?19/25/19862?source=see_link\">",
"      see \"Cyproheptadine: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Allergic conditions:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children: 0.25 mg/kg/day or 8 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     /day in 2-3 divided doses",
"     <b>",
"      or",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     2-6 years: 2 mg every 8-12 hours (not to exceed 12 mg/day)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     7-14 years: 4 mg every 8-12 hours (not to exceed 16 mg/day)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults: 4-20 mg/day divided every 8 hours (not to exceed 0.5 mg/kg/day)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Appetite stimulation (anorexia nervosa): Children &gt;13 years and Adults: 2 mg 4 times/day; may be increased gradually over a 3-week period to 8 mg 4 times/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cluster headaches: Adults: 4 mg 4 times/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Migraine headaches:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children: 4 mg 2-3 times/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults: 4-8 mg 3 times/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Spasticity associated with spinal cord damage: Children &ge;12 years and Adults: 4 mg at bedtime; increase by a 4 mg dose every 3-4 days; average daily dose: 16 mg in divided doses; not to exceed 36 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dosage adjustment in hepatic impairment:",
"     </b>",
"     Reduce dosage in patients with significant hepatic dysfunction",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F155692\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Syrup, oral, as hydrochloride: 2 mg/5 mL (473 mL, 480 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral, as hydrochloride: 4 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F155678\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1057574\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral: Administer with food or milk",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1057573\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Perennial and seasonal allergic rhinitis and other allergic symptoms including urticaria; appetite stimulant (useful in the management of anorexia nervosa); prophylactic treatment of cluster and migraine headaches; spinal cord damage associated with spasticity",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F155758\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Cyproheptadine may be confused with cyclobenzaprine",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Periactin may be confused with Percodan&reg;, Persantine&reg;",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      BEERS Criteria medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       This drug may be potentially inappropriate for use in geriatric patients (Quality of evidence - moderate; Strength of recommendation - strong).",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      International issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Periactin brand name for cyproheptadine [U.S., multiple international markets] may be confused with Perative brand name for an enteral nutrition preparation [multiple international markets] and brand name for ketoconazole [Argentina]",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F155756\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Extrasystoles, hypotension, palpitation, tachycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Confusion, coordination disturbed, dizziness, excitation, euphoria, faintness, hallucinations, headache, hysteria, insomnia,  irritability, nervousness, neuritis, restlessness, sedation, seizure, sleepiness, tremor, vertigo",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Angioedema, photosensitivity, rash, urticaria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal pain, anorexia, appetite increased, constipation, diarrhea, nausea, vomiting, xerostomia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Difficult urination, urinary frequency, urinary retention",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Agranulocytosis, hemolytic anemia, leukopenia, thrombocytopenia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: Cholestasis, hepatic failure, hepatitis, jaundice",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Paresthesia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Blurred vision, diplopia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Otic: Labyrinthitis (acute), tinnitus",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Bronchial secretions (thickening), nasal congestion, pharyngitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Allergic reactions, anaphylactic shock, chills, diaphoresis, fatigue",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1057577\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to cyproheptadine or any component; narrow-angle glaucoma, bladder neck obstruction, acute asthmatic attack, stenosing peptic ulcer, GI tract obstruction, those on MAO inhibitors",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299111\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F155687\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acetylcholinesterase Inhibitors (Central): Anticholinergics may diminish the therapeutic effect of Acetylcholinesterase Inhibitors (Central). Acetylcholinesterase Inhibitors (Central) may diminish the therapeutic effect of Anticholinergics. If the anticholinergic action is a side effect of the agent, the result may be beneficial.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aclidinium: May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): CNS Depressants may enhance the CNS depressant effect of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amphetamines: May diminish the sedative effect of Antihistamines.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticholinergics: May enhance the adverse/toxic effect of other Anticholinergics.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Azelastine (Nasal): CNS Depressants may enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Benzylpenicilloyl Polylysine: Antihistamines may diminish the diagnostic effect of Benzylpenicilloyl Polylysine.  Management: Suspend systemic H1 antagonists for benzylpenicilloyl-polylysine skin testing and delay testing until systemic antihistaminic effects have dissipated. A histamine skin test may be used to assess persistent antihistaminic effects.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Betahistine: Antihistamines may diminish the therapeutic effect of Betahistine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Buprenorphine: CNS Depressants may enhance the CNS depressant effect of Buprenorphine.  Management: Consider reduced doses of CNS depressants used in combination with buprenorphine.  Consider avoiding other CNS depressants in patients thought to be at high risk of buprenorphine overuse or self-injection.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the adverse/toxic effect of other CNS Depressants.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Droperidol: May enhance the CNS depressant effect of CNS Depressants. Management: Consider dose reductions of droperidol or of other CNS agents (e.g., opioids, barbiturates) with concomitant use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hyaluronidase: Antihistamines may diminish the therapeutic effect of Hyaluronidase.  Management: Patients receiving antihistamines (particularly at larger doses) may not experience the desired clinical response to standard doses of hyaluronidase.  Larger doses of hyaluronidase may be required.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrOXYzine: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ipratropium (Oral Inhalation): May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Sulfate: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrimeprazine: CNS Depressants may enhance the CNS depressant effect of Methotrimeprazine. Methotrimeprazine may enhance the CNS depressant effect of CNS Depressants.  Management: Reduce adult dose of CNS depressant agents by 50% with initiation of concomitant methotrimeprazine therapy. Further CNS depressant dosage adjustments should be initiated only after clinically effective methotrimeprazine dose is established.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: CNS Depressants may enhance the sedative effect of Metyrosine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirtazapine: CNS Depressants may enhance the CNS depressant effect of Mirtazapine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paraldehyde: CNS Depressants may enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of CNS Depressants. Management: Patients taking perampanel with any other drug that has CNS depressant activities should avoid complex and high-risk activities, particularly those such as driving that require alertness and coordination, until they have experience using the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramipexole: CNS Depressants may enhance the sedative effect of Pramipexole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramlintide: May enhance the anticholinergic effect of Anticholinergics. These effects are specific to the GI tract.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ROPINIRole: CNS Depressants may enhance the sedative effect of ROPINIRole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rotigotine: CNS Depressants may enhance the sedative effect of Rotigotine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: Cyproheptadine may diminish the therapeutic effect of Selective Serotonin Reuptake Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: May enhance the CNS depressant effect of CNS Depressants. Management: Consider alternatives to combined use. When combined use is needed, consider minimizing doses of one or more drugs. Use of sodium oxybate with alcohol or sedative hypnotics is contraindicated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tiotropium: Anticholinergics may enhance the anticholinergic effect of Tiotropium.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: CNS Depressants may enhance the CNS depressant effect of Zolpidem.  Management: Reduce the Intermezzo brand sublingual zolpidem dose to 1.75 mg for men who are also receiving other CNS depressants.  No such dose change is recommended for women.  Avoid use with other CNS depressants at bedtime; avoid use with alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F155689\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F14389393\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events have been observed in some animal reproduction studies. Maternal antihistamine use has generally not resulted in an increased risk of birth defects; however, information specific to cyproheptadine is limited. Antihistamines are recommended for the treatment of rhinitis, urticaria, and pruritus with rash in pregnant women (although second generation antihistamines may be preferred). Antihistamines are not recommended for treatment of pruritus associated with intrahepatic cholestasis in pregnancy.",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1057563\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     A potent antihistamine and serotonin antagonist, competes with histamine for H",
"     <sub>",
"      1",
"     </sub>",
"     -receptor sites on effector cells in the GI tract, blood vessels, and respiratory tract",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1057576\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Well absorbed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Extensively by conjugation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: &gt;50% excreted in urine (primarily as metabolites); approximately 25% excreted in feces",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1057569\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?34/28/35268?source=see_link\">",
"      see \"Cyproheptadine: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May cause drowsiness and impair ability to perform activities requiring mental alertness or physical coordination; may cause dry mouth. May rarely cause photosensitivity reactions (eg, exposure to sunlight may cause severe sunburn, skin rash, redness, or itching); avoid direct exposure to sunlight",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Gracies JM, Nance P, Elovic E, et al, &ldquo;Traditional Pharmacological Treatments for Spasticity. Part II: General and Regional Treatments,&rdquo;",
"      <i>",
"       Muscle Nerve Suppl",
"      </i>",
"      , 1997, 6:S92-120.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/2/40996/abstract-text/9826984 /pubmed\" id=\"9826984 \" target=\"_blank\">",
"        9826984",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13194 Version 42.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-115.66.252.144-C264CC6E5B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_2_40996=[""].join("\n");
var outline_f40_2_40996=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14959840\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057570\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057564\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F155692\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F155678\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057574\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057573\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F155758\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F155756\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057577\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299111\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F155687\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F155689\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14389393\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057563\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057576\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057569\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13194\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13194|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?19/25/19862?source=related_link\">",
"      Cyproheptadine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?34/28/35268?source=related_link\">",
"      Cyproheptadine: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_2_40997="Lymphatic system female PI";
var content_f40_2_40997=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F86801&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F86801&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 505px\">",
"   <div class=\"ttl\">",
"    Lymphatic system in women",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 485px; height: 709px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This figure shows the organs of the lymphatic system, which include the bone marrow, thymus, spleen, and lymph nodes. These organs are connected by lymph vessels.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_2_40997=[""].join("\n");
var outline_f40_2_40997=null;
var title_f40_2_40998="Gonorrhea purpura";
var content_f40_2_40998=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F82060&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F82060&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Disseminated gonococcal infection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 363px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This adolescent girl developed tender purpuric papules on her right leg associated with fever and arthralgias. A cervical examination revealed cervical and adnexal tenderness, and a culture was positive for",
"    <em>",
"     Neisseria gonorrhoeae",
"    </em>",
"    .",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Copyright &copy; Bernard Cohen, MD, Dermatlas;",
"     <a href=\"file://www.dermatlas.org\" target=\"_blank\">",
"      file://www.dermatlas.org",
"     </a>",
"     .",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_2_40998=[""].join("\n");
var outline_f40_2_40998=null;
var title_f40_2_40999="Renal pathology of late diffuse mesangial sclerosis";
var content_f40_2_40999=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F56256&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F56256&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Renal pathology of late diffuse mesangial sclerosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 352px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Pathologic specimen from a patient with diffuse mesangial sclerosis demonstrating the characteristic contraction of the glomerular tuft into sclerotic masses.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_2_40999=[""].join("\n");
var outline_f40_2_40999=null;
var title_f40_2_41000="Obstetrical manifestations of the antiphospholipid syndrome";
var content_f40_2_41000=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Obstetrical manifestations of the antiphospholipid syndrome",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/2/41000/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/2/41000/contributors\">",
"     Charles J Lockwood, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/2/41000/contributors\">",
"     Peter H Schur, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/2/41000/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/2/41000/contributors\">",
"     Susan M Ramin, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/2/41000/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/2/41000/contributors\">",
"     Vanessa A Barss, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?40/2/41000/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 4, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The antiphospholipid syndrome (APS) refers to a syndrome characterized by arterial or venous thrombosis or specific pregnancy complications in women with laboratory evidence of antibodies to proteins bound to anionic phospholipids. Pregnancy complications that have been associated with APS include pregnancy-related maternal thrombosis, late fetal death, early severe preeclampsia, fetal growth restriction, and recurrent pregnancy loss. The two main types of antiphospholipid antibodies (aPL) of concern to obstetricians are lupus anticoagulants (LA) and anticardiolipin antibodies (aCL) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/1\">",
"     1",
"    </a>",
"    ], although detection of anti-beta-2-glycoprotein-1 antibodies may be a risk for later miscarriages",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    thromboembolic complications [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/2\">",
"     2",
"    </a>",
"    ]. There is no consensus about which, if any, autoantibody profile (eg, LA versus aCL versus both) best predicts pregnancy outcome in women with aPL.",
"   </p>",
"   <p>",
"    Pregnancy-related complications associated with APS will be discussed in this review. The evaluation, treatment and monitoring of pregnancies complicated by aPL and general issues related to APS in the nonpregnant population are reviewed separately:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?43/0/44041?source=see_link\">",
"       \"Management of pregnant women with antiphospholipid antibodies or the antiphospholipid syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/31/23034?source=see_link\">",
"       \"Clinical manifestations of the antiphospholipid syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/29/27096?source=see_link\">",
"       \"Diagnosis of the antiphospholipid syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/12/23754?source=see_link\">",
"       \"Treatment of the antiphospholipid syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/16/35081?source=see_link\">",
"       \"Pathogenesis of the antiphospholipid syndrome\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOGENESIS OF ADVERSE PREGNANCY OUTCOME",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role of aPL as a causal factor in pregnancy loss was demonstrated in experiments in which aPL from women with fetal loss was injected into the peritoneal cavity of pregnant mice and caused fetal death [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/3\">",
"     3",
"    </a>",
"    ]. Initially, aPL was believed to cause obstetrical complications primarily by inducing thrombosis in the uteroplacental circulation. Thrombosis could be induced by a variety of pathways [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/4-11\">",
"     4-11",
"    </a>",
"    ]; as an example, aPL can reduce the levels of trophoblast-associated annexin V, thereby promoting placental villus thrombosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/12-18\">",
"     12-18",
"    </a>",
"    ]. In a murine model, APS appears to increase monocytic expression of tissue factor, the major initiator of coagulation in vivo [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/19\">",
"     19",
"    </a>",
"    ]. If true in humans, this may also play a role in thrombosis and adverse pregnancy outcome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/19\">",
"     19",
"    </a>",
"    ]. Eicosanoid imbalance and cross reactivity with glycosaminoglycans are other possible prothrombotic mechanisms. Further investigation is required, and studies in humans need to be performed.",
"   </p>",
"   <p>",
"    Although thrombosis may be one mechanism for adverse pregnancy outcome, not all affected placentas have signs of thrombosis or infarction. Experimental models suggest that additional factors are responsible for adverse pregnancy outcomes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/7,20-24\">",
"     7,20-24",
"    </a>",
"    ]. As an example, complement activation is a critical component of APS-related adverse pregnancy outcomes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/25-28\">",
"     25-28",
"    </a>",
"    ]. APL-induced neutrophil tissue factor expression has been linked to induction of placental bed inflammation in an experimental murine model [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/29\">",
"     29",
"    </a>",
"    ]. Interleukin-3 (IL-3), which is an important factor for embryo implantation and placental development, is decreased in pregnant women with APS compared with controls without APS, and in animal models of APS. Mice with APS and low IL-3 have high rates of pregnancy loss that can be partially prevented by treatment with IL-3 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/7\">",
"     7",
"    </a>",
"    ]. In addition, aPL appears to have a direct effect on human placental trophoblast, inhibiting the expression of human chorionic gonadotrophin, inducing apoptosis, decreasing trophoblast fusion, altering expression of adhesion molecules, limiting trophoblast invasiveness, and inhibiting decidualization of cultured endometrial stromal cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/30-34\">",
"     30-34",
"    </a>",
"    ]. Thus, the association of APS and pregnancy complications may not be just an epiphenomenon occurring after antecedent endothelial injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/3,23,35\">",
"     3,23,35",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/16/35081?source=see_link\">",
"     \"Pathogenesis of the antiphospholipid syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13613276\">",
"    <span class=\"h1\">",
"     PREVALENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The reported prevalence of aCL in women with uncomplicated pregnancies ranges from 0 to 11 percent, with a median value of about 2 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/36-44\">",
"     36-44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     OBSTETRICAL OUTCOMES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Definitions",
"    </span>",
"    &nbsp;&mdash;&nbsp;An international committee proposed the following criteria for defining adverse pregnancy outcomes in the diagnosis of APS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Abortion is the delivery of a pregnancy, either spontaneously (miscarriage) or electively, before 20 weeks of gestation. A first trimester abortion occurs up to 13 weeks of gestation, a second trimester abortion occurs between 14 and 20 weeks.",
"     </li>",
"     <li>",
"      Recurrent pregnancy loss (also known as recurrent abortion) refers to two or more spontaneous abortions (the abortions do not have to be in consecutive pregnancies).",
"     </li>",
"     <li>",
"      Pre-embryonic loss occurs from conception through the end of the fourth week of gestation.",
"     </li>",
"     <li>",
"      Embryonic loss occurs from the fifth through the ninth week of gestation.",
"     </li>",
"     <li>",
"      Preterm delivery constitutes a live birth or stillbirth after 20 and before 37 weeks of gestation. After this, the birth is considered a term delivery.",
"     </li>",
"     <li>",
"      A fetal demise refers to an intrauterine death at any time after 10 weeks of gestation. Stillbirth refers to a demise after 20 weeks of gestation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These definitions were proposed because fetal loss and pregnancy loss are imprecise terms used in different ways by different investigators. Fetal loss may be used to refer to an abortion or fetal death at a gestational age defined by the investigator (eg, only after 10 weeks of gestation, only in the second or third trimester). Pregnancy loss can mean an abortion, fetal death at any gestational week, or delivery of an infant of any gestational age that does not survive. The broad usage of these terms for case selection in studies of adverse pregnancy outcome has contributed to variable, and often conflicting, results.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Adverse outcomes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adverse pregnancy outcomes attributed to the presence of aPL include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/45\">",
"     45",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Late (ie, &gt;10 weeks of gestation) fetal death (Sapporo criteria)",
"     </li>",
"     <li>",
"      Recurrent early pregnancy loss. This a controversial area; some investigators believe aPL antibodies are not a cause of embryonic loss before 10 weeks [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/39,46,47\">",
"       39,46,47",
"      </a>",
"      ], but they are part of the Sapporo criteria for APS. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/29/27096?source=see_link\">",
"       \"Diagnosis of the antiphospholipid syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Pregnancy-related maternal thromboembolic disease (venous or arterial)",
"     </li>",
"     <li>",
"      Early, severe",
"      <span class=\"nowrap\">",
"       preeclampsia/eclampsia",
"      </span>",
"     </li>",
"     <li>",
"      Fetal growth restriction",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Pregnancy complications such as preeclampsia and fetal growth restriction often lead to preterm delivery, which places the neonate at risk of complications of prematurity. A prospective follow-up of a European multicentre cohort reported women with APS had a preterm delivery rate of 17 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/48\">",
"     48",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/15/31992?source=see_link\">",
"     \"Short-term complications of the premature infant\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/31/13814?source=see_link\">",
"     \"Long-term complications of the premature infant\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is no good evidence of an association between aPL and primary infertility [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/49-53\">",
"     49-53",
"    </a>",
"    ]. Although some studies have reported an increased incidence of in vitro fertilization failure in women with aPL [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/36,54\">",
"     36,54",
"    </a>",
"    ], a meta-analysis failed to confirm this association [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Difficulties with causality",
"    </span>",
"    &nbsp;&mdash;&nbsp;Since aPL can be found in normal asymptomatic individuals, it is sometimes unclear whether there is a causal relationship between these antibodies and a clinical event in any one individual, particularly when the adverse obstetrical outcome is relatively common (eg, spontaneous abortion before 10 weeks). Additional explanations for the poor predictive value of a given positive LA or aCL result include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Reliance upon non-standardized assays for aPL and failure to use internationally recognized standards",
"     </li>",
"     <li>",
"      Failure to control for the severity of co-existing diseases (eg, systemic lupus erythematosus [SLE], diabetes, renal disease, hypertension, and infections) known to cause adverse obstetrical outcomes",
"     </li>",
"     <li>",
"      Failure to recognize co-existing inherited coagulopathies (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/5/26714?source=see_link\">",
"       \"Inherited thrombophilias in pregnancy\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Inclusion of patients with low positive aPL levels among patients considered positive",
"     </li>",
"     <li>",
"      Broad definitions for case selection in series involving pregnancy wastage (pre-embryonic versus later loss)",
"     </li>",
"     <li>",
"      The variable thrombogenic potential of a given patient's aPL",
"     </li>",
"     <li>",
"      Population heterogeneity in concentrations of clotting, anti-clotting, and fibrinolytic proteins",
"     </li>",
"     <li>",
"      Population heterogeneity with respect to the clinical phenotype of APS, which may be recurrent early pregnancy loss, late pregnancy loss, thrombosis, or premature birth before 34 weeks of gestation because of eclampsia, preeclampsia, or placental insufficiency [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/56\">",
"       56",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Recurrent abortion and fetal loss",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although aPL are not associated with an increased risk of sporadic fetal loss or early fetal loss, there is good evidence that aPL are associated with late fetal loss (10 or more weeks of gestation), and that subsequent pregnancies are at increased risk of recurrent late fetal loss [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/33,46,57,58\">",
"     33,46,57,58",
"    </a>",
"    ]. In contrast, pregnancy loss in women without aPL usually occurs before 10 weeks of gestation.",
"   </p>",
"   <p>",
"    There appears to be a correlation between the level of IgG aCL and the risk of pregnancy loss [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/59\">",
"     59",
"    </a>",
"    ]. Although many women with aPL also have systemic lupus erythematosus (SLE), the risk of pregnancy loss appears to be independent, at least in part, of their underlying autoimmune disease. A review of 10 studies involving 554 women with SLE found fetal loss was more common among those with than among those without aPL (38 to 59 percent versus 16 to 20 percent), LA (36 versus 13 percent), or aCL (39 versus 18 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition, a meta-analysis including 2000 women without autoimmune disease found a significant association between IgG aPL and pregnancy loss before 13 weeks of gestation (OR 3.56, 95% CI 1.48&ndash;8.59); for pregnancy loss before 24 weeks, this association was stronger for LA (OR 13) than for IgM aCL (OR 5.6) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/58\">",
"     58",
"    </a>",
"    ]. No study looked at pregnancy loss before 13 weeks and LA.",
"   </p>",
"   <p>",
"    Some studies suggest there is also an association between aPL and pre-embryonic (less than 6 weeks of gestation) and embryonic (6 through 9 weeks of gestation) loss [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/33,47,61,62\">",
"     33,47,61,62",
"    </a>",
"    ], while other studies fail to establish a link [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/63\">",
"     63",
"    </a>",
"    ]. Causality is difficult to establish since there are many disorders associated with recurrent early pregnancy loss. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/6/8298?source=see_link\">",
"     \"Definition and etiology of recurrent pregnancy loss\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In another study, the risk of aPL and fetal loss was examined in a cohort of 491 patients with a history of adverse pregnancy outcomes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/47\">",
"     47",
"    </a>",
"    ]. These women were evaluated for both aCL and LA, as well as inherited thrombophilias. The presence of a maternal thrombophilia was found to be protective of recurrent losses at &lt;10 weeks of gestation (OR 0.55, 95% CI 0.33-0.92), but was associated with a modestly increased risk of loss &gt;10 weeks (OR 1.76, 95% CI 1.05-2.94). Women who experienced only euploid losses were not more likely to have an identified thrombophilia than women who experienced only aneuploid losses (OR 1.03; 95% CI 0.38-2.75).",
"   </p>",
"   <p>",
"    The paradoxical observation that maternal thrombophilias, including aPL, might be protective of early loss is not unexpected [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/47\">",
"     47",
"    </a>",
"    ]. Early pregnancy is normally associated with a low oxygen environment, trophoblast plugging of the intervillous space, and low Doppler flow of the uteroplacental circulation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/64,65\">",
"     64,65",
"    </a>",
"    ]. Thus, the early pregnancy environment may be relatively immune to the effects of aPL.",
"   </p>",
"   <p>",
"    Based on these are other observations, an international consensus committee concluded that women with the following obstetrical history met clinical criteria for APS: one or more unexplained deaths of a morphologically normal fetus &ge;10",
"    <sup>",
"     th",
"    </sup>",
"    week of gestation or three or more unexplained consecutive spontaneous pregnancy losses before the 10",
"    <sup>",
"     th",
"    </sup>",
"    week of pregnancy in the absence of maternal anatomic or hormonal abnormalities and paternal and maternal chromosomal abnormalities. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/29/27096?source=see_link\">",
"     \"Diagnosis of the antiphospholipid syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Fetal growth restriction",
"    </span>",
"    &nbsp;&mdash;&nbsp;The best evidence of an association between aPL and growth restriction derives from a prospective study of 860 unselected Japanese women evaluated for aCL in the first trimester [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/66\">",
"     66",
"    </a>",
"    ]. The rate of fetal growth restriction was significantly higher among the 60 aCL positive than the 800 aCL negative women (12 versus 2 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/66\">",
"     66",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Among patients with symptomatic APS, the frequency of growth restriction approaches 30 percent, which is significantly higher than the rate of 10 percent or less observed in the general population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/67,68\">",
"     67,68",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Preeclampsia/HELLP",
"    </span>",
"    &nbsp;&mdash;&nbsp;Systematic reviews have concluded there is a significant association between the development of preeclampsia and the presence of aCL [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/33,69\">",
"     33,69",
"    </a>",
"    ], and possibly LA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/33\">",
"     33",
"    </a>",
"    ]. For aCL, the odds ratios were 2.73 (95% CI 1.65-4.51) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/33\">",
"     33",
"    </a>",
"    ] and 2.86 (95% CI 1.37-5.98) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/69\">",
"     69",
"    </a>",
"    ] and, for LA, the odds ratio was 1.45 (95% CI 0.70-4.61) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/33\">",
"     33",
"    </a>",
"    ]. Severe preterm preeclampsia and HELLP syndrome (Hemolysis, Elevated Liver function enzymes, and Low Platelet count) are particular concerns in this population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/66,69-75\">",
"     66,69-75",
"    </a>",
"    ], while mild or near",
"    <span class=\"nowrap\">",
"     term/term",
"    </span>",
"    preeclampsia does not appear to be strongly associated with aPL [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/72\">",
"     72",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As a result, one or more premature births of a morphologically normal neonate before the 34th week of gestation because of eclampsia, severe preeclampsia, or features consistent with placental insufficiency is one of the clinical criteria for diagnosis of APS. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/29/27096?source=see_link\">",
"     \"Diagnosis of the antiphospholipid syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Maternal thrombosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnancy and the puerperium are associated with an increased incidence of thromboembolic disease, including stroke. The risk of thromboembolism among aPL positive patients is highly variable and is exacerbated by co-existent hereditary coagulopathies (eg, factor V Leiden) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/67,76\">",
"     67,76",
"    </a>",
"    ], but aPL is likely to increase the risk of pregnancy-related venous thrombosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/77\">",
"     77",
"    </a>",
"    ]. In a cohort study, 24 percent of thrombotic events in women with aPL occurred in association with pregnancy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/78\">",
"     78",
"    </a>",
"    ]. In a prospective study, the risk of thrombosis during pregnancy was 5 percent among women with known APS (compared with 0.025 to 0.10 percent in the general obstetrical population) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/68\">",
"     68",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/27/39353?source=see_link\">",
"     \"Deep vein thrombosis and pulmonary embolism in pregnancy: Epidemiology, pathogenesis, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Risk in unselected populations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Whether asymptomatic women with aPL and no prior adverse pregnancy outcome (no thrombotic event or pregnancy complication) have an increased risk of complications during pregnancy is unclear.",
"   </p>",
"   <p>",
"    Some studies show little or no increase in risk:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among 1449 healthy pregnant women, positive aCL tests occurred infrequently and were rarely associated with adverse pregnancy outcome [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/38\">",
"       38",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      An elegant study comparing women with spontaneous abortion or fetal death with pregnant controls also found no association between aPL and an adverse pregnancy outcome [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/39\">",
"       39",
"      </a>",
"      ]. Among 331 women with spontaneous abortion or fetal death and 993 control women, no increased risk of miscarriage was observed in first pregnancies in women with aPL. This study concluded that routine screening of women with one pregnancy loss for aPL was not indicated.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In contrast, a prospective study of asymptomatic nulliparas with normal pregnancies reported a higher rate of fetal loss in women found to have high-titer IgG aCL before 25 weeks of gestation than in those who were aCL negative (28 versus 7 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/79\">",
"     79",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     NEONATAL APS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neonatal APS is defined by the same criteria as APS in other populations: presence of at least one type of aPL in serum and the occurrence of at least one clinical feature such as venous or arterial thromboses or thrombocytopenia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/80\">",
"     80",
"    </a>",
"    ]. A confounding factor, however, is that aPL in the neonate results from placental transfer of maternal antibody, and thus may not have the same significance as endogenously produced antibody. Passively acquired aPL completely disappears by 6 to 12 months of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/81\">",
"     81",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Neonatal APS is rare to nonexistent. Studies reporting neonatal outcome of maternal APS have not described any cases of neonatal APS among 277 neonates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/81-86\">",
"     81-86",
"    </a>",
"    ]; a registry that collects outcome data on pregnancies complicated by APS also has not recorded any cases of neonatal APS during follow-up of 134 children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/48\">",
"     48",
"    </a>",
"    ]. However, a literature review found 16 case reports of thrombosis in infants born to women with aPL, and 12 of these infants met criteria for neonatal APS (for the other four infants, aPL was detected only in the mother) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/87\">",
"     87",
"    </a>",
"    ]. Causality related to aPL has not been established, as almost all of these infants had additional risk factors for arterial or venous thrombosis (eg, asphyxia, sepsis, indwelling vascular catheters, cardiac disease, inherited thrombophilia, antenatal disorders [preeclampsia, growth restriction]).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     WHEN TO EVALUATE FOR ANTIPHOSPHOLIPID ANTIBODIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Given the confusion surrounding causality and association with adverse outcomes, the population that should be evaluated for aPL because of obstetrical complications is controversial.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The American College of Obstetricians and Gynecologists (ACOG) recommends testing women with a prior unexplained arterial or venous thromboembolism, or a new arterial or venous thromboembolism during pregnancy, or a history of venous thromboembolism who have not been tested previously [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/88\">",
"       88",
"      </a>",
"      ]. Obstetric indications for antiphospholipid antibody testing include:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      One or more unexplained deaths of a morphologically normal fetus at &ge;10",
"      <sup>",
"       th",
"      </sup>",
"      week of gestation, or",
"     </li>",
"     <li>",
"      Three or more unexplained consecutive spontaneous pregnancy losses before the 10",
"      <sup>",
"       th",
"      </sup>",
"      week of pregnancy, in the absence of maternal anatomic or hormonal abnormalities and paternal and maternal chromosomal abnormalities",
"     </li>",
"     <li>",
"      Although one or more premature births of a morphologically normal neonate before the 34",
"      <sup>",
"       th",
"      </sup>",
"      week of gestation because of eclampsia, severe preeclampsia, or features consistent with placental insufficiency is a clinical criterion for APS, ACOG opines that there is insufficient evidence that screening and treatment of women with these conditions improves subsequent pregnancy outcomes. Low dose ASA may be prescribed for these women whether or not aPL antibodies are present. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?40/40/41609?source=see_link&amp;anchor=H2#H2\">",
"       \"Prevention of preeclampsia\", section on 'Antiplatelet agents'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The American College of Chest Physicians Evidence-Based Clinical Practice Guidelines recommend that women with recurrent early pregnancy loss (three or more miscarriages before 10 weeks of gestation) be tested for the presence of LA and aCL antibodies [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/2/41000/abstract/74\">",
"       74",
"      </a>",
"      ]. This has generally been accepted by both the hematology and obstetrics communities, despite the absence of clear evidence of biological plausibility and of adequately sized, prospective cohort studies in which the outcomes in a fourth pregnancy were compared between aPL positive and negative women.",
"     </li>",
"     <li>",
"      The American College of Rheumatology recommends testing for aPL in women with a history of miscarriage after 10 weeks who are considering pregnancy. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/29/27096?source=see_link\">",
"       \"Diagnosis of the antiphospholipid syndrome\"",
"      </a>",
"      .) &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    ACOG recommends testing for the presence of LA, aCL (IgG and IgM), and anti-beta2-glycoprotein I (IgG and IgM). If the initial screening test is positive, it should be repeated in 12 weeks to determine whether the aPL is transient or persistent. The diagnostic evaluation of APS is described in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/29/27096?source=see_link\">",
"     \"Diagnosis of the antiphospholipid syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Evaluation for aPL is also indicated in nonpregnant women and women with no history of pregnancy complications if other clinical manifestations of APS are present or if they have SLE. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/31/23034?source=see_link\">",
"     \"Clinical manifestations of the antiphospholipid syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Thrombus formation, infarction, and vasculopathy are assumed to account for many of the clinical manifestations of the APS, but additional factors, such as direct effects on trophoblast and complement activation, may also play a role in adverse pregnancy outcomes. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Pathogenesis of adverse pregnancy outcome'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest that patients with the following pregnancy complications be tested for the presence of LA and aCL antibodies:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      One or more fetal losses after 10 weeks of gestation",
"     </li>",
"     <li>",
"      Three or more miscarriages before 10 weeks of gestation",
"     </li>",
"     <li>",
"      Unexplained intrauterine growth restriction",
"     </li>",
"     <li>",
"      Early, severe preeclampsia",
"     </li>",
"     <li>",
"      Pregnancy-related maternal thrombosis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    (See",
"    <a class=\"local\" href=\"#H14\">",
"     'When to evaluate for antiphospholipid antibodies'",
"    </a>",
"    above.)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/1\">",
"      Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/2\">",
"      Giannakopoulos B, Passam F, Ioannou Y, Krilis SA. How we diagnose the antiphospholipid syndrome. Blood 2009; 113:985.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/3\">",
"      Branch DW, Dudley DJ, Mitchell MD, et al. Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB/c mice: a model for autoimmune fetal loss. Am J Obstet Gynecol 1990; 163:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/4\">",
"      Out HJ, Kooijman CD, Bruinse HW, Derksen RH. Histopathological findings in placentae from patients with intra-uterine fetal death and anti-phospholipid antibodies. Eur J Obstet Gynecol Reprod Biol 1991; 41:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/5\">",
"      De Wolf F, Carreras LO, Moerman P, et al. Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant. Am J Obstet Gynecol 1982; 142:829.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/6\">",
"      Ogishima D, Matsumoto T, Nakamura Y, et al. Placental pathology in systemic lupus erythematosus with antiphospholipid antibodies. Pathol Int 2000; 50:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/7\">",
"      Fishman P, Falach-Vaknine E, Zigelman R, et al. Prevention of fetal loss in experimental antiphospholipid syndrome by in vivo administration of recombinant interleukin-3. J Clin Invest 1993; 91:1834.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/8\">",
"      Cosgriff TM, Martin BA. Low functional and high antigenic antithrombin III level in a patient with the lupus anticoagulant and recurrent thrombosis. Arthritis Rheum 1981; 24:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/9\">",
"      Malia RG, Kitchen S, Greaves M, Preston FE. Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies. Br J Haematol 1990; 76:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/10\">",
"      P&ouml;tzsch B, Kawamura H, Preissner KT, et al. Acquired protein C dysfunction but not decreased activity of thrombomodulin is a possible marker of thrombophilia in patients with lupus anticoagulant. J Lab Clin Med 1995; 125:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/11\">",
"      Cariou R, Tobelem G, Bellucci S, et al. Effect of lupus anticoagulant on antithrombogenic properties of endothelial cells--inhibition of thrombomodulin-dependent protein C activation. Thromb Haemost 1988; 60:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/12\">",
"      Rand JH, Wu XX, Guller S, et al. Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion. Am J Obstet Gynecol 1994; 171:1566.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/13\">",
"      Rand JH, Wu XX, Guller S, et al. Antiphospholipid immunoglobulin G antibodies reduce annexin-V levels on syncytiotrophoblast apical membranes and in culture media of placental villi. Am J Obstet Gynecol 1997; 177:918.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/14\">",
"      Rand JH, Wu XX, Andree HA, et al. Pregnancy loss in the antiphospholipid-antibody syndrome--a possible thrombogenic mechanism. N Engl J Med 1997; 337:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/15\">",
"      Krikun G, Lockwood CJ, Wu XX, et al. The expression of the placental anticoagulant protein, annexin V, by villous trophoblasts: immunolocalization and in vitro regulation. Placenta 1994; 15:601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/16\">",
"      Rand JH, Arslan AA, Wu XX, et al. Reduction of circulating annexin A5 levels and resistance to annexin A5 anticoagulant activity in women with recurrent spontaneous pregnancy losses. Am J Obstet Gynecol 2006; 194:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/17\">",
"      R&ouml;misch J, Schorlemmer U, Fickenscher K, et al. Anticoagulant properties of placenta protein 4 (annexin V). Thromb Res 1990; 60:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/18\">",
"      Tait JF, Gibson D, Fujikawa K. Phospholipid binding properties of human placental anticoagulant protein-I, a member of the lipocortin family. J Biol Chem 1989; 264:7944.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/19\">",
"      Redecha P, van Rooijen N, Torry D, Girardi G. Pravastatin prevents miscarriages in mice: role of tissue factor in placental and fetal injury. Blood 2009; 113:4101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/20\">",
"      Katsuragawa H, Rote NS, Inoue T, et al. Monoclonal antiphosphatidylserine antibody reactivity against human first-trimester placental trophoblasts. Am J Obstet Gynecol 1995; 172:1592.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/21\">",
"      Di Simone N, Raschi E, Testoni C, et al. Pathogenic role of anti-beta 2-glycoprotein I antibodies in antiphospholipid associated fetal loss: characterisation of beta 2-glycoprotein I binding to trophoblast cells and functional effects of anti-beta 2-glycoprotein I antibodies in vitro. Ann Rheum Dis 2005; 64:462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/22\">",
"      Redecha P, Tilley R, Tencati M, et al. Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody induced fetal injury. Blood 2007; 110:2423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/23\">",
"      Sthoeger ZM, Mozes E, Tartakovsky B. Anti-cardiolipin antibodies induce pregnancy failure by impairing embryonic implantation. Proc Natl Acad Sci U S A 1993; 90:6464.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/24\">",
"      Cervera R, Balasch J. Autoimmunity and recurrent pregnancy losses. Clin Rev Allergy Immunol 2010; 39:148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/25\">",
"      Holers VM, Girardi G, Mo L, et al. Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J Exp Med 2002; 195:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/26\">",
"      Shamonki JM, Salmon JE, Hyjek E, Baergen RN. Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies. Am J Obstet Gynecol 2007; 196:167.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/27\">",
"      Tincani A, Cavazzana I, Ziglioli T, et al. Complement activation and pregnancy failure. Clin Rev Allergy Immunol 2010; 39:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/28\">",
"      Cohen D, Buurma A, Goemaere NN, et al. Classical complement activation as a footprint for murine and human antiphospholipid antibody-induced fetal loss. J Pathol 2011; 225:502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/29\">",
"      Girardi G. Role of tissue factor in the maternal immunological attack of the embryo in the antiphospholipid syndrome. Clin Rev Allergy Immunol 2010; 39:160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/30\">",
"      Di Simone N, De Carolis S, Lanzone A, et al. In vitro effect of antiphospholipid antibody-containing sera on basal and gonadotrophin releasing hormone-dependent human chorionic gonadotrophin release by cultured trophoblast cells. Placenta 1995; 16:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/31\">",
"      Di Simone N, Ferrazzani S, Castellani R, et al. Heparin and low-dose aspirin restore placental human chorionic gonadotrophin secretion abolished by antiphospholipid antibody-containing sera. Hum Reprod 1997; 12:2061.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/32\">",
"      Di Simone N, Caliandro D, Castellani R, et al. Low-molecular weight heparin restores in-vitro trophoblast invasiveness and differentiation in presence of immunoglobulin G fractions obtained from patients with antiphospholipid syndrome. Hum Reprod 1999; 14:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/33\">",
"      Robertson L, Wu O, Langhorne P, et al. Thrombophilia in pregnancy: a systematic review. Br J Haematol 2006; 132:171.",
"     </a>",
"    </li>",
"    <li>",
"     Pericleous, C, Rahman, A, Giles, I. Do antiphospholipid antibodies have direct pathologic effects upon endometrial and trophoblast cells? Curr Rheumatol Rep 2009. [Epub ahead of print].",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/35\">",
"      Blank M, Cohen J, Toder V, Shoenfeld Y. Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. Proc Natl Acad Sci U S A 1991; 88:3069.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/36\">",
"      Kutteh WH. Antiphospholipid antibodies and reproduction. J Reprod Immunol 1997; 35:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/37\">",
"      Polzin WJ, Kopelman JN, Robinson RD, et al. The association of antiphospholipid antibodies with pregnancies complicated by fetal growth restriction. Obstet Gynecol 1991; 78:1108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/38\">",
"      Harris EN, Spinnato JA. Should anticardiolipin tests be performed in otherwise healthy pregnant women? Am J Obstet Gynecol 1991; 165:1272.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/39\">",
"      Infante-Rivard C, David M, Gauthier R, Rivard GE. Lupus anticoagulants, anticardiolipin antibodies, and fetal loss. A case-control study. N Engl J Med 1991; 325:1063.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/40\">",
"      Lockwood CJ, Romero R, Feinberg RF, et al. The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. Am J Obstet Gynecol 1989; 161:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/41\">",
"      Petri M. Diagnosis of antiphospholipid antibodies. Rheum Dis Clin North Am 1994; 20:443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/42\">",
"      Parke AL, Wilson D, Maier D. The prevalence of antiphospholipid antibodies in women with recurrent spontaneous abortion, women with successful pregnancies, and women who have never been pregnant. Arthritis Rheum 1991; 34:1231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/43\">",
"      Petri M, Golbus M, Anderson R, et al. Antinuclear antibody, lupus anticoagulant, and anticardiolipin antibody in women with idiopathic habitual abortion. A controlled, prospective study of forty-four women. Arthritis Rheum 1987; 30:601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/44\">",
"      Haddow JE, Rote NS, Dostal-Johnson D, et al. Lack of an association between late fetal death and antiphospholipid antibody measurements in the second trimester. Am J Obstet Gynecol 1991; 165:1308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/45\">",
"      American College of Obstetricians and Gynecologists Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin No. 118: Antiphospholipid syndrome. Obstet Gynecol 2011; 117:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/46\">",
"      Oshiro BT, Silver RM, Scott JR, et al. Antiphospholipid antibodies and fetal death. Obstet Gynecol 1996; 87:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/47\">",
"      Roqu&eacute; H, Paidas MJ, Funai EF, et al. Maternal thrombophilias are not associated with early pregnancy loss. Thromb Haemost 2004; 91:290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/48\">",
"      Mekinian A, Lachassinne E, Nicaise-Roland P, et al. European registry of babies born to mothers with antiphospholipid syndrome. Ann Rheum Dis 2013; 72:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/49\">",
"      Stern C, Chamley L, Norris H, et al. A randomized, double-blind, placebo-controlled trial of heparin and aspirin for women with in vitro fertilization implantation failure and antiphospholipid or antinuclear antibodies. Fertil Steril 2003; 80:376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/50\">",
"      Porter TF. Antiphospholipid antibodies and infertility. Clin Obstet Gynecol 2001; 44:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/51\">",
"      Hornstein MD. Antiphospholipid antibodies in patients undergoing IVF: the data do not support testing. Fertil Steril 2000; 74:635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/52\">",
"      Cervera R, Balasch J. Bidirectional effects on autoimmunity and reproduction. Hum Reprod Update 2008; 14:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/53\">",
"      Bellver J, Pellicer A. Ovarian stimulation for ovulation induction and in vitro fertilization in patients with systemic lupus erythematosus and antiphospholipid syndrome. Fertil Steril 2009; 92:1803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/54\">",
"      Stern C, Chamley L, Hale L, et al. Antibodies to beta2 glycoprotein I are associated with in vitro fertilization implantation failure as well as recurrent miscarriage: results of a prevalence study. Fertil Steril 1998; 70:938.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/55\">",
"      Hornstein MD, Davis OK, Massey JB, et al. Antiphospholipid antibodies and in vitro fertilization success: a meta-analysis. Fertil Steril 2000; 73:330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/56\">",
"      Bramham K, Hunt BJ, Germain S, et al. Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome. Lupus 2010; 19:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/57\">",
"      Rai RS, Clifford K, Cohen H, Regan L. High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies. Hum Reprod 1995; 10:3301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/58\">",
"      Opatrny L, David M, Kahn SR, et al. Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: a metaanalysis. J Rheumatol 2006; 33:2214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/59\">",
"      Loizou S, Byron MA, Englert HJ, et al. Association of quantitative anticardiolipin antibody levels with fetal loss and time of loss in systemic lupus erythematosus. Q J Med 1988; 68:525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/60\">",
"      McNeil HP, Chesterman CN, Krilis SA. Immunology and clinical importance of antiphospholipid antibodies. Adv Immunol 1991; 49:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/61\">",
"      Geis W, Branch DW. Obstetric implications of antiphospholipid antibodies: pregnancy loss and other complications. Clin Obstet Gynecol 2001; 44:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/62\">",
"      Chauleur C, Galanaud JP, Alonso S, et al. Observational study of pregnant women with a previous spontaneous abortion before the 10th gestation week with and without antiphospholipid antibodies. J Thromb Haemost 2010; 8:699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/63\">",
"      Backos M, Rai R, Regan L. Antiphospholipid antibodies and infertility. Hum Fertil (Camb) 2002; 5:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/64\">",
"      Rodesch F, Simon P, Donner C, Jauniaux E. Oxygen measurements in endometrial and trophoblastic tissues during early pregnancy. Obstet Gynecol 1992; 80:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/65\">",
"      Jaffe R. Investigation of abnormal first-trimester gestations by color Doppler imaging. J Clin Ultrasound 1993; 21:521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/66\">",
"      Yasuda M, Takakuwa K, Tokunaga A, Tanaka K. Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy. Obstet Gynecol 1995; 86:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/67\">",
"      Lima F, Khamashta MA, Buchanan NM, et al. A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin Exp Rheumatol 1996; 14:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/68\">",
"      Branch DW, Silver RM, Blackwell JL, et al. Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet Gynecol 1992; 80:614.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/69\">",
"      do Prado AD, Piovesan DM, Staub HL, Horta BL. Association of anticardiolipin antibodies with preeclampsia: a systematic review and meta-analysis. Obstet Gynecol 2010; 116:1433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/70\">",
"      Alsulyman OM, Castro MA, Zuckerman E, et al. Preeclampsia and liver infarction in early pregnancy associated with the antiphospholipid syndrome. Obstet Gynecol 1996; 88:644.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/71\">",
"      Le Thi Thuong D, Tieuli&eacute; N, Costedoat N, et al. The HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 cases in 15 women. Ann Rheum Dis 2005; 64:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/72\">",
"      Branch DW, Porter TF, Rittenhouse L, et al. Antiphospholipid antibodies in women at risk for preeclampsia. Am J Obstet Gynecol 2001; 184:825.",
"     </a>",
"    </li>",
"    <li>",
"     American College of Obstetricians and Gynecologists. Antiphospholipid syndrome. ACOG educational bulletin 244. ACOG 1998; Washington, DC.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/74\">",
"      Bates SM, Greer IA, Middeldorp S, et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141:e691S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/75\">",
"      Appenzeller S, Souza FH, Wagner Silva de Souza A, et al. HELLP syndrome and its relationship with antiphospholipid syndrome and antiphospholipid antibodies. Semin Arthritis Rheum 2011; 41:517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/76\">",
"      Montaruli B, Borchiellini A, Tamponi G, et al. Factor V Arg506--&gt;Gln mutation in patients with antiphospholipid antibodies. Lupus 1996; 5:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/77\">",
"      Long AA, Ginsberg JS, Brill-Edwards P, et al. The relationship of antiphospholipid antibodies to thromboembolic disease in systemic lupus erythematosus: a cross-sectional study. Thromb Haemost 1991; 66:520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/78\">",
"      Silver RM, Draper ML, Scott JR, et al. Clinical consequences of antiphospholipid antibodies: an historic cohort study. Obstet Gynecol 1994; 83:372.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/79\">",
"      Lynch A, Marlar R, Murphy J, et al. Antiphospholipid antibodies in predicting adverse pregnancy outcome. A prospective study. Ann Intern Med 1994; 120:470.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/80\">",
"      Tincani A, Rebaioli CB, Andreoli L, et al. Neonatal effects of maternal antiphospholipid syndrome. Curr Rheumatol Rep 2009; 11:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/81\">",
"      Motta M, Chirico G, Rebaioli CB, et al. Anticardiolipin and anti-beta2 glycoprotein I antibodies in infants born to mothers with antiphospholipid antibody-positive autoimmune disease: a follow-up study. Am J Perinatol 2006; 23:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/82\">",
"      Pollard JK, Scott JR, Branch DW. Outcome of children born to women treated during pregnancy for the antiphospholipid syndrome. Obstet Gynecol 1992; 80:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/83\">",
"      Botet F, Romera G, Montagut P, et al. Neonatal outcome in women treated for the antiphospholipid syndrome during pregnancy. J Perinat Med 1997; 25:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/84\">",
"      Ruffatti A, Dalla Barba B, Del Ross T, et al. Outcome of fifty-five newborns of antiphospholipid antibody-positive mothers treated with calcium heparin during pregnancy. Clin Exp Rheumatol 1998; 16:605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/85\">",
"      Brewster JA, Shaw NJ, Farquharson RG. Neonatal and pediatric outcome of infants born to mothers with antiphospholipid syndrome. J Perinat Med 1999; 27:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/86\">",
"      Tincani A, Lojacono A, Taglietti M, et al. Pregnancy and neonatal outcome in primary antiphospholipid syndrome. Lupus 2002; 11:649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/87\">",
"      Boffa MC, Lachassinne E. Infant perinatal thrombosis and antiphospholipid antibodies: a review. Lupus 2007; 16:634.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41000/abstract/88\">",
"      Committee on Practice Bulletins&mdash;Obstetrics, American College of Obstetricians and Gynecologists. Practice Bulletin No. 132: Antiphospholipid syndrome. Obstet Gynecol 2012; 120:1514.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6813 Version 15.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-210.101.131.232-6DA085BC69-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_2_41000=[""].join("\n");
var outline_f40_2_41000=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H15\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOGENESIS OF ADVERSE PREGNANCY OUTCOME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13613276\">",
"      PREVALENCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      OBSTETRICAL OUTCOMES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Definitions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Adverse outcomes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Difficulties with causality",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Recurrent abortion and fetal loss",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Fetal growth restriction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Preeclampsia/HELLP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Maternal thrombosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Risk in unselected populations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      NEONATAL APS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      WHEN TO EVALUATE FOR ANTIPHOSPHOLIPID ANTIBODIES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/31/23034?source=related_link\">",
"      Clinical manifestations of the antiphospholipid syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/27/39353?source=related_link\">",
"      Deep vein thrombosis and pulmonary embolism in pregnancy: Epidemiology, pathogenesis, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/6/8298?source=related_link\">",
"      Definition and etiology of recurrent pregnancy loss",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/29/27096?source=related_link\">",
"      Diagnosis of the antiphospholipid syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/5/26714?source=related_link\">",
"      Inherited thrombophilias in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/31/13814?source=related_link\">",
"      Long-term complications of the premature infant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/0/44041?source=related_link\">",
"      Management of pregnant women with antiphospholipid antibodies or the antiphospholipid syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/16/35081?source=related_link\">",
"      Pathogenesis of the antiphospholipid syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/40/41609?source=related_link\">",
"      Prevention of preeclampsia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/15/31992?source=related_link\">",
"      Short-term complications of the premature infant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/12/23754?source=related_link\">",
"      Treatment of the antiphospholipid syndrome",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_2_41001="Measurement of prostate specific antigen";
var content_f40_2_41001=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Measurement of prostate specific antigen",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/2/41001/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/2/41001/contributors\">",
"     Stephen Freedland, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/2/41001/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/2/41001/contributors\">",
"     Michael P O'Leary, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/2/41001/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/2/41001/contributors\">",
"     David M Rind, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?40/2/41001/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 11, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prostate specific antigen (PSA) is a glycoprotein that is expressed by both normal and neoplastic prostate tissue. PSA is consistently expressed in nearly all prostate cancers, although its level of expression on a per cell basis, especially in very poorly differentiated prostate cancers, is lower than in normal prostate epithelium. The absolute value of serum PSA is useful for determining the extent of prostate cancer and assessing the response to prostate cancer treatment; its use as a screening method to detect prostate cancer is also common, although controversial. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/16/36101?source=see_link\">",
"     \"Clinical presentation and diagnosis of prostate cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/8/42122?source=see_link\">",
"     \"Screening for prostate cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The measurement of PSA, causes of abnormal values, and advances in PSA testing will be reviewed here. Recommendations for the clinical use of PSA testing in screening for prostate cancer are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/8/42122?source=see_link\">",
"     \"Screening for prostate cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PSA EXPRESSION AND PROCESSING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Under normal conditions, PSA is produced as a proenzyme (proPSA) by the secretory cells that line the prostate glands (acini) and secreted into the lumen, where the propeptide is removed to generate active PSA. The active PSA can then undergo proteolysis to generate inactive PSA, of which a small portion then enters the bloodstream and circulates in an unbound state (free PSA). Alternatively, active PSA can diffuse directly into the circulation where it is rapidly bound by protease inhibitors, including alpha-1-antichymotrypsin (ACT) and alpha-2-macroglobulin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although generating less PSA per cell than normal tissue, prostate cancer lacks basal cells, resulting in the disruption of the basement membrane and normal lumen architecture. As a result, the secreted proPSA and several truncated forms have direct access to the circulation resulting in more PSA &ldquo;leaked&rdquo; into the blood and a larger fraction of the PSA produced by malignant tissue escapes proteolytic processing (ie, activation of proPSA to active PSA and degradation of active PSA to inactive PSA).",
"   </p>",
"   <p>",
"    In men with a normal prostate (ie, no cancer and no major",
"    <span class=\"nowrap\">",
"     inflammation/infection),",
"    </span>",
"    the majority of free PSA in the serum reflects the mature protein that has been inactivated by internal proteolytic cleavage. In contrast, this cleaved fraction is relatively decreased in prostate cancer. Thus, the percentage of free or unbound PSA is lower in the serum of men with prostate cancer (and conversely, the amount of complexed PSA is higher) compared with those who have a normal prostate or BPH [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/3-6\">",
"     3-6",
"    </a>",
"    ]. This finding has been exploited in the use of the ratio of free to total PSA and complexed PSA (cPSA) as a means of distinguishing between prostate cancer and BPH as a cause of an elevated PSA. (See",
"    <a class=\"local\" href=\"#H18\">",
"     'Serum free and bound PSA'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H19\">",
"     'Complexed PSA'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PSA MEASUREMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of assays are available to measure serum PSA; although the exact value that is considered \"abnormal\" is highly controversial, historically a concentration above 4",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    was considered abnormal in most. (We describe PSA values in",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    throughout this topic, but this is equivalent to the SI units of",
"    <span class=\"nowrap\">",
"     mcg/L;",
"    </span>",
"    that is, 4",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    = 4",
"    <span class=\"nowrap\">",
"     mcg/L.)",
"    </span>",
"    Although concerns have been raised regarding calibration of the various assays, this is of little clinical relevance, except that it makes it more difficult to interpret subtle changes in PSA over time (ie, PSA velocity) when those changes involve PSA values that were measured using different assays [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/7,8\">",
"     7,8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Age-specific reference ranges",
"    </span>",
"    &nbsp;&mdash;&nbsp;In men without prostate cancer, serum PSA reflects the amount of glandular epithelium, which in turn reflects prostate size. Thus as prostate size increases with increasing age, the PSA concentration also rises; it increases at a faster rate in elderly men [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/9\">",
"     9",
"    </a>",
"    ]. In one study of 471 men, the serum PSA concentration increased by approximately 3.2 percent (0.04",
"    <span class=\"nowrap\">",
"     ng/mL)",
"    </span>",
"    per year for a healthy 60-year-old [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/10\">",
"     10",
"    </a>",
"    ]. As a result, different normal reference ranges may be appropriate based upon a man's age. The following ranges have been suggested:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      40 to 49 years-old &mdash; 0 to 2.5",
"      <span class=\"nowrap\">",
"       ng/mL",
"      </span>",
"     </li>",
"     <li>",
"      50 to 59 years-old &mdash; 0 to 3.5",
"      <span class=\"nowrap\">",
"       ng/mL",
"      </span>",
"     </li>",
"     <li>",
"      60 to 69 years-old &mdash; 0 to 4.5",
"      <span class=\"nowrap\">",
"       ng/mL",
"      </span>",
"     </li>",
"     <li>",
"      70 to 79 years-old &mdash; 0 to 6.5",
"      <span class=\"nowrap\">",
"       ng/mL",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These age-specific reference ranges have been proposed as a means of improving specificity and positive predictive value of the serum PSA in screening for prostate cancer. However, it should be recognized that the use of a higher upper range of normal for older men reduces the sensitivity of serum PSA testing for the detection of early prostate cancer, while increasing specificity. Whether these higher cutoffs should be used, which could result in missing clinically significant cancers in older men, remains controversial; although there is increasing evidence suggesting PSA-based screening may be beneficial for some, this remains a highly controversial area (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/8/42122?source=see_link\">",
"     \"Screening for prostate cancer\"",
"    </a>",
"    ). The best cutoff to separate cancer from benign causes of elevated PSA remains hotly debated. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/8/42122?source=see_link&amp;anchor=H15#H15\">",
"     \"Screening for prostate cancer\", section on 'Age-specific reference ranges'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Race-specific normal ranges",
"    </span>",
"    &nbsp;&mdash;&nbsp;Men without cancer from different ethnic and racial groups have different average PSA concentrations. In particular, black men without prostate cancer tend to have higher PSA values than white men without prostate cancer. It has been proposed that the definition of a \"normal\" PSA should vary by race using race-specific reference ranges [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/11\">",
"     11",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      40 to 49 years-old &mdash; 0 to 2.0",
"      <span class=\"nowrap\">",
"       ng/mL",
"      </span>",
"      (blacks); 0 to 2.5 (whites)",
"     </li>",
"     <li>",
"      50 to 59 years-old &mdash; 0 to 4.0",
"      <span class=\"nowrap\">",
"       ng/mL",
"      </span>",
"      (blacks); 0 to 3.5 (whites)",
"     </li>",
"     <li>",
"      60 to 69 years-old &mdash; 0 to 4.5",
"      <span class=\"nowrap\">",
"       ng/mL",
"      </span>",
"      (blacks); 0 to 3.5 (whites)",
"     </li>",
"     <li>",
"      70 to 79 years-old &mdash; 0 to 5.5",
"      <span class=\"nowrap\">",
"       ng/mL",
"      </span>",
"      (blacks); 0 to 3.5 (whites)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, the utility of race-specific normal reference ranges remains unclear and they are not commonly used in clinical practice. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/8/42122?source=see_link&amp;anchor=H16#H16\">",
"     \"Screening for prostate cancer\", section on 'Race-specific reference ranges'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Other effects on normal range",
"    </span>",
"    &nbsp;&mdash;&nbsp;Weight appears to be associated with PSA concentration. In population-based studies of men without prostate cancer, increasing body mass index (BMI) is associated with a lower mean PSA concentration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/12-15\">",
"     12-15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One study looked at PSA concentration, total mass of PSA in the blood (ie, the amount of PSA calculated as PSA concentration multiplied by plasma volume), and plasma volume in three separate cohorts totaling nearly 14,000 men, all with early stage prostate cancer treated by radical prostatectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/16\">",
"     16",
"    </a>",
"    ]. The study found that although men with higher BMI had lower PSA concentrations, they had a similar amount of circulating PSA mass as men with lower BMI [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/16\">",
"     16",
"    </a>",
"    ]. Thus, the lower PSA concentrations in men with higher BMI (up to 20 percent lower in very obese men) may have been due to increased plasma volume in men with higher BMI leading to hemodilution of the PSA.",
"   </p>",
"   <p>",
"    The implications of this observation for screening men with a high BMI are uncertain, but it is possible that the normal PSA range should be lower in men with a high BMI.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Medications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several classes of medication may affect serum PSA levels:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      5-alpha-reductase Inhibitors &mdash;",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?38/24/39301?source=see_link\">",
"       Finasteride",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?35/33/36372?source=see_link\">",
"       dutasteride",
"      </a>",
"      , inhibitors of 5-alpha-reductase, produce an approximately 50 percent or greater decrease in serum PSA during the first three to six months of therapy, which persists as long as the drug is continued. This is probably due to direct interference by these drugs with the prostatic intracellular androgen response mechanism [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/17\">",
"       17",
"      </a>",
"      ], although these agents actually reduce prostate size which likely contributes to the lower PSA levels as well. Thus, the appropriate serum PSA reference range for men receiving finasteride or dutasteride needs to be adjusted [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/18\">",
"       18",
"      </a>",
"      ]. Even the doses used to treat male pattern baldness (eg, 1 mg daily of finasteride versus 5 mg daily for BPH) result in similar declines in PSA such that the PSA reference range will also need to be adjusted [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/19\">",
"       19",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Longitudinal results from the Prostate Cancer Prevention Trial suggest that PSA values should be corrected by a factor of 2 for the first two years of finasteride therapy and by 2.5 for longer term use [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/20\">",
"       20",
"      </a>",
"      ]. However, it is important to note that an average drop in PSA of 50 percent means that half the men have PSA values that fall by less than 50 percent, and thus simply doubling the PSA (by multiplying the pre-finasteride baseline by two) would result in an apparent increase in PSA values for half the men. There is increasing interest in examining change in PSA in men on finasteride or dutasteride. An analysis from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) trial found that after establishing a new baseline six months after starting dutasteride, any rise from that point forward was associated with a higher risk of prostate cancer or high-grade prostate cancer compared to men in whom the PSA did not rise from the new baseline [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/21,22\">",
"       21,22",
"      </a>",
"      ]. These results suggest that any rising PSA on dutasteride should prompt further evaluation. Whether these data apply equally to finasteride is unclear, and it is also uncertain whether the correction factor for finasteride applies to dutasteride. However, given the similar mechanisms of action, it seems prudent to evaluate PSA similarly in patients on either medication. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?8/31/8698?source=see_link\">",
"       \"Medical treatment of benign prostatic hyperplasia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      NSAIDs and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?15/27/15802?source=see_link\">",
"       acetaminophen",
"      </a>",
"      &mdash; In a population-based study of 1319 men, those who were regularly taking non-steroidal antiinflammatory drugs (NSAIDs) or acetaminophen had lower PSA levels (0.10",
"      <span class=\"nowrap\">",
"       ng/mL",
"      </span>",
"      and 0.28",
"      <span class=\"nowrap\">",
"       ng/mL",
"      </span>",
"      respectively, compared with men taking neither drug) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/23\">",
"       23",
"      </a>",
"      ]. There were few men regularly taking acetaminophen and only the results for NSAIDs were statistically significant. The link between lower PSA and NSAIDs was further validated in a separate study of 1864 men [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/24\">",
"       24",
"      </a>",
"      ]. This latter study also found that longer duration of NSAID use was associated with even lower PSA values. The degree to which this may alter PSA screening remains to be determined. The mechanism through which this might occur is not known, although it could relate to the antiinflammatory properties of these agents.",
"     </li>",
"     <li>",
"      Statins &mdash; A study in 1214 men found that median PSA levels dropped by 4.1 percent over approximately one year after starting a statin medication compared to the natural history of PSA to rise by 3.2 percent per year [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/25\">",
"       25",
"      </a>",
"      ]. The decline in PSA was correlated with the decline in LDL-cholesterol (LDL-C), with greater LDL-C declines being associated with greater PSA declines. This drop in PSA was also correlated with the dose of statin given and the baseline starting PSA. As an example, men with a baseline PSA &gt;2.5",
"      <span class=\"nowrap\">",
"       ng/ml,",
"      </span>",
"      who were in the quartile with the greatest decrease in LDL-C (&gt;41 percent) experienced a median 17.4 percent decline in PSA. These results have subsequently been validated in several studies [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/24,26\">",
"       24,26",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Thiazides &ndash; A cross-sectional study of 1864 men found that thiazide diuretic use was associated with lower PSA levels [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/24\">",
"       24",
"      </a>",
"      ]. Longer-term use was associated with even lower PSA levels, with five years of use being associated with a 26 percent reduction in serum PSA levels. These results are preliminary.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Whether the relatively small changes in PSA with NSAIDs,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    , statins, and thiazides have clinical relevance is unknown. It is uncertain whether the reduction in PSA reflects an actual reduction in prostate cancer risk or rather an effect on PSA production that would alter the screening characteristics of PSA measurement. At the least, interim initiation of any of these medications may affect serial PSA measurement, and so should be taken into account when evaluating PSA changes over time.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Random variation",
"    </span>",
"    &nbsp;&mdash;&nbsp;PSA levels that are measured repeatedly over time may vary both because of imprecision in the analysis and biologic variability where the true PSA level in a given man is different on different measurements. This could potentially lead to an apparent rise in PSA level, when no actual rise had occurred.",
"   </p>",
"   <p>",
"    A study of prior PSA results in 3568 men with a PSA concentration below 2.0",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    during a fourth round of PSA screening estimated that the average analytic variation in PSA was about 6 percent and average biologic variation was less than 14 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/27\">",
"     27",
"    </a>",
"    ]. A change in PSA of more than 30 percent in men with a PSA initially below 2.0",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    was likely to indicate a true change beyond normal random variation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     CAUSES OF AN ELEVATED SERUM PSA",
"    </span>",
"    &nbsp;&mdash;&nbsp;The major causes of an elevated serum PSA include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Benign prostatic hyperplasia (BPH)",
"     </li>",
"     <li>",
"      Prostate cancer",
"     </li>",
"     <li>",
"      Prostatic",
"      <span class=\"nowrap\">",
"       inflammation/infection",
"      </span>",
"     </li>",
"     <li>",
"      Perineal trauma",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Benign prostatic hyperplasia",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common explanation for an elevated serum PSA is BPH because of the very high prevalence of this condition in men over the age of 50 (",
"    <a class=\"graphic graphic_figure graphicRef55614 \" href=\"mobipreview.htm?27/51/28477\">",
"     figure 1",
"    </a>",
"    ). BPH produces more PSA per gram than normal prostate tissue. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/19/34104?source=see_link\">",
"     \"Epidemiology and pathogenesis of benign prostatic hyperplasia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    One illustrative study compared 148 men with a serum PSA above 4.0",
"    <span class=\"nowrap\">",
"     ng/mL,",
"    </span>",
"    findings suspicious for cancer on digital rectal examination (DRE), and multiple negative biopsies, with 64 men who had a suspicious DRE, multiple negative biopsies, and a serum PSA of 4.0",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    or less [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/28\">",
"     28",
"    </a>",
"    ]. The higher PSA group had larger prostates (68 versus 33 mL), and a simultaneous regression analysis determined that prostate size accounted for 23 percent of the variance in serum PSA concentration.",
"   </p>",
"   <p>",
"    Serum PSA levels overlap considerably in men with BPH and those with prostate cancer. As an example, one report retrospectively examined preoperative serum PSA in 187 men with a histologic diagnosis of BPH on a transurethral resection of the prostate (TURP) specimen and 198 men with organ-confined prostate cancer as determined by step-section analysis of a radical prostatectomy specimen [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/29\">",
"     29",
"    </a>",
"    ]. The median serum PSA concentrations were 3.9 (range 0.2 to 55) and 5.9",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    (range 0.4 to 58), respectively. Although this difference was statistically significant, the distribution of serum PSA values in both groups overlapped considerably with a clustering of PSA values below 10.0",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    (90 and 73 percent, respectively).",
"   </p>",
"   <p>",
"    A potentially confounding problem is that medical treatment for BPH can reduce serum PSA concentrations. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Medications'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Prostate cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;Studies in the 1980s confirmed that serum total PSA could be used to identify men with prostate cancer. As a screening tool, serum PSA was clearly more sensitive than the DRE, but it lacked specificity. Furthermore, although the majority of prostate cancers express PSA, between 20 and 50 percent of men with newly diagnosed screen-detected prostate cancers in the United States have serum PSA values below 4.0",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/30-33\">",
"     30-33",
"    </a>",
"    ]. Those cancers that are detected at a time when the serum PSA is less than 4.0",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    are more likely to be organ confined than cancers detected at a time when the PSA level is &gt;4.0",
"    <span class=\"nowrap\">",
"     ng/mL,",
"    </span>",
"    and they have a better prognosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. A complete review of PSA testing for prostate cancer screening is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/8/42122?source=see_link\">",
"     \"Screening for prostate cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Prostatic inflammation and infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prostatitis with or without active infection is an important cause of an elevated PSA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/28,35-38\">",
"     28,35-38",
"    </a>",
"    ]; levels as high as 75",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    have been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/39\">",
"     39",
"    </a>",
"    ]. Thus, many physicians will initially treat a man with an isolated elevated serum PSA with antibiotics for a presumed diagnosis of prostatitis and then obtain a repeat serum PSA. One study tested this approach by randomly assigning 216 men with either a positive (n = 108) or negative (n = 108) expressed prostate secretion culture to antibiotics, anti-inflammatory drugs, or a control group [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/40\">",
"     40",
"    </a>",
"    ]. Only in the group of men with a positive culture assigned to antibiotics did the PSA decrease. Thus, for men with a negative culture, antibiotics had no effect on PSA. Likewise, anti-inflammatory drugs had no effect on PSA regardless of the culture results. These findings support the observation that a reduction in PSA levels can be expected if prostatitis with infection was solely responsible; however, prostatitis can often exist without active infection, in which case the PSA will not uniformly normalize. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/42/4776?source=see_link\">",
"     \"Acute bacterial prostatitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In one of the studies cited above, evaluating men with suspicious findings on DRE but with multiple negative prostate biopsies, both acute and chronic inflammation were more prevalent in those with a serum PSA &gt;4.0",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    compared with those with lower values (63 versus 27 percent and 99 versus 77 percent, respectively) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/28\">",
"     28",
"    </a>",
"    ]. The percent free PSA may be less affected by the presence of inflammation, particularly when the total serum PSA is less than 10",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/41\">",
"     41",
"    </a>",
"    ]. However, at least one study suggests that the free to total ratio of serum PSA is unable to distinguish chronic inflammation from prostate cancer, as both conditions lower the percentage of free PSA as would be expected in that inflammation leads to elevated serum PSA in a similar fashion as prostate cancer - through disruption of the basal membrane and increased leakage of \"immature\" PSA into the blood stream [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/42\">",
"     42",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H18\">",
"     'Serum free and bound PSA'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Perineal trauma and sexual activity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Any perineal trauma can increase the serum PSA. DRE may cause minor transient elevations that are clinically insignificant. As an example, one study of 2750 healthy men over the age of 40 undergoing DRE divided patients into four groups based upon their initial serum PSA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/43\">",
"     43",
"    </a>",
"    ]. The two groups with the lowest initial serum PSA values (0.1 to 4 and 4.1 to 10",
"    <span class=\"nowrap\">",
"     ng/mL)",
"    </span>",
"    had statistically insignificant changes in the serum PSA after DRE, while PSA increases in the group with an initial serum PSA 10.1 to 20",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    showed a trend toward statistical significance, and those with an initial serum PSA greater than 20",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    had statistically significant increases after DRE. The PSA increase in the two groups with the highest serum values was not clinically relevant, since they did not change ultimate management. Thus, it is reasonable to perform PSA testing without regard to whether a patient has had a recent DRE.",
"   </p>",
"   <p>",
"    A study of PSA measurements 30 minutes after one minute of prostatic massage found that massage increased total PSA and free PSA levels to a greater extent than complexed PSA levels [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/44\">",
"     44",
"    </a>",
"    ]. Thus, it is advisable to check PSA levels prior to performing a prostate massage.",
"   </p>",
"   <p>",
"    Mechanical manipulation of the prostate by cystoscopy, prostate biopsy, or TURP can more significantly affect the serum PSA. This was illustrated in a study of 101 men who underwent one of these procedures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/45\">",
"     45",
"    </a>",
"    ]. The median time required for the serum PSA to return to baseline after prostate biopsy was 15 days (range 5 to 21 days) and 17 days (range 3 to 30+ days) for men with and without prostate cancer, respectively, and 18 days (range 12 to 30+ days) for men who underwent TURP. The median change in serum PSA was of a lesser magnitude following flexible or rigid cystoscopy. Thus, a serum PSA determination after either a flexible or rigid cystoscopy is reliable, but a serum PSA determination should not be obtained for at least six weeks after either a prostate biopsy or TURP.",
"   </p>",
"   <p>",
"    Vigorous bicycle riding has been reported to cause substantial elevations in the serum PSA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/46\">",
"     46",
"    </a>",
"    ], but this is not a consistent finding [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/47,48\">",
"     47,48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Sexual activity can minimally elevate the PSA (usually in the 0.4 to 0.5",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    range) for approximately 48 to 72 hours after ejaculation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/49\">",
"     49",
"    </a>",
"    ]. We do not usually ask men to abstain from sexual activity prior to PSA measurement. However, if an initial measurement is high enough to potentially prompt an intervention (ie, biopsy), but close to a borderline value, it is not unreasonable to repeat the PSA measurement after having the man abstain from ejaculation for at least 48 hours. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/8/42122?source=see_link\">",
"     \"Screening for prostate cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although PSA has traditionally been thought to be prostate gland specific, some studies have documented the presence of PSA in the serum and tumors of women with breast cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/50,51\">",
"     50,51",
"    </a>",
"    ] and rarely other tumors, most notably salivary gland tumors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/52\">",
"     52",
"    </a>",
"    ]. The significance of this finding is unclear.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     ADVANCES IN PSA TESTING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Emerging concepts regarding PSA testing that may help refine the interpretation of an elevated concentration include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      PSA density",
"     </li>",
"     <li>",
"      PSA velocity",
"     </li>",
"     <li>",
"      Free versus complexed or bound PSA",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These modifications would presumably be most useful for prostate cancer screening when the total PSA is 2.5 to 10.0",
"    <span class=\"nowrap\">",
"     ng/mL,",
"    </span>",
"    the range in which decisions regarding further diagnostic testing are most difficult. However, in clinical practice, the use of these techniques is not consistent and remains debated. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/8/42122?source=see_link\">",
"     \"Screening for prostate cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     PSA density",
"    </span>",
"    &nbsp;&mdash;&nbsp;To more directly compensate for BPH and prostate size, transrectal ultrasound (TRUS) has been used to measure prostate volume. Serum PSA is then divided by prostate volume to give a PSA density, with higher PSA density values (greater than 0.15",
"    <span class=\"nowrap\">",
"     ng/mL/cc)",
"    </span>",
"    being more suggestive of prostate cancer while lower values are more suggestive of BPH [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/53,54\">",
"     53,54",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    While an early study suggested that PSA density was a promising method for distinguishing patients with benign and malignant prostate disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/53,55\">",
"     53,55",
"    </a>",
"    ], subsequent reports have found considerable overlap in PSA densities between these groups [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/56\">",
"     56",
"    </a>",
"    ]. One multicenter study that compared PSA density versus PSA for the early detection of prostate cancer found that almost one-half of the cancers would have been missed using 0.15",
"    <span class=\"nowrap\">",
"     ng/mL/cc",
"    </span>",
"    as a cutoff for biopsy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/57\">",
"     57",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Another report of 1809 men with untreated prostate disease found that the sensitivity of PSA density could improve with adjustment of the cutoff value for different ranges of total PSA (tPSA): 0.1",
"    <span class=\"nowrap\">",
"     ng/mL/cc",
"    </span>",
"    for tPSA 4 to 10",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    and 0.19",
"    <span class=\"nowrap\">",
"     ng/mL/cc",
"    </span>",
"    for tPSA 10 to 20",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/58\">",
"     58",
"    </a>",
"    ]. In this cohort, 111 of 401 men (27.7 percent) with tPSA in the 2 to 4",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    range had prostate cancer. PSA density measurement performed better than free PSA measurement (see below) in identifying cancer in patients with tPSA in the 2 to 4",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    range. This was not a screening study, and the applicability of PSA density determinations for asymptomatic men with screening tPSA in the 2 to 4",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    range is questionable.",
"   </p>",
"   <p>",
"    There are inherent difficulties in measuring PSA density, which include errors of prostatic volume measurement with TRUS and an intrapatient variation of up to 15 percent in PSA density with repeated measurements [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/59\">",
"     59",
"    </a>",
"    ]. Furthermore, although PSA density can reliably differentiate between large groups of patients with BPH and prostate cancer, the ability to extrapolate these data to the individual patient is quite limited. Most importantly, the requirement for TRUS substantially increases cost and discomfort, and is impractical for widespread screening purposes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     PSA velocity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Another approach has been to assess the rate of PSA change over time (the PSA velocity). An elevated serum PSA that continues to rise over time is more likely to reflect prostate cancer than one that is consistently stable [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/60\">",
"     60",
"    </a>",
"    ]. In one study, a PSA velocity cutoff of 0.75",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    per year distinguished patients with prostate cancer from those with either BPH or no prostate disease with a specificity of 90 and 100 percent, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/61\">",
"     61",
"    </a>",
"    ]. A further study from the same group found that when PSA was &lt;4",
"    <span class=\"nowrap\">",
"     ng/mL,",
"    </span>",
"    a PSA velocity &gt;0.35",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    per year measured over several years was associated with a high risk of death from prostate cancer 15 years later [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/62\">",
"     62",
"    </a>",
"    ]. Similarly, another series of studies from a different group found that among men with prostate cancer, a PSA velocity &gt;2",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    per year in the year prior to diagnosis was associated with an increased risk of death from prostate cancer after radical prostatectomy or radiation therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/63,64\">",
"     63,64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A community-based study examined PSA velocity in 1851 men with a normal DRE who underwent prostate biopsy for an elevated PSA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/65\">",
"     65",
"    </a>",
"    ]. In this study, very high PSA velocities (above 3.0",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    per year) were associated with prostatic inflammation as the etiology of the elevated PSA, and thus a reduced risk of prostate cancer on biopsy.",
"   </p>",
"   <p>",
"    In practicality, the clinical usefulness of PSA velocity is in part limited by intrapatient variability in the serum PSA; at least three consecutive measurements should be performed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/66\">",
"     66",
"    </a>",
"    ]. A longer time over which values are measured can help reduce the general variation (ie, \"noise\") in the PSA measurements. Depending upon the magnitude of the abnormal serum PSA, it is likely that a patient with an initially abnormal level would undergo prostate biopsy before waiting for a second measurement to be performed one year later. Said in a different way, a rapid PSA velocity will quickly result in an abnormal PSA level, which would be further evaluated due the PSA elevation alone even in the absence of a rapid velocity. Furthermore, men with cancer often have a PSA velocity of less than 0.75",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    per year, especially those with lower PSA levels [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/67,68\">",
"     67,68",
"    </a>",
"    ]. Multivariate and receiver operator characteristic (ROC) analyses as well as a systematic review suggest that calculation of PSA velocity and PSA doubling time are of limited value in screening [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/69-72\">",
"     69-72",
"    </a>",
"    ], though some studies do suggest they may be useful in detecting the most aggressive cancers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/62\">",
"     62",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/8/42122?source=see_link&amp;anchor=H11#H11\">",
"     \"Screening for prostate cancer\", section on 'PSA velocity'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Serum free and bound PSA",
"    </span>",
"    &nbsp;&mdash;&nbsp;As noted previously, prostate cancer is associated with a lower percentage of free PSA in the serum as compared with benign conditions. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'PSA expression and processing'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The percentage of free PSA",
"    <span class=\"nowrap\">",
"     (f/t",
"    </span>",
"    PSA) has been used to improve the sensitivity of cancer detection when total PSA is in the normal range (&lt;4",
"    <span class=\"nowrap\">",
"     ng/mL)",
"    </span>",
"    and to increase the specificity of cancer detection when total PSA in the \"gray zone\" (4.1 to 10",
"    <span class=\"nowrap\">",
"     ng/mL).",
"    </span>",
"    In this latter group, the lower the value of",
"    <span class=\"nowrap\">",
"     f/t",
"    </span>",
"    PSA, the greater the likelihood that an elevated PSA represents cancer and not BPH. As an example, in one study of men with PSA values in this range, the probability of cancer in men with a",
"    <span class=\"nowrap\">",
"     f/t",
"    </span>",
"    PSA below 10 percent was 56 percent, compared with only 8 percent of men with a value &gt;25 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/73\">",
"     73",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As with PSA, there is no absolute",
"    <span class=\"nowrap\">",
"     f/t",
"    </span>",
"    cutoff that completely discriminates prostate cancer from BPH. The optimal cutoff value for",
"    <span class=\"nowrap\">",
"     f/t",
"    </span>",
"    PSA is unclear and depends upon whether optimal sensitivity or specificity is sought [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/74,75\">",
"     74,75",
"    </a>",
"    ]. The higher the cutoff value, the greater the sensitivity (ie, fewer cancers missed), but the lower the specificity (greater number of false positives). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/8/42122?source=see_link&amp;anchor=H13#H13\">",
"     \"Screening for prostate cancer\", section on 'Free PSA'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Free PSA may be useful for risk stratification in men with prostate cancer. A lower percentage of",
"    <span class=\"nowrap\">",
"     f/t",
"    </span>",
"    PSA may be associated with a more aggressive form of prostate cancer. This was illustrated in a study that examined banked frozen serum from 20 men with prostate cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/76\">",
"     76",
"    </a>",
"    ]. Ten years before the diagnosis of cancer, at a time when the total PSA was not different between those who ultimately developed aggressive versus nonaggressive tumors (aggressive defined by clinical stage T3 disease, nodal or bone metastases, pathologically positive margins, or Gleason score of 7 or greater), there was a statistically significant difference in the percentage of",
"    <span class=\"nowrap\">",
"     f/t",
"    </span>",
"    PSA between the two groups. All eight men with aggressive cancers had a",
"    <span class=\"nowrap\">",
"     f/t",
"    </span>",
"    PSA of &le;14 percent, compared with only two of six (33 percent) with nonaggressive cancer.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Complexed PSA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Considerable effort has been expended to develop assays for ACT-complexed PSA (cPSA); only recently has this been achieved [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/77-79\">",
"     77-79",
"    </a>",
"    ]. Such an assay would theoretically provide a similar enhanced degree of specificity as the",
"    <span class=\"nowrap\">",
"     f/t",
"    </span>",
"    PSA but require only the measurement of a single analyte. In addition to the obvious economic advantage, the variability associated with nonuniformity of different manufacturers' assays for total or",
"    <span class=\"nowrap\">",
"     f/t",
"    </span>",
"    PSA could be avoided.",
"   </p>",
"   <p>",
"    Most [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/80-86\">",
"     80-86",
"    </a>",
"    ], but not all [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/87-90\">",
"     87-90",
"    </a>",
"    ], reports suggest that cPSA outperforms both total PSA and the ratio of",
"    <span class=\"nowrap\">",
"     f/t",
"    </span>",
"    PSA, with similar sensitivity but a higher specificity. In one representative series, the diagnostic utility of the Bayer Immuno-One cPSA assay was compared with the Tandem R free and total PSA assay by using archival sera obtained from 300 men, 75 of whom had biopsy-confirmed prostate cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/80\">",
"     80",
"    </a>",
"    ]. When compared with total PSA (cutoff &ge;4.0",
"    <span class=\"nowrap\">",
"     ng/mL),",
"    </span>",
"    cPSA (cutoff 3.75",
"    <span class=\"nowrap\">",
"     ng/mL)",
"    </span>",
"    provided significantly higher specificity (48 versus 33 percent) with only a modest decrease in sensitivity (81 versus 83 percent). Although a higher specificity could be achieved with a 25 percent cutoff for",
"    <span class=\"nowrap\">",
"     f/t",
"    </span>",
"    PSA (44 percent), sensitivity was only 77 percent. Stated another way, if only cPSA were measured, one cancer would have been missed and 35 negative biopsies avoided, while in contrast, using a",
"    <span class=\"nowrap\">",
"     f/t",
"    </span>",
"    PSA cutoff of 25 percent, five cancers would have been missed and 25 biopsies avoided.",
"   </p>",
"   <p>",
"    For men with total PSA in the diagnostic gray zone (4.0 and 10.0",
"    <span class=\"nowrap\">",
"     ng/mL),",
"    </span>",
"    the use of cPSA alone would have missed one of the 36 men with cancer who would be identified using total PSA, and 34 biopsies could be avoided. By contrast,",
"    <span class=\"nowrap\">",
"     f/t",
"    </span>",
"    PSA alone would also have missed one cancer, but eliminated biopsy in only 20 men. The utility of cPSA in men with a lower total PSA (2 to 4",
"    <span class=\"nowrap\">",
"     ng/mL)",
"    </span>",
"    is under study; there are conflicting data as to whether cPSA improves specificity compared with",
"    <span class=\"nowrap\">",
"     f/t",
"    </span>",
"    PSA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/86,91\">",
"     86,91",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Others have not been able to show improved specificity from the use of cPSA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/87-90\">",
"     87-90",
"    </a>",
"    ]. In at least one case, the discrepancy might be explained by selection bias and the inability to demonstrate higher total PSA levels in men with malignancy compared with benign disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/87\">",
"     87",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Complexed PSA has been approved for the monitoring of men with prostatic carcinoma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/92\">",
"     92",
"    </a>",
"    ]. The utility of complexed PSA for screening is uncertain and is not routinely used in current practice; a multicenter screening trial is currently underway. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/8/42122?source=see_link&amp;anchor=H14#H14\">",
"     \"Screening for prostate cancer\", section on 'Complexed PSA'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2750833\">",
"    <span class=\"h2\">",
"     Percent [-2]proPSA",
"    </span>",
"    &nbsp;&mdash;&nbsp;As discussed above (see",
"    <a class=\"local\" href=\"#H2\">",
"     'PSA expression and processing'",
"    </a>",
"    above), PSA is initially produced as proPSA and this form can preferentially leak into the blood stream in men with prostate cancer. One specific isoform of proPSA is [-2]proPSA, which is unbound and potentially higher in men with prostate cancer. Based upon this observation, there has been growing interest in using the ratio of [-2]proPSA to free PSA (expressed as percent [-2]proPSA or %[-2]proPSA) for prostate cancer screening. One multicenter study of 566 men undergoing biopsy found that %[-2]proPSA significantly outperformed both total PSA and percent free PSA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/2/41001/abstract/93\">",
"     93",
"    </a>",
"    ]. At 80 percent sensitivity, %[-2]proPSA had 52 percent specificity, compared to 30 percent for PSA and 29 percent for percent free PSA. Percent [-2]proPSA is currently approved by the European Union for prostate cancer detection and is being evaluated in the United States by the Food and Drug Administration.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?15/21/15698?source=see_link\">",
"       \"Patient information: Benign prostatic hyperplasia (enlarged prostate) (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?31/27/32176?source=see_link\">",
"       \"Patient information: Prostate cancer screening (PSA tests) (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?27/51/28467?source=see_link\">",
"       \"Patient information: Benign prostatic hyperplasia (BPH) (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?37/55/38770?source=see_link\">",
"       \"Patient information: Prostate cancer screening (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serum prostate specific antigen (PSA) is a valuable marker for prostate cancer. However, its sensitivity and specificity are not perfect as a screening tool, although they are comparable to other cancer screening methods such as mammography.",
"   </p>",
"   <p>",
"    Age and race-specific PSA reference ranges, and perhaps BMI-specific reference ranges, may limit the number of false-negative biopsies but miss several clinically important cancers. The use of PSA density and PSA velocity to improve specificity has not been widely adopted due to methodologic difficulties, though there is currently much interest in PSA velocity as a means to detect aggressive cancers that are more likely to be life-threatening; and while it is being used clinically, the data remain mixed as to whether PSA velocity achieves those goals.",
"   </p>",
"   <p>",
"    One promising method to improve specificity of PSA testing for men who have total PSA values 4 to 10",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    and to improve sensitivity at levels below 4",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    is to include PSA isoforms such as the free to total PSA ratio, the amount of complexed PSA, and the %[-2]proPSA, with the last appearing to be the most promising. Additional prospective studies are needed to define the optimal cutoff points for these PSA derivatives in individual groups of men and their utility in risk assessment. However, the only modest improvements in sensitivity and specificity associated with these PSA isoforms has resulted in their limited use in general clinical practice to date, although free PSA is becoming more commonly used. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/8/42122?source=see_link\">",
"     \"Screening for prostate cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Recommendations for the clinical use of PSA testing in screening for prostate cancer are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/8/42122?source=see_link\">",
"     \"Screening for prostate cancer\"",
"    </a>",
"    .)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/1\">",
"      Lilja H, Christensson A, Dahl&eacute;n U, et al. Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin. Clin Chem 1991; 37:1618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/2\">",
"      Mikolajczyk SD, Marks LS, Partin AW, Rittenhouse HG. Free prostate-specific antigen in serum is becoming more complex. Urology 2002; 59:797.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/3\">",
"      Bj&ouml;rk T, Piironen T, Pettersson K, et al. Comparison of analysis of the different prostate-specific antigen forms in serum for detection of clinically localized prostate cancer. Urology 1996; 48:882.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/4\">",
"      Christensson A, Bj&ouml;rk T, Nilsson O, et al. Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer. J Urol 1993; 150:100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/5\">",
"      Partin AW, Hanks GE, Klein EA, et al. Prostate-specific antigen as a marker of disease activity in prostate cancer. Oncology (Williston Park) 2002; 16:1024.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/6\">",
"      Balk SP, Ko YJ, Bubley GJ. Biology of prostate-specific antigen. J Clin Oncol 2003; 21:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/7\">",
"      Coley CM, Barry MJ, Fleming C, Mulley AG. Early detection of prostate cancer. Part I: Prior probability and effectiveness of tests. The American College of Physicians. Ann Intern Med 1997; 126:394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/8\">",
"      Link RE, Shariat SF, Nguyen CV, et al. Variation in prostate specific antigen results from 2 different assay platforms: clinical impact on 2304 patients undergoing prostate cancer screening. J Urol 2004; 171:2234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/9\">",
"      Crawford ED. Prostate Cancer Awareness Week: September 22 to 28, 1997. CA Cancer J Clin 1997; 47:288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/10\">",
"      Oesterling JE, Jacobsen SJ, Chute CG, et al. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. JAMA 1993; 270:860.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/11\">",
"      Morgan TO, Jacobsen SJ, McCarthy WF, et al. Age-specific reference ranges for prostate-specific antigen in black men. N Engl J Med 1996; 335:304.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/12\">",
"      Baillargeon J, Pollock BH, Kristal AR, et al. The association of body mass index and prostate-specific antigen in a population-based study. Cancer 2005; 103:1092.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/13\">",
"      Werny DM, Thompson T, Saraiya M, et al. Obesity is negatively associated with prostate-specific antigen in U.S. men, 2001-2004. Cancer Epidemiol Biomarkers Prev 2007; 16:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/14\">",
"      Rundle A, Neugut AI. Obesity and screening PSA levels among men undergoing an annual physical exam. Prostate 2008; 68:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/15\">",
"      Beebe-Dimmer JL, Faerber GJ, Morgenstern H, et al. Body composition and serum prostate-specific antigen: review and findings from Flint Men's Health Study. Urology 2008; 71:554.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/16\">",
"      Ba&ntilde;ez LL, Hamilton RJ, Partin AW, et al. Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer. JAMA 2007; 298:2275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/17\">",
"      Wang LG, Liu XM, Kreis W, Budman DR. Down-regulation of prostate-specific antigen expression by finasteride through inhibition of complex formation between androgen receptor and steroid receptor-binding consensus in the promoter of the PSA gene in LNCaP cells. Cancer Res 1997; 57:714.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/18\">",
"      Guess HA, Gormley GJ, Stoner E, Oesterling JE. The effect of finasteride on prostate specific antigen: review of available data. J Urol 1996; 155:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/19\">",
"      D'Amico AV, Roehrborn CG. Effect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: a randomised controlled trial. Lancet Oncol 2007; 8:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/20\">",
"      Etzioni RD, Howlader N, Shaw PA, et al. Long-term effects of finasteride on prostate specific antigen levels: results from the prostate cancer prevention trial. J Urol 2005; 174:877.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/21\">",
"      Andriole GL, Bostwick D, Brawley OW, et al. The effect of dutasteride on the usefulness of prostate specific antigen for the diagnosis of high grade and clinically relevant prostate cancer in men with a previous negative biopsy: results from the REDUCE study. J Urol 2011; 185:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/22\">",
"      Marberger M, Freedland SJ, Andriole GL, et al. Usefulness of prostate-specific antigen (PSA) rise as a marker of prostate cancer in men treated with dutasteride: lessons from the REDUCE study. BJU Int 2012; 109:1162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/23\">",
"      Singer EA, Palapattu GS, van Wijngaarden E. Prostate-specific antigen levels in relation to consumption of nonsteroidal anti-inflammatory drugs and acetaminophen: results from the 2001-2002 National Health and Nutrition Examination Survey. Cancer 2008; 113:2053.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/24\">",
"      Chang SL, Harshman LC, Presti JC Jr. Impact of common medications on serum total prostate-specific antigen levels: analysis of the National Health and Nutrition Examination Survey. J Clin Oncol 2010; 28:3951.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/25\">",
"      Hamilton RJ, Goldberg KC, Platz EA, Freedland SJ. The influence of statin medications on prostate-specific antigen levels. J Natl Cancer Inst 2008; 100:1511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/26\">",
"      Mondul AM, Selvin E, De Marzo AM, et al. Statin drugs, serum cholesterol, and prostate-specific antigen in the National Health and Nutrition Examination Survey 2001-2004. Cancer Causes Control 2010; 21:671.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/27\">",
"      Bruun L, Becker C, Hugosson J, et al. Assessment of intra-individual variation in prostate-specific antigen levels in a biennial randomized prostate cancer screening program in Sweden. Prostate 2005; 65:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/28\">",
"      Nadler RB, Humphrey PA, Smith DS, et al. Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels. J Urol 1995; 154:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/29\">",
"      Sershon PD, Barry MJ, Oesterling JE. Serum prostate-specific antigen discriminates weakly between men with benign prostatic hyperplasia and patients with organ-confined prostate cancer. Eur Urol 1994; 25:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/30\">",
"      Partin AW, Carter HB, Chan DW, et al. Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia. J Urol 1990; 143:747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/31\">",
"      Lange PH, Ercole CJ, Lightner DJ, et al. The value of serum prostate specific antigen determinations before and after radical prostatectomy. J Urol 1989; 141:873.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/32\">",
"      Hudson MA, Bahnson RR, Catalona WJ. Clinical use of prostate specific antigen in patients with prostate cancer. J Urol 1989; 142:1011.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/33\">",
"      Catalona WJ, Smith DS, Ornstein DK. Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements. JAMA 1997; 277:1452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/34\">",
"      Freedland SJ, Aronson WJ, Kane CJ, et al. Biochemical outcome after radical prostatectomy among men with normal preoperative serum prostate-specific antigen levels. Cancer 2004; 101:748.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/35\">",
"      Dalton DL. Elevated serum prostate-specific antigen due to acute bacterial prostatitis. Urology 1989; 33:465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/36\">",
"      Tchetgen MB, Oesterling JE. The effect of prostatitis, urinary retention, ejaculation, and ambulation on the serum prostate-specific antigen concentration. Urol Clin North Am 1997; 24:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/37\">",
"      Kawakami J, Siemens DR, Nickel JC. Prostatitis and prostate cancer: implications for prostate cancer screening. Urology 2004; 64:1075.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/38\">",
"      Simardi LH, Tobias-MacHado M, Kappaz GT, et al. Influence of asymptomatic histologic prostatitis on serum prostate-specific antigen: a prospective study. Urology 2004; 64:1098.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/39\">",
"      Hara N, Koike H, Ogino S, et al. Application of serum PSA to identify acute bacterial prostatitis in patients with fever of unknown origin or symptoms of acute pyelonephritis. Prostate 2004; 60:282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/40\">",
"      Ugurlu O, Yaris M, Oztekin CV, et al. Impacts of antibiotic and anti-inflammatory therapies on serum prostate-specific antigen levels in the presence of prostatic inflammation: a prospective randomized controlled trial. Urol Int 2010; 84:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/41\">",
"      Ornstein DK, Smith DS, Humphrey PA, Catalona WJ. The effect of prostate volume, age, total prostate specific antigen level and acute inflammation on the percentage of free serum prostate specific antigen levels in men without clinically detectable prostate cancer. J Urol 1998; 159:1234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/42\">",
"      Jung K, Meyer A, Lein M, et al. Ratio of free-to-total prostate specific antigen in serum cannot distinguish patients with prostate cancer from those with chronic inflammation of the prostate. J Urol 1998; 159:1595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/43\">",
"      Crawford ED, Schutz MJ, Clejan S, et al. The effect of digital rectal examination on prostate-specific antigen levels. JAMA 1992; 267:2227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/44\">",
"      Tarhan F, Or&ccedil;un A, K&uuml;&ccedil;&uuml;kercan I, et al. Effect of prostatic massage on serum complexed prostate-specific antigen levels. Urology 2005; 66:1234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/45\">",
"      Oesterling JE, Rice DC, Glenski WJ, Bergstralh EJ. Effect of cystoscopy, prostate biopsy, and transurethral resection of prostate on serum prostate-specific antigen concentration. Urology 1993; 42:276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/46\">",
"      Crawford ED 3rd, Mackenzie SH, Safford HR, Capriola M. The effect of bicycle riding on serum prostate specific antigen levels. J Urol 1996; 156:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/47\">",
"      Luboldt HJ, Peck KD, Oberpenning F, et al. Bicycle riding has no important impact on total and free prostate-specific antigen serum levels in older men. Urology 2003; 61:1177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/48\">",
"      Saka T, Sofikerim M, Demirtas A, et al. Rigorous bicycling does not increase serum levels of total and free prostate-specific antigen (PSA), the free/total PSA ratio, gonadotropin levels, or uroflowmetric parameters. Urology 2009; 74:1325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/49\">",
"      Tchetgen MB, Song JT, Strawderman M, et al. Ejaculation increases the serum prostate-specific antigen concentration. Urology 1996; 47:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/50\">",
"      Black MH, Giai M, Ponzone R, et al. Serum total and free prostate-specific antigen for breast cancer diagnosis in women. Clin Cancer Res 2000; 6:467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/51\">",
"      Alanen KA, Kuopio T, Collan YU, et al. Immunohistochemical labelling for prostate-specific antigen in breast carcinomas. Breast Cancer Res Treat 1999; 56:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/52\">",
"      Diamandis EP. Prostate specific antigen--new applications in breast and other cancers. Anticancer Res 1996; 16:3983.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/53\">",
"      Benson MC, Whang IS, Olsson CA, et al. The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. J Urol 1992; 147:817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/54\">",
"      Andriole GL, Telle WB, Coplen DE, Catalona WJ. PSA index (PSAI) as a predictor of prostate cancer in men with persistent serum PSA elevation (abstract). J Urol 1992; 147:387A.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/55\">",
"      Benson MC, Whang IS, Pantuck A, et al. Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol 1992; 147:815.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/56\">",
"      Bare R, Hart L, McCullough DL. Correlation of prostate-specific antigen and prostate-specific antigen density with outcome of prostate biopsy. Urology 1994; 43:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/57\">",
"      Catalona WJ, Richie JP, deKernion JB, et al. Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristic curves. J Urol 1994; 152:2031.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/58\">",
"      Stephan C, Stroebel G, Heinau M, et al. The ratio of prostate-specific antigen (PSA) to prostate volume (PSA density) as a parameter to improve the detection of prostate carcinoma in PSA values in the range of &lt; 4 ng/mL. Cancer 2005; 104:993.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/59\">",
"      Brawer MK, Aramburu EA, Chen GL, et al. The inability of prostate specific antigen index to enhance the predictive the value of prostate specific antigen in the diagnosis of prostatic carcinoma. J Urol 1993; 150:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/60\">",
"      Smith DS, Catalona WJ. Rate of change in serum prostate specific antigen levels as a method for prostate cancer detection. J Urol 1994; 152:1163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/61\">",
"      Carter HB, Pearson JD, Metter EJ, et al. Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA 1992; 267:2215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/62\">",
"      Carter HB, Ferrucci L, Kettermann A, et al. Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability. J Natl Cancer Inst 2006; 98:1521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/63\">",
"      D'Amico AV, Chen MH, Roehl KA, Catalona WJ. Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy. N Engl J Med 2004; 351:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/64\">",
"      D'Amico AV, Renshaw AA, Sussman B, Chen MH. Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy. JAMA 2005; 294:440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/65\">",
"      Eggener SE, Yossepowitch O, Roehl KA, et al. Relationship of prostate-specific antigen velocity to histologic findings in a prostate cancer screening program. Urology 2008; 71:1016.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/66\">",
"      Riehmann M, Rhodes PR, Cook TD, et al. Analysis of variation in prostate-specific antigen values. Urology 1993; 42:390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/67\">",
"      Fang J, Metter EJ, Landis P, Carter HB. PSA velocity for assessing prostate cancer risk in men with PSA levels between 2.0 and 4.0 ng/ml. Urology 2002; 59:889.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/68\">",
"      Loeb S, Roehl KA, Nadler RB, et al. Prostate specific antigen velocity in men with total prostate specific antigen less than 4 ng/ml. J Urol 2007; 178:2348.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/69\">",
"      Roobol MJ, Kranse R, de Koning HJ, Schr&ouml;der FH. Prostate-specific antigen velocity at low prostate-specific antigen levels as screening tool for prostate cancer: results of second screening round of ERSPC (ROTTERDAM). Urology 2004; 63:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/70\">",
"      Raaijmakers R, Wildhagen MF, Ito K, et al. Prostate-specific antigen change in the European Randomized Study of Screening for Prostate Cancer, section Rotterdam. Urology 2004; 63:316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/71\">",
"      Vickers AJ, Savage C, O'Brien MF, Lilja H. Systematic review of pretreatment prostate-specific antigen velocity and doubling time as predictors for prostate cancer. J Clin Oncol 2009; 27:398.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/72\">",
"      Vickers AJ, Till C, Tangen CM, et al. An empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detection. J Natl Cancer Inst 2011; 103:462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/73\">",
"      Catalona WJ, Partin AW, Slawin KM, et al. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. JAMA 1998; 279:1542.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/74\">",
"      Hoffman RM, Clanon DL, Littenberg B, et al. Using the free-to-total prostate-specific antigen ratio to detect prostate cancer in men with nonspecific elevations of prostate-specific antigen levels. J Gen Intern Med 2000; 15:739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/75\">",
"      Lee R, Localio AR, Armstrong K, et al. A meta-analysis of the performance characteristics of the free prostate-specific antigen test. Urology 2006; 67:762.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/76\">",
"      Carter HB, Partin AW, Luderer AA, et al. Percentage of free prostate-specific antigen in sera predicts aggressiveness of prostate cancer a decade before diagnosis. Urology 1997; 49:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/77\">",
"      Allard WJ, Zhou Z, Yeung KK. Novel immunoassay for the measurement of complexed prostate-specific antigen in serum. Clin Chem 1998; 44:1216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/78\">",
"      Chichibu K, Kuroe K, Hashimoto C, Goto S. [Specific quantification of gamma-seminoprotein-alpha 1 antichymotrypsin complex in serum by monoclonal antibody-based enzyme immunoassay]. Rinsho Byori 1995; 43:1153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/79\">",
"      Kuriyama M, Ueno K, Uno H, et al. Clinical evaluation of serum prostate-specific antigen-alpha1-antichymotrypsin complex values in diagnosis of prostate cancer: a cooperative study. Int J Urol 1998; 5:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/80\">",
"      Brawer MK, Meyer GE, Letran JL, et al. Measurement of complexed PSA improves specificity for early detection of prostate cancer. Urology 1998; 52:372.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/81\">",
"      Brawer MK, Cheli CD, Neaman IE, et al. Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer. J Urol 2000; 163:1476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/82\">",
"      Mitchell ID, Croal BL, Dickie A, et al. A prospective study to evaluate the role of complexed prostate specific antigen and free/total prostate specific antigen ratio for the diagnosis of prostate cancer. J Urol 2001; 165:1549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/83\">",
"      Miller MC, O'Dowd GJ, Partin AW, Veltri RW. Contemporary use of complexed PSA and calculated percent free PSA for early detection of prostate cancer: impact of changing disease demographics. Urology 2001; 57:1105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/84\">",
"      Okihara K, Fritsche HA, Ayala A, et al. Can complexed prostate specific antigen and prostatic volume enhance prostate cancer detection in men with total prostate specific antigen between 2.5 and 4.0 ng./ml. J Urol 2001; 165:1930.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/85\">",
"      Partin AW, Brawer MK, Bartsch G, et al. Complexed prostate specific antigen improves specificity for prostate cancer detection: results of a prospective multicenter clinical trial. J Urol 2003; 170:1787.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/86\">",
"      Horninger W, Cheli CD, Babaian RJ, et al. Complexed prostate-specific antigen for early detection of prostate cancer in men with serum prostate-specific antigen levels of 2 to 4 nanograms per milliliter. Urology 2002; 60:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/87\">",
"      Stamey TA, Yemoto CE. Examination of the 3 molecular forms of serum prostate specific antigen for distinguishing negative from positive biopsy: relationship to transition zone volume. J Urol 2000; 163:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/88\">",
"      Okihara K, Cheli CD, Partin AW, et al. Comparative analysis of complexed prostate specific antigen, free prostate specific antigen and their ratio in detecting prostate cancer. J Urol 2002; 167:2017.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/89\">",
"      Tanguay S, B&eacute;gin LR, Elhilali MM, et al. Comparative evaluation of total PSA, free/total PSA, and complexed PSA in prostate cancer detection. Urology 2002; 59:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/90\">",
"      Bratslavsky G, Fisher HA, Kaufman RP Jr, et al. PSA-related markers in the detection of prostate cancer and high-grade disease in the contemporary era with extended biopsy. Urol Oncol 2008; 26:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/91\">",
"      Lein M, Kwiatkowski M, Semjonow A, et al. A multicenter clinical trial on the use of complexed prostate specific antigen in low prostate specific antigen concentrations. J Urol 2003; 170:1175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/92\">",
"      Allard WJ, Cheli CD, Morris DL, et al. Multicenter evaluation of the performance and clinical utility in longitudinal monitoring of the Bayer Immuno 1 complexed PSA assay. Int J Biol Markers 1999; 14:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/2/41001/abstract/93\">",
"      Sokoll LJ, Sanda MG, Feng Z, et al. A prospective, multicenter, National Cancer Institute Early Detection Research Network study of [-2]proPSA: improving prostate cancer detection and correlating with cancer aggressiveness. Cancer Epidemiol Biomarkers Prev 2010; 19:1193.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7568 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-118.195.65.248-D4C8FA2A70-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_2_41001=[""].join("\n");
var outline_f40_2_41001=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H20\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PSA EXPRESSION AND PROCESSING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PSA MEASUREMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Age-specific reference ranges",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Race-specific normal ranges",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Other effects on normal range",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Medications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Random variation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      CAUSES OF AN ELEVATED SERUM PSA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Benign prostatic hyperplasia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Prostate cancer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Prostatic inflammation and infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Perineal trauma and sexual activity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Other",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      ADVANCES IN PSA TESTING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      PSA density",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      PSA velocity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Serum free and bound PSA",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Complexed PSA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2750833\">",
"      Percent [-2]proPSA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PC/7568\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/7568|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?27/51/28477\" title=\"figure 1\">",
"      Prevalence of BPH with age",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/42/4776?source=related_link\">",
"      Acute bacterial prostatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/16/36101?source=related_link\">",
"      Clinical presentation and diagnosis of prostate cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/19/34104?source=related_link\">",
"      Epidemiology and pathogenesis of benign prostatic hyperplasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/31/8698?source=related_link\">",
"      Medical treatment of benign prostatic hyperplasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?27/51/28467?source=related_link\">",
"      Patient information: Benign prostatic hyperplasia (BPH) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?15/21/15698?source=related_link\">",
"      Patient information: Benign prostatic hyperplasia (enlarged prostate) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?37/55/38770?source=related_link\">",
"      Patient information: Prostate cancer screening (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?31/27/32176?source=related_link\">",
"      Patient information: Prostate cancer screening (PSA tests) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/8/42122?source=related_link\">",
"      Screening for prostate cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_2_41002="Collagenous colitis Light I";
var content_f40_2_41002=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F60570%7EGAST%2F74390&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F60570%7EGAST%2F74390&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1108px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Collagenous colitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 434px; height: 252px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High power view of a colonic biopsy from a patient with collagenous colitis. There is a thickened subepithelial collagenous band (arrow) associated with increased mononuclear cell infiltration and epithelial degeneration.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Robert Odze, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 518px\">",
"   <div class=\"ttl\">",
"    Normal colon",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 518px; height: 172px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCACsAgYDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD3ECnDJ6Uwe3SnD1r22cKHjpnOQPWpAe3eowOeaeuB3496hjHcnpRn5R/jR+XWgVIwGcYxQPrzQcZ4/nQfccY/KgLi5Jzjg0g4FGBnimgdz0FAxwz2pePSmjpx+FPPPBNACDnHOemcUh69aUYznNIPQ0DEXBYA08rwCTnimEHPNBc42/qKBiseMgH/AAFNyOp59qQnPTjPakPNNIBQSOlJmim0xi5BOBR2pOAc88Uh6cUwDqPxpAfxFI3TnmkyeeaYCg54puRz1pG780h5NUkAuc45/Wkz1xmkJA6mkJ/CnYBe1BPP8qTP5mk3DNBIpODnpQD7VGcZ70oP51VhD9aP/FLJz/y+D/0A1yvbGTiup1nnwshxnN4P/RZrlONx46dq6ML8D9WYVviF4zuPU0pPB64pvHPal75/DrXUZWFz27U0knvx6UHBGOg9qO9AIdnH0xSZP40lApDHHsADxTc89eaXPU4z9ab70DHZ60dqbQDkfjigQ7cQDg/nQODzxUaFizblwM8c/rTwfwoGOB5OT2pc9ecjNN3dhQM8c85pAOzntxQffp/Omk578noaXpjAyTQOw7PocfpS5H4g8Ui4OeevrTjknkUAL+HvmlBGBTQDjk5pQc57UhD88CjI4/pTc4pSaAD1NND9u/8AOlz6VR1FJpECW+WLkK/z7QF7n1ppXY0rjZtYtI7sWwkDS43YXuO+KuqwZQVPGOKzotKhghCRFmOchpDuINXSrqiKm3jGeO3tVadCpKP2SRj1G79KQ89OnrQcn29Pek4GetCIaDI7mmk8/wA+aD09qa2cYFMVhaKb19qKBnZg04HI6muF8ZeNP7Isx/Ylt/aV4JNssag4jXB/NjjgVwkXxG8Y39nHNDYJBJJu/dLGv7tV7sSD74FckMDUmr7ep6VLB1aiulb7/wDI92BHbmn8E+pr550b4jeLNQ1VrW4kmgKDzC6wqECk9OQNx9x/9euqTxh4htmjkad7iHcBh1TdJ7ADkZ9a0/syq9mvx/yNPqE/5l/Xqj17rxj3pSeeveuFn8cDT4ka90+5aVxkIny8evNRXvxO0qykP2i3nSE4xIzKuenY/Wud4Gv0iYrC1mubl0PQCf1oyMVwN58VfC9paRXE89ysT/dPk9fpzz+FdEvibS1uzaXF0Le4VVZlnG0KSM7S3QMPSspYWrHeLIdCot4m5jnk9qaenv3xVaG+tJ4WnhuoHhBILrKCoPpmpnmRIxK8iLGcYdmAB/GseVrSxDTW5IBg8jn1oyARzyelUrjUrK1K/aLy2izyBJKFz+Bqude0lsY1Sy4P/PZeDVKlN6pMpQk9UjV74B5pAeMdKpxalZSxh4r21dMfeWZSP50x9V09CQ9/arxnmZR/Wj2cuw1F9i/3x29KQjpVI6nYhN/221C9j5y/41Edb0sAn+0LTGcf60GmqU+iYKMn0NHPakJH0rjdc+IGk2EvlW+68mxn5GCxgDuWNcjrvxcig0p5YVjs7mNir+crOCfROma6YYGtJXtZeZvHDVJa2t6nrxYZwaXIzjmvBbX4yX1w4jhi86YANs+yHdIMdua6GP4o3EE6G/sYjFIUCqu9WG4cc4IOOQfStHl9XpZ/Mp4Spa6t956wTkkUhPBGcVymn+N9Iu3Eczy2knOROMKD6bhxSTeO/D8cu06gZBzykLkZ/KsHhqqduVmfsKt7cr+46rI/SmnqOPeucHjTw+VU/wBpxqG6BkYH8sVHqHiG0vNOnTQ9b02O/dR5TyuCBzz8p9qaw9TrFr5MXsp3tJW9TpiaaT14NVbabbboJZ0klVQruSFywHJx257dqgm1WyicpLfWiFRlg0yg/qalU23ZGduxfJOe/vTdwyOK5XWPHvh3S4y1xqKSbeW8gGTaPUkcVw2s/FrzmddL8q1hG799IPMkOBnO3ov05rop4SpPpb1NqeGqTdkreuh7C0mxCTkgDPBpqSLIu4dDXjlt4t1HWUgibUGJJBUbFjUkcgvjnA64OM0/+29eFpqM0OpW80GSNxYfMQOSucbR/OuhZfK2rNJYRxdnJf18j115HEqrHFuGMlywAH+JqUEc+teS6F421KytCs9pHcA4dd8hRsH8/WugtviRpghdr+Ge2aMhZNuJAp98dv8AGs54OotlcmeCrR6XO91rnwouAT/po/8AQDXKk84PWsD4teIob74QR3ekXcqRf2ysMhXKMf3DNtPfuprxHSPEer2h8621OdQhztdtyn8DTwtK0Wno7slZfOquZOz7H0bS/SuT8P8Aipb7RUu7qIo6ukchAyMnAz9K1L3xHpNlKYZ71PNUBiiAucHp0BrdU5X0RwTozhLla1Ng8ikJ4qhZavZ3tuJYZMKTgbhjmrgYhcuVBz+ApOLTszNpx3H0MegP6U0HK5x9KI2Yrll2n0pCHdTQKWkP/wCukAooA9elGfekBPpQMX3oPAorJ1/XrXQv7N+1xzP9vvYrCLygDiR84LZI+Xg9Mn2qW1FXYJXNc9f/AK1H16UA9zSgDcBzg0wAd+M0oGMUe/Bpe4GOaQxAQcnmnGk6k8c0p+p56UWC4D6ClHU8UnUDjn0pPp0oAUnrigsaQnnA7UgwegBxwKBj84z7UduaaBxx9aUYwO9ABkkY7UHODyfrS9etN9hkZpiAZGOc0h6kfNx39aX6UAcHr6UwGt/u/rTOnJ5/pT+2elNz35oATp2ooHGaKYjzjxTdXmhqkkX2pFhjEcFyxBjZnfBaUIOgAHzc4zg9aHtMz2q3ckgsbBVkmS1tWgT7QzlUXjlxkFjnAA5PUCr+j67f6hd7b2TT7KGZd8Atb4yJdeX/AAxqw+7z8xA5Ix2zWZ4p1e+07wlpcF9q0ey+knnlcRM27L/IVJy2BznPPTAGK7U3KyPoIyk2rvcz7ZNS1bXb6RHaSIMyKTEsMYY84X+JjwcHgVc0hU0rV47q6Uh7dxKQPmwccZ7D6GsrwRc6ZBDI13HazRMSsVzHGTGTjBDDrn39624NXj0pr6O13TWrjcpxhW4xnk5wPxroXvJo6FKo04KOjX5+Zra3fS6lP9oEezAHkSRnlV6//Xrk9PuJ/EN5dNqaWh06KUW48wYk88HBBBP3uPTBDGrMN3qOrWlt4atYpBHes7R3cGMwOvQEjt+X6V0cunWVtNvdo5EtZ4pmuJbUiOWcoQvlsCDK5PAzhfr1rNyUPdQub2SUGtv6/rzK62kVvff2Lp8Fk/iMFZbaKVTMkS5y0jBchRgcZI5xWbrzaZq1zazT3uoQahNO0Xy2ksbFycOShGB/vZ4rTt7dLXQtf0eK1ltkunRA91MsDXKk7mUOMkoCecZ6Yz3rQ0fT7hvGl2mmy6hPpFkq29xZXBKNDOoGPKLE/Iw5z3H1rB1OVtt/1/XQzdZuT5v6/E5HWdLGk2Xm3WtG007iJA0WdzH+J25JOM4GPxNVm0zW7zTkaz1mC6gQl42cfum6fLjsAMnjqeOK6PUdN8Q2+o2bWsH9o/bkmto42gCW8Z2HDMqcMOuWduOw9H+CtOsLPThbW82lwmRni+wszhp5VAExVZOq9QAOMHOav2ytuV7dX/4JgnRtVe7eVtYsYlb5IYxhw4DAkg+uMjjpxzVa90awsbSP7brU84Cm2mEcRZ3O8MMBeSy8dunWupv9JstMsr4f2roNrZwyCKG1llRI7OUHMg+RXffjkr+FbGgX17b6NcW/he0gudQsrg2+69k8yNZCcs+9OTkEHb2BAJ4pOu+XmX/AJ+srVR1froctD4Os5hNf28l1pyzpHavKYWjOBz8gxuy3c9q1NZ8O2t5biC4unY248z92DF1BALEnLcHpXQ+LDqUC2eqF7wTmN1uL6InNtH1Ihgwd5PTJ5ArAsk0bVLoO+gT6hdG8Ek2IfKa3YqNskoLDGeuF6dxmojVbXMONbRtrQzdNsrCNLe2s7tZIkxD5zYckg85Oef51VTSJ766mkm1i2Nhc7hbQWrANIu3HUfMMHJrupZPDd9vtW0mZJoZ2d2giCIrkfPJuYYI+brznnFYUPhmaDXYprO00fTdFNq8EdxG6s0jlTtVc8sMYOAR0/Oo1rb6FvEqaSatY5Wz0bSdcF1bI94Dax+W5uMq21MDeV6kE45PXFa9zo9u0FvE1tBLHFGF3uo4OeMDnjocjntVzUtXsraO7ga50yC7d1huHhi3klBnbI/ABwDjnjHSm6jqT6JbeRLZmCKZFeCfzQ8jjrgIfmVQOcnrWibdvM1pzUtu5z+k6K9kslzeQLZCEgAG4DKyc8scdB2zW/HYm9hhkS8ieB5FkR1KusqqeVBPAyPfIrgZ/Fs1yAbWKKWKYMsgu1ZoSoPcHAJPpXa2kumajFZrr7TwR3flrbWVupNqk65YMjbQV4GSDwB17UTdloOpUaWmq7mP4mtJNC+03to6mQkxtDPJtjDM3zHPdjwM5wO1c7YeKLmC8El3Y7bZpWid2RiyqFyT9c/p+ddtDaZvbm3srF5NLUM8rvIJ/tT43AW+WKj0IPT9KyLC4nuYdQC3FlBfzSki1vreRFES8BcgbmbryARngUczsR7VX0djHuNEubp/t9vayQ3MmQjSOQIs8BwPTqT9eKntfDGsx2NzcT3E09w+S0cSK3zHAUrn0H9TWhpWsXbXNlb22tPqN2qHbby2TCO43Lldz7RsAA6jtVw38ltezyS20ssJEUC2s0ixxPI33gsjEZHUD+Ic0nLqg9pDV9f67FVtG1RDIimNcPG3muNzMgA8zIHcnI/OszUdNv821vNcAXzt57ssWFZAclQO3BHU5J4rRW+uE89NIltobGwSGWO1tVkumliYnIDY67gRnr64q9aaXfXN5dtJdMt4WDtaCYq1urKrIkisMI+M5HP0p87b1ZUa0Vuyn4V0Ca6aa31NZYLUsG+0yj5jknIwM8dBxUep+EtMtp0vIv3kUDZQc4Zs9SD24rVifWtNmtx5crZgeOS1jMYQPn5pmy2/YFPYdB2q3q4i07wTfajLc3ZN35XlNJFtCIF58pTyASc8/pUSk7iVaLlZ6/ccVoFvfyalcWaoJ5jukbDKodicnjsBwAOp610Mz6ZGYJYreKG7ikw9sVOWx1Dtzn2Nc14L0VJLqS2+3fZ3kdm82R8GQj06c9en612Uej2pszZQQxf2iGxK7buP+mm4881uttTKpNXSm3bsv1OX8QX1495HbWMRVLhZSsSMCOnClvxP51uaP4WtI4xA0q/abqJFkjkk/1hC88kjJH9OawQn9neK0iluAJywRkWTg7TncD+fPua6bTrfTbq1sVudbtL2Sa8lNvchmjmRjwpiyMKqpnJOeeR0FZyk1ojSc401zR/rYu+N9JdvglJaWc0TzL4kG9l7FbYrg++APwxXjegkXL3WnagDDeRcAAfeHb9cc+9e5+LRZ6J8EYG014prU64jyTq5cS7rYkuG/iJyOa+f5tSmugxTYLgkbZ1GHbbkgE9PyrhpLWUk+r+ZzOr73MjpPDXi86cklvMXg2uIZUb51x6kevWuuvrvT4Ar6ZdwpGSPNbG4A+/69a8WkW4mupZCxMkq+YxJ+8e/9a1oVmg0u5sghImCzEd29efx/Stqc3K6aJU5c3Md54z1y+tVsbvTrpgkTNHMqHhtw+Vj+RrWHxDmu9NaK9soFuHjKbkl+U8EA47c44z/9fjvDWiXF4f3yyyW1xZ8pnsGxx7jiodSiS38SPFOZVtXRW2kAr045+o7VvG19UY1KCm+Znofg/wAQRNeQ3MLXUVohaKeB3L5bb94Dt83pXWaV4rWa6aPUo47Tdkxnfkf7jH+9+leEy2c+mXWj3wcmJizM6ZOcHv8AhXT6ZLLc+I7u01G4RPMUqFZcgseQPfsaUoKd7kzw9OestGez6Vq0WoySLbxsVQ/eHb0rQZsKTjI56c187aNqT22q3tnfr9laM/JLHIUxg9CcjqO9bk97BaNIUnuYQqfNJ57dDx2P0rN0U9UYfUG9VJHte7KqegP609SK8LsbiWKQS6ZqF7AxTcrCYtke6kkY+orqNM8X63bII9RtoL9CPlaHMcp/Dof0qHQfQieBqRV46ryPTa+fPiT8UEvdXtLBNGnh/sbVo7pjNcKHdoshoyFDBfmJG4M3TPevbfDmpf2nYCcq6ksRscDcvscV4H8cfCrxeP7N9Ltv+Q3tCKCiq9zuCsAOMZyhJbqXJz1x5WYupCn7nfUypRSm1I9t8A+IX8U+G4NWFm1kJXZRG8gl4ViuVIwcZB6gHIPBGCelIyBz9M+tZui6Pa6No9np+mrshtYxGhwAXx1ZsAAknJJwMkk1owsTEpZVDY5AORXXC6iuZ6mMt9CQdFB5NDcZ5FBwRnmg4H0+tUIcOuMdKRWBYgfjTGdd4XIDt0FKSOATgnp9aAsSjnrScdO3WoJrqG3XdNLHEuersBTPtsBTzBNEYwMl/MBUD65p8rHYmY/MB0z3x0pVGB/UVSGsaaYhINRs/KxnJnXGPXrWZceL9HilEUN2lzOxwsUJ3k/j0A96pQk9kVGLk7JHQqwIyDSFuKw7nxHbW4ImgmJHXZgj6AkisZvFl7NIkdjZRszsRk7jtHYHpzimqUmaRw1WSuonak5xigMCeSCcdM84+lcQviq6kVLqa3WIoCPIil3CTnnkgdPxriL7ULv+111rU5SJJiELxOY/Lj6AKQeMfzq1R7s3pZfVne+h7cDwPSms5DAY6968jl8Y3OLiBNYWWC3ADN8u8knABOM1pSa1fyXzQw38kkEQ3MVXBXAyc8c1SoeYLL6vdHpe4nP8z3piklQDjd3xXmkXxAMcqW18ZI5jzwnBHbJz6Vu23i6K4jngVVkuwuUjQ/eU8Bvpmk8PNK6MJYecZcr3OtDEj5cMPY0Vg2OtadZWqRTTCMp8rknOX70VLpyT0JdCpfSLZzWl6uurapp9zrrWVtcyRfZDbNG0MySF2wqjONjYOFwDxzXO/EHRdQku5Vm1C21LALxBSP3UfVRtXIx/nNehacLWeEC2tRLPBMuZ0VCqgqRuLA5Q4PPfB75rjL7wxLf/ANoK3h2SKOIbLHyb9VjmVj867zyADltuOK6aclBvtt0Pai+R26Hn+n319Y5iktflg+WRQeFOM59QMe1bWmDUdckc28TyJ5ij90ynKEZO9jwigc7jXUp4csrl01OBtWubO3mSFbGOIxzx8YLbpPvw8cHG4E12lroGoa4b3TbnSodI8OkgpFbIQ90mfuyMeQcgcCnLEKC3+82+stQ3fzM3QLKwjbUdA8Nm5FxOhlub4RMIgduSqv8Awr0579q57w9AdFtru5067sZ9ZlmWzV47iSeJGzl2di2wOwX5VXkdCeufSdSttUsVGlaK2nWGirbGJJS482G56KpVmG/g565rBvfsml3mn2Mel6bqytJGELW8ZlS5AxJNJyOmPvHJ9DXNGo5p29f+H/yORz9pIreGpXufsWrto1/LrT209qdRA2rE4OHCjJQnJ4fGPlJzzVe4sdU1PQ7i119rq6ggWSS2iedknuQuOW4GFJO3HQ549a6Gw0N77XLjUGgu1mEa6d8oKRqi4ciMNwV55bnnIFUbnTovsr29lpn2qxVGZmtrozb33kmNOeT+OO3FVCUeZu+v9eZceVXT/wAzG0+GOCAJPqd8k+lzrcPYQ3UeISQDteNML5ajPHfn3ro4dSsruye/3Qrdyho7Ge4jXEIcdWAJEm4/MFXrkcVzF7b6odWsbIaml1r12dkulWGAn2RlGBMGyqED7zHJxgD1rd07Tby9vTptlC+m2Fkr+bqKoLcjA2kQN821euXOCR0ok48t2yXJNMt6Dc293F9p0+1VLyZAJ7s6eIJWx/FtxncfU9KbH9gurq98NWNtf2tokYeW9s5FVYnJzsJwfnJ5Pr71xurfEjTvDGzSPDT3GoQ28jfaby9Yzvct/eR8jKj6fQVzM3xT164lfCwW0T5kWJQF3KRjoe+Oc96UYN+X9f1YtR512R7dd2Fpocx1XTNLutW1ggwjy5sKGI6nLbYx3JUVpLpi2OnwWSxW1lZsMTBned2HU+WTnuTyfyry3wL4v1XXvEy6WdXVLSSzKs1vGN8T44MRx98dwcjmu9ublL21vW8M6kt3LbP9lkNxuKrIuBI24DJOOcDgk44FYTpyjK0n89fl5fgZTi4SszkLq/1WMS6eZdC1FJ2MEmni98pY0xgsgYAgkHcc7jkHHtb1iFL3RrWwFhb31xatEj2yyuiQIeBLvONwAGfXkZ61p6HoMY8ttYudHM894wsJ44gJS2wkjj5S3UnHy+tOTUmv7oQq8k+mWcAT7XLlzcuASzbQPnwAOVGCxAHSt+dX93oaRs3ZMxRDYa4+pahrFn9ns9IZojh94faNwkVQNpfkcYx0zmvPPEt4dV1ZQ95KzB/LlZ2jWZj0JJ4xkcHaK9L17UtKtzJbX1haSMlss+n206v9ocvgvJOn3V+YKQOTwK87fQp9f1W5vbC2uvIMpG+6Cjc/HMXGf6V0UdVzNaHRSdrt6J9/69CGLw3HMGhuprONbeIrFGsZCZ6gnJByO/50eHbvXfKurOyliuNQjVQHmueApJJyo44z26gc11Nhp0F5avaJay/2jGSkzTHhPVsfptFctp1hHp/jKWK7vjYRxAyvcRT+XtUEEqePunGOfWtZpdDWUlrbddP1/wAjuLqyvtHnvJ9CeyutTntzJ/Zsc6H96CB5oj4PPJbnAxiuUjtphqra5rMV5cSrMXiaBmKIr5yUDEMgUDPp6CptdV9O8W6hqkWrDTpYZhPJLPF521ZGwItyjKqDwVB/Crd5pja3Po93psaXAlQyCO7LxxwhjzIoJDEE8bSeeB71hHTWRzOPK9eg62vtP1e60m7i1i7v75hLFHE2baG4RDgCRcYCjcMuepPPSrlvd6jY+HdRbS9OgvTHLtgtlsPKNu55LbnzvCnJDgEn2FRalf6rNc2lkNOtkbVF8o2NwjLOoUnJOGOwEDIX1OSa3vC+lWeoi1uf7RlmtrZlmgjWfMqSZ+dJZFJDrjClegxxUS+G7Mm1Yo6FDfzWU+naVqN1qRd2tr7UUuVgNpJtBIhwoGA3XB/iyKp2ejW9wtxZXzjWbeNObtpU2/alG3ZJt+dmAIbLk4GPpXYrpGn2OtR3C/ZoFkb7OsIlI8+QZdvl4UufvZx2qqmm6NfXkWpwS2LQ28jCQWoUiTJ+ZGJPLdMnAbjGcVCkriuuhjS6bqbaY0t9DNLKIFBaKVYo5XLKT+/bDHAU5IwNvGDWT8X9WRX0X7FcN+9hMplUeYHQkABOox8vHqK7mDR5tW1X+0fEken3Eao8NlawxMAsT9AdxwTjIJA9s4FeParJJceLyNQtV+zWgMMEdoR5EMa/KoGec4x3z1xVUm5yV90aUE3O/Yv6DqttBdiO80+5mWaMEyEAmPGeOe/PQVavJ0ttVbzYrmzs5QN0SyfMRjv/AIVbsZ4NQeCwt4nleWQBA44UZ6/lWnJBDbaldiztpLuKNzE0pcFyQB0z2rtvrudM5Ri25RabXf0OL1ptOm8RaeNLhERKk5ZTtA44JPIzg13Ph6HTrXw3o9/qy29wk1w/2ZIYGVYxKNoXGM4AyCx555rm55tLHjzRWjt7wFpRG4CbfmLAdPUZyfYV6rLbPcaNImh3dvDPGDHFLMWdevKsRz6HiuWvJKxzVZ+6ottevmupy/xyihsfgpbW1q8cUMOvRxKkG3agFq/yYHQfWvnK8mS2gCRxssvyyB1PB46j/Cvon4m6U3h/4C6Zaz/Zbt01pXuGYHZKxt5MnJ56454NeFwadDfywAxGGFULrIhLggn7vPXuK4aKupKL6szhFyVolvSNNEqGWXY0cqAgAEMoOM49q6G106KCCF41DvFwHkALEdTz6cmrlrDG8cCphE4Q8cADAz9K27HTvNRxDFJOqNkPGAAR7Z/nXcmo7nc1GCKFnO8Cr5B2Hrk/w56j8apaw6NAFuIRJk+SHx90H3rf/s6Tn7RAy/wxSk4AbPQjnNTPolx5aIIN24ZKlhnjHIz7+lHtI3JlOmUbCNDpdjF5W2eGYruxkFOoqKC3jub/AO0TriUP5iOOMcnnPcAZrp7G1W2Mq3lpIjlcJIGxsP4VjSxfvViD4l3FQpypI9TnpmkppmalGba6HM+KdNm1HT0+zBQzygDI5K/WifRIodJERbMqxIjEdMjqf8+ldeLD7OIEkaM+cDsAk3EY7+3esS7jS6kcO3yIxCtnHyj275qoyV7jtGeqOW8GQTvrUuImkhUFd2MbeeOfwrodevhpEiXNzbb4GYBZVfleOmP85rP8RS3lrY26WBZGeXezxjBwOg4rHvpZGs7sXjMY775Y1fJG4c7l9AKpNrUxnGycDvtJ1rUbUxSaSmHuyMRTYZZcD73B+UY75rqb5f7RvtLn1vTbV73TpvPiELrINxQjgsM4zhscfMintXm+jawunWOn23LXMEGzcThCrdt3YjjrVv8A4SPT1u0iu4rr7X/HHvUknsBzUypxqayRxVqOuiPVf+EgtV1CKzZZVeXGxmUhc/3SexrY3Edq8gu/EK2sguruJorUJ5SiY7nOTnkD6cY/OlbW7x7P7VZ312tuV8zbFM3T6HNZSop7CWBlJaaep6zdXltaRh7yeK3Q/wAUrhB+tU28RaKr+WdX0/fjOPtC/wCNeVz27XC+ZLJJOWXcXlkLkg9+a528hu1vIktbOFrLjjaM9e1L2CNf7OSV5S/A9n17xfpWlRP/AKRFdXmzMdtC29nPYEjOAfU15fL4k8RXd3LJdah5fmPuFuI1CKOyg9QPfNJaRxzPItp5QkGN0a4Uj0JFcp4t1VrSWMWxIkBIbAwQffNWoxpas6IYSjQjzS946bUN9/As2oytsQkBS+1F/H0+tVLi0t4ljkAj2scKE5B+gBwa56G8D6QyqVmuLlgZIGyQw6hgOxqxHpb3uiwiGZobhJMhC33D/TOP0rXm6nRCcbWhFDpL6xj1K4tJ4CsiZKtsHzkDOAPetHQtctA0V5bxyQuHETxKg5Yjg7vSrGm2Mo8qS+CT3UYB88rznp+PFbFtBbxqI4YIkAOfkjAyfXApJvqaclR6t2+Rm6xqWvSwI9vCrEPyQQx28cY96vy3N5/acMS48u4AdmJ4XIxg+vNXvJj+ZsA87lwcCptOsjdX6mJ40YttUuwVRjpk/wBKLi5FFXucdbaZqupX1hc3sjILG6O/JIypPUAdeRikv9CutRgSAX01xHPeead5yIY1zk9fw9OlemPpRtmZXZJJ9uf3LbgSTzk46+1UIbEwRDCYjjXa7Lgc5zjP1/pUXUkYx9m07HAa/oEWmQR39g8jhZ2laBlByecOx9j2oS+lfQra0kuXhubv97cTs2CIieB9T1rf1YfZyI5oslgW2sPvk9MA9qivNNjlMJuArTAhlAH3f88Y9K1g0vQ1eHvqnucHeSTa14kd4g8dtGFhQHnai8DI7k9ee9bDa1DpkywaWg3rxPPjcWA/hH8ia6WGBYXZreCIH5icICPc/wA+a43xQkFk+2wBimmfLNnp/h68Vmv3a01JlSdNN3NwX0+oWcdzcXDoS7DZHhNtFUdAuptFUxyJFN8gCho84HUnnuTRXTG1t7EpzSty3+aPoa10Qw3Vnqek6bBp85yZPtjsuUbGcxoQvmYAALZwBWpb2OqT20Q1eeyV2ZhJHahgpGfl2k88jqPWq6axd3+qX9kdMktZrMKVubhP3JVj1VjwWA5wPpmqV34tsNFa0stZuY77UZi4LW8W1Dt5JILHYAMd/pXkfvJPRa/ecPvN7a/eXRoOmaO9/qt1qGrXVssBBtPNZ44lA5McagHdgdQeO1c/ZeJoX0K4uLhJ9H0fyn+zJLMZLm+QfxRhm345Hv2rG/4WdqH2u6tk06zN/btvNuk5IePjDoxGM+xrX1GabxT9g1JB5N9tAst1qJZInYjJweOMEc5A61rCjNO9T+vl+poqU170jN8HeG7S50F7PxBZXeoW90PtZZ95ghBBCIoJ3BgCOCM5PWuj8M6GttBPqb6GYdWUfZo5JVHmyRp8qkkk7eOMeg5qW51eO61q+s7u5MQ0PYZpPtAgiZ5FwoYA4b1AOOTVh42sNP0XS7vXVubrmadpELNKnJYjYcDBICg8YHcipnKUnr19X5kuTdkYt5qviVNdlsrTULoTS+XNG7abmzjhXO6ISk8ueu7GBUWm6Te6JaXSnUbrVoQpW3skjRJGdmyz5BGWOSCxIAA710P9kXdzqtpJb3E0dmqES2sknyMOoYhRkt0GCcYHTNU/FvjDSvAFsqzwS3OpSrvESYXg5+Z2Jwo9B19u9Lmt7sFd+X6hdLRLUp22haP4T8M6nEgl0qxuV2zzeeZpEJGDHC2AQeeMfWvNfG/xEj1mOLRtAlk0zR48IGd/mmwMAMPSpft+p/EK4m1TU59ukQzBJLWMFJI0IzuUDqOgJ6nqPStxPCug2kF1ClnE0siF7eUsXZTwNo7HnHPvXZSpctnLV/1/X5G8HGLV9zhdE8JxT3KpqF08Edxhopim1AwHTJ4yeead4i063hiWG4YXSRJ5MNxyFaMcADHXv19K7u/knuvDTQzx2sL2xEZiHzOSjY4AHH696yvHuyXQ4JJ7iG9R9ypFbxqrZwPmPOSox04rpWu6OqMrOzXdd/ne3Uxvg1FJ/wALDtZ4Ink+zpIZUwcwjHDc9OMCvZ7y9ijtHW0toIbuVmhs4AcRy3ABblgvQdS2MDvXE/DTwpqNj4envTcLZ3WsW5itIwvz4Awrtk/KoPzADrx9K7ttA/tWSx0vUInu7W2gSW5vN+1JZRwECg5JJyxzlRgDkmvOrzhzczf9L+rHHWmrv+v6/wAyhFYalrIitpESxv4LfyWvbUD9wWA80Rk8Lkgc9eM1yOsePG055tB8KSS3N2C6zam4DmNhk7VAGAo9fXmnfF/xXNFfQ6DoF2sWnxfubtYD8zMeuWGeFHbuc+grH0XTbXQtQgudMlfUonBWbcmGI9uOR36VvRpc6UprTov8/wDI1p0+bVr5f5+pl6DDc3eoG+1WKfVVhy0kifMy7hySe9dTpmpWkN5dW2nXXlW7hJY4WX/loTtPXke/Pb2q3bT2y6pcvp8kcPnoreWI8hpBnqG6H9M1XV7VNbjkil2tcqRK86YHmememDzzXW9ehq/eupJrQr39jfLqRltriS4vJEZyYSFGBjkY/Adq5zwLbPqOqavfTrpv2mzicudTjcwpgjmZe4GCR7jntW/4h1ObwxcLMFVjdx7UWPKkEHr9PocGqOjuljoWoTatOEh1cpczNdwsYo4dwBR/Qu3CKM8LnvWdV+5buZyqylDW1rf19x0k1rpMuoLdWbOLa4uGe72FJIbiR03EybiSo7r3A7Gs/RYbmXxgptNSlexubNJVjnjCvcR5KrFGrfMqJ1zjknPpSeJv7HsoodTstOWe4ndLeKSF/JlV2HEqkjkBRjgd+tdhfaXHqGjB72zf7Q9sCTDdeXOzZ4XzF4UNzz2rmlLlRnL3dDE0670WXxRfTQafJNqFlE1k8iw5Mrnl4lJ5aTA/ADGeeblrocr2VxBN4ihttLOUia2gjieGXeCpJzj5fu7cc5Oa29Gt5LrTrLzbafTvLUia1aYO+/G075B99sYO7vWbpHiG2uJlsItEgtNOkcxwubdwJZFOXJQqNqjjDE5LdKxcm9FuYuTbLniBpINMstDtb23kv7tSk91K7JN5QT95MpQHa+OnI4rF0fSrqx0GwRrfTtTluxIbnVLZtsaKBhGCEZeQ4AzgH1Oa6rQre+toLsaveRyyT3ckiRbQFhhP3UPHJA7HNS3kMCWH+kXCrasGEkkb7Dt/2CP4u/ArJS5dv+HIi+VnE+MNRfSdPOtCy1G31ra1tDBLIoUDbjeUU5IXsCepyRXBeFW0Kewlk1yZjf3DE7kQgADpjnr61D4n1WDXtRg06wiltdMtF227Tu29VPO9myTuY8nd60mmWAs5xbXhkusfdeMh930969GjTfLqejSpe7q3fy/rodh4Yso7WS6vrGdZreJPJjJ4HmN23fT+dU3ttXtJPtFjMWeQ5cqysrH0wR9RVvV4ns9HtNLiVQyASyI3DknkAgcVy2p+KNU06xKCN9gO0eZHu2n0Ddq0TunL+rCipyTmmnfv2/rU0/Bwk1vxDqN/qJRrK2jGVT92EYcYJ/P9c126Pc6npyi1nXR7+5dHVEZZ2jB5zgEAllHXrz7Vy/wqsrhrMsFW5jvpXWYSsCUUDJBGMNksOvauvtrnwv4eEsyX9nAZpZDJO025pJABvwe+3gfLwBxXLVlrbqc9aWtjkviTMH+B0LR3F1d2tx4rKwm4TaUQwSYC46jIOM+pryrRpoIIIImKtK0hVABkEnnP4V7v8aNTsrn4MWd5ZSpNGdbQwylMgt9nc559s814HoV7DaSIpiZvtD7N2OFz1+n4Vz4Zu8m+7KovW53lpZCa0W5uZXijGJEdMfvNvO3HYHvWJoGh6/Z67aaveXpj+0EupEmEcEHA9OtdDe69bafJZpc6YbnTpFWMzw8snbIwM9a63wr4bg03SrpZtQN/BcSGVDLjaikcDHY45PStZvqyK2JUJe8iaxQtawyzRk3CqCNx+VyP5HNVNctdUudR+3w6fiaG2ZUcPkDIzxzz+VW7eaOCWeG3ljnijUHeANyMP4c9+Mc1Q1vxDc2WlzvFau12o3LHu4PfpUJtO6Oe0nK6VzI0zU7+00G6/tZme8hVpIi68kduKd4Y1O28TaMb14THLCwiuApx15B/GmLevqlhZau1lJbzMGE0DcgfgegNV9LtYNBN3Po8/leeRI9pKNyrjJGPpk1pJ36G8YNpOBN4rvINIsBfyaddw2M0ixh0X/Vpzk49T2zSyQW89taXdvcLLDIqiKNU2SsD7Dqfeur0DxXpOuW0tvNcW8lzGuJ4SNwI6Zx3FVmttFXUDrWlahFD9nQo6RSDyjxjoOhGO1ZqTvZoiGJnB2ktv63OZuYo5AyxKuSceVuyRjHGDVHV7GDU1MV3HgLgopO0g4/hI6HtSav4rU+NTpV/AYYePKnyTuYjIPupyK2ptKmt4kNzEqiZNzfMCATwMY6VrzaHZTqxktTltV8P+bFFNZP8wVcxMMIQOMZ+lUr/AES4/tibWVXzC6hwsSltrYAyPYV3EUMy2ixT20rKTkSdCje3qOlMs44LaCaC4Fx57sCs8WQgX6Yzinz38xOMXqcJe2F7dRfZ5Ij5EaLKj5/eSseox2x/SnTvqMF3YWdufLhhVNwXADdzkdx2ruX0+GREn+yv5xyVlUscjPXH9ajksGI3MjjHR2j7Gn7VdRxjF9TjZdX1vR9Y/wBIZpYZH+SIAEbOgI4pmoT6l/bdhb20Ey27hXKgZA55BPbFdwLVJX3GNgBk7+Ov9Kt/2ZNK6DySFC4wE5x13D1oVS3UTjFXTZ5rqGk3+kXd7qWnyzySSMRtaPJwT+tVrvTbrXLO3u7u136hG3lu+cZQdCR616VPppjlV5/MQAkDIwKkfSmPyrC3pkgjPak3Fqz2Hy0++jOBvdGfdbXkMUT6gu0yMG2gkYx7HAFa1jYJaCV4YX8yXlyCSOvOM+9djH4duI4mP7sp0xvySfWtTTPDwkiee9heQkElVcrv9OKXtEloN16NP3kc9omg3l/IRGQEB/1pGAB711Nn4KihXdLcGU4+6qYB9s5qtrt02lacrW8YtLWE+ZIi5BKjrjPWuE8JaZq3jPXH16PW5I7CGbAtS5LDuF25wBjv+lTdy1vZHJWxFWa5lKyOk1jXPDXh7UTbalCFnYfIsgLEehI/rWX4q8Qafoptbh7ETCc4SGJDtIx2xjvXR3Om6TP4ji1DVLa3klt1AEiEOc9BkHkkfStWTX9D+0R28kUiIQSWkiI2Y7Y6ik27aLUSnNbJvQwdHtjc2UNze26WD3Ee5IbiQq4HPJTrmp9K1DQblZLWO6hnuEPSGT51XPVgOBVxrnSNbkntLe3kDTI0YkkXbkEdAeoyK8q8aXkPhKAaT4d05raKRQ89wSS+4/wk+39aHJL4h3nP4tD0y30K3niN6ZI0bcQr3B3Mec5z347VXsNFjluXmtcXTwSfvA6YQsOcfjV/4c6mmseDbQxgPexIA4lXo3rVjUk8QT6tFb26Qw6aq5uZz8pb/ZXHsBk1V2pWuR9ZqJuLdjl/FWoXF1JsuAltbwAkRpt2n3yO1eU6rch9aSaKCS8I+55g2xRr247+uTXsPi/SoYNGS6gvvtQSQBsAYKk5HTrjpXll/tt9Ta4aW3vrwKPJsWyFTI79if8AZqotW00sdsXGVFcv9feaGn3Ul2Gad1C/wmNDj88YoqzoGvzfYgNQVYHH/LMIePoB0FFdtubVMmNSSXwMl1Dxb44S3V71UFlKxRBvyCRjK5z3z6VyN19puIbrUL2T95KFwkkRWKXB2kkg8NznnHQ/SvUJtKe6RRmUzAkx2xiwqqG5Kk8AfjXmniApPrMVvZNMnSJpIY2L7gecc/NjuK56kFCLaY5JKOjJtA0HVNRuDJp8fnTW4zvtZcYJUlTu6fNz1/HFfTXw/wBHuLTSIpb6WR7iVB+6PWI45Ga5D4W/DttIikvtTnbzbgDgZzIAfldgTwa9K1H7TZ6cWtopLqdsKqLiNfqx/hQdyOcVwVq3MvZxZzV6qS5IvXr/AF+ZzWnaPpup6Xqcp0Z/KurySa6hmZZjK8YwrYz0yOB+NXNHjW71N4dNeJ7KEg3N2pUl5evkqAMBR7VBZeHxq9jHC15YwaKxaa4tdIDIlxKTksZyQzDrnAGeM9K5n4g+P9J8H6fHoHhuJI5gCgW3G1Y/YN6n15oTc24w/wCG9fMzg224r/hvUteO/HK+Eftmm6bcpd6rw5RbYlbVOAXfBy7Y9wB6V5auk33jXUVvHnE19F82ZkKi8G7lsZIAPA9Ks+DoL60u5tZima9iJZbqC4wZGDdWB5wenPQ4NdaZrOJj/Zm20+7PbggqQH++uDwQcZ616NKj7PZa9zqhS5dErvv/AJlWPxE9zJFLp1lNBrEJMF1atH8u1R8ysRwQOqkc4NJYXE1xZm5ja+bUIiWiQANDGhPAw3Y8/lTpmIuxeeWI+vy8SAnGDn+8KVr/AFnTrN7m1iS8s0gMJ8k5bywSRx3x0rXl00N/ZqnFWtfz/If4d1tnmuYrq+gspXcvvkTazsevzdvoa5+30eLXPGN3aWQvNT03z1a4W0HMj4yWDE4Uc4zUOv6rpPiTTNLtdP06+ub2V9jNCCPl9M9zk9K9x8F+HLTwho8VrZbZLiVgHcj7xIycHvXPia6orTdmFScY3mla/T+ug2Hwxb6jZ26a5aIJbe4WaNbaRh5W37iBs5IC4B7E5xXP+P8AxLNc6k/hrwzeJb6juK3EzEIiDafkU9SfoOuB611fjjxHB4V8M3V9dXHl3LKUg+UMfMPAIXPO3Oa+efCs9i+pT3HiBJdUhucPHe4zIGzk7lzlfqK5MJF1X7Sey2OejGVR89rgvhLVtN1C4SeSQzOcIzDCS55+8fU+9dv4J0261G3YSZWwib5pmJV0YdVX1IGc+lS6PBPrF8thp+sT3OmSjc0dxHuESA8lW6k9BXU+INQiSNNHhuDaQlDG8gTCKMf6vd0XIPJ/qa7p1JJqEd/nojtnWlGKp21/LzOR1Ga1N87vv0mMHMFz5ZcM3pJ6ZrnNe1rUBYzWF1p8ctyvzQzRvlWGe34/zrrtXivNIs5P3huo4gA6zbZE24/vDkH65rznRo7nxF4xhax0e4ns45VJgh+bHPJUk4QcdTgY9eK15klzX0KhKLXN2/r1/Q1Phx4XvfFEw1XVrtlson8pIkHMjqRwOwX1Nd5d3Nrqms6zpYkvbucqsrgKVWIoANkGRtxnrnk0nie+t9JgiNqY0trmXZPb6ZB5hZc42hwcKeME1ujw7aXt8NQivNTM8siTzqr+Wsuxdqow9ADzjGSO9cc6j0nJ/wBf1/XbnlJ6SZzGg2djf+JLvS7nSHe4hYXu/VQ0jShjjdEo+VRxjGRnvW5DDa6f4sKado99JeNPF9tuB+7hji5wQW4cJx8i/XrXV3jS29u00t1DZWcYJ3tjAGOhJ7DrWL4bhtpraa7h1aXV0uJTIrvOJY4ug2oV4VeM7RXN7RyTfQwcuZGJpuo32lPqV74lNtp+mtO32WxRkV2Y9DJJnBLk5wT9a6Xw/qv9tQT3Y+zkwzfZnit5BKIWXqGbHLcjPb0qW/bT7XR7ufWRD/ZijzJFljWVWA6EDGSc9OOtS217FqPh2DUtKhksrd2EvlTW/lM4zjJXtngg9+Kick+nlciTu7Fqfc0sYeNTjOAwx9OfWvNvi3qNhp72rSEy6miPFAw4ECsAGCDpux3612Gt67HodsbzUDPPbyb5vmCgQHA2RjHXJzjPOMk9K+cb/VpvEmvm81RryK1kyqywqQVGewJxmtsPTbak9jbDQ97msdH4LeW0tpvsjwSJP80sdwCCTjpn/wDX0rr9D0+wkv5NWitW0/TrLDS72DEyY/hA4A7/AI1xVto9pYzxytqA1ODdmMlmimAPZl6dveut1XVbCDTLDRROYtPx5k8yDLO5ORkdwD/SvQldpW0O2VPS8E9d/Tr8yiqWWr3Us0t9NDdPIWwCFzzwOevGODWXq+ranPqS+GLeTT3+0Msa3EMX7wHsMdFPuBU+pTaZDpxjttZ027RssFcbZkI5wO9U/h94am12Z52/dQ3jiEOW2OsfWRlwM5xhfT5qUmkvIym4yXOnov0+49L8JabrukPDYLbwXEEqM02obgiJg8BUHzMW7k49ai0nRtMhunNxBp17cHfC0EapIIFLHKrxgAkktxnOa3tThsY9bgW3hhW+ESQ71J3iPPC59OKt2WgWmn3c1xZ29vayS5LNHGB1OefXqT+Nee6nV9Ti59Ly6mF8arNLr4R2sUqoA2sqVVV2jIt5AB+lfPWmxTGWzge0BS1cMu4ZDY6gnpXvfxwtZLf4QWyW91tb+3lfzJJDkgwScZ/p7V88S35sLqO2sYB9oYL5kmCy5OOVX05qMO0oyfmzopOKjd7fmd7Hpeo6g8Js76O0ihm8yeEBsrk/Ljjt6V2RjnsyDKYZbeZt0rru8z8B69Pyqp4Rlkvp3a8bbPJAsYZV+UcdfaujtryCLS5obqFI3th5bR7hhvQg9s1rOTvYxr1GptWOMvdWtU1DVm07VbeR4bdmEaRnz45On0x/Wl+GZmuNGfWdZcSRNIY4yzDLY65z71J4Z0bwnba5c3IEIvMOpPnMUOeuc9+taPiXRdG1Tw4un2yTrZscwtA2AjZ+8Qe31FS5O1miJN/BrcwvEMWsajrVs9gzWltu2oirgOM9iKveBtai8RRX2ny6dm5tHaO4kGPnwSAc468dPatHwzoUHhq1sLaO7e72lt3mkcBuoGOgB5ra8P6Zoug/aXsWEZuJN0ju5bJ+vpSlK60FVq2ilFHEL4at/C2sy31rab2eNkwMhNjcMp9CaxPCWiHw/wCM5reGU/2ddowMc7BQUKkgEf3gcc16ZKTd61E8qzC2t2J2GLcGJ/l9ap+LPAen+I9YsdX+1TW9xBtBWPBSVQc4x2PuKXMk1dFSrRSXOtTiLw6raWr/AGqxGorbSqLYmIM0S5ydrYJwPbI5FZ+o674j0ayvJNQjikty6C3hkBPlr15/Dg57mu38U+Er628PyPol5Kt1EMjM2DjPXd+P0qhpml6ywSHVY4bmBohJJISJFlbAzz/Me1a8yaumbKcJ6p/8Oa+i6nPeeHdL1F1eNSnzQg9Segweuax9U1eB9YisrbUTbahK+PsrAck/dBP5UvhzU7m88c/2Y8TfY7Fd80vSNTtz9AOcfga6jUtG0LULya/tbKzuNVUAxzbsjcO5Ge3rUt2dzJzVOXKtSkPDMusiDfqkkMcJ2tHGASxHXk+tZfi3wffy3Vpa6RqF5bGZyjMy5jUAEhnIOQCRjgHmrUnh+8v9Mjh1l1tFkOWSJjjIyQVYc9KisPDmoRXsdra6jq7RsQzGWTCKOSMA89vWk239orXVqehseH/Dd5oWnKmqXkeoPnBfbgY9Ofatu41WK3iKPZzpJ0GQMfUEHpWXY208l0lq+oTvLGxSQE7hnHVc9a17PQkFxK94pmbd+6kZiXA9/epb/mZhNxX8R3ObuPEVpqc5ijtYZ47bmYt1Vhxnj0rQa9lhkWW7lhgtcExxFgu7jvk5NacXh/SYJdiW6LKcPyfvHPU+tcf478Cadqtyb++ubqN1G3EbArgd8Hp+FVzx2RSnTl7sUbkVwjzYWYKsjfK6cgn0PvT5L+7SCZDIY5Y8uGB+V1Hpnp9K4uWUWWjrplk0sMKx4VmAPHsPX3p/h/ULO3h8i6d5ABjccnIz3FXynX9W05mijF4v1hbqddf03ybNs4uXcFRz/DuxnI7CvQdMtdMsbG3msoQsEq5AaArnuSAO/vXJ/EXw5B4ru7DUVvlWKBAojX1Jz0/Ku20O0cW1m2pXMcl3bKVG0Dayn2PQ0r3jd6HNUdop7L+vI4jTtd0zW/Ec1loekXUNyAytI6EAY4JB/h/Guht/DkUe+ecS3B3Ayuke4vt4wc9frWnrevzabrOnWlppzzQ3x2tdoQUjI7MoGTWlp82o3MZa7t4oYz0YMVY++OcUudpIh16ijdaL8TCOpWdjqkj3E6WsJVY0kuhtA46YP4c1oxaZJIz3sl5GzPg7lVSrL2PPWvK/F3gLVLrXbxo5xqQuWBVWlyIlz0J7Yz1rY8S6CW8Mabph1h7G9tHV0l+YhsDGFwenOadk1puaTg9HTe6Nnw/HqHhyG6tX1KHUxM7TR3DgiSJOcjGPn561tQ6gdT0O1hkkld72IhhGAZQD3x2FWIbuys/D9vNq8sSRBFD3LlUEhxjceeMmnWWt6JZ6cbyKSK1s9wQTEYV/TBHUU+j0vY5pTW/LqcB41ae8jtJ9JvreLRrItaT2aMN5k7ggcDHH+TXmF7bm1vWe1KRqTuluHAYgntz0r1TxHpnh7TvD9xd6BcSOuoXZuMBt6uwyG2gjgc/nXl0dpc3bFFtUWzZ90vmP83Xr65q46rVanq4f3qKsuv8AX/BOos9Hje3E1tdKY3I5CnBOKKhs7C6itES2t7jyF+7tBx/LNFdfPFHRHnS1miHxB4pc26wWct1HcKMRfMxADHkL6HpkGvRfgp4KltWl1nxDcAknzIYGAA9S7gjIx6H+VS+GvhA+nWyXUsscOpb8yiIiRtoJBCM3ALDBJIOK9AtrZLi0mt2jvdNmDlUt7qRWEqjoVIOMH65rhrV1UVlL7v6/E86daMlaMvu6GxBq9nqM8kOl6hZzyxqGkMUqybAenAPesvVZzq6zWFnqawwKxju7uzlVpYmHVB1CHsSe1cpqFhFqVtfaMka6PGSPt729qCXxggE8bgQCCRjBxgmqnxSvH0TwxpujaGgS91PEUZQKpSJcf99E8A5OcZrGNBRkkv68zGNJJpMo/Evx55kZ0LwxNCqiMq8juQ0qAYKxnpn3PftXD+EtEEMz38xa6uLYCZJZxu3ISeD6+me1bFpoNvo+nxWF5Es0xYSNao4kAcggvFJjKnPVW6VoRS6fotnEdUzekrtW3BKxRHI64+9njPbNenSpRpxSSO+lCMY3iv6/rqbFppCX1xFdWExttMkUSm5Hy7ecMg6dcZOeAapa1AEYHw8kb+U4PlXGWadCOq8dD64qjL4r36vZwahbp9kjYoLTYNnlsuA69mI560abqmjWVnpkN/qUYERktke4cqyfMSrZz02kDPtiqSlG7kxN1Kestv6+8pXGq6lpNtNdyL9p0qCRJ4gseDDnORnvnBFUv+E/utT1UWHgfT5p3vgQ0c6DAk/vgDgcdT0rT0m71nXb+70nR7Vks7vfHJc3MY8p0PV1I+7kDnqPTBr1Twn4Lh0FLJNIKWsandeSLCC90NpATJ5VcnJxycVz4msqXUxrVVrf+vvKnw48IxeEbAtcvHc65dNvuJUTCqcYIUDj6txnNbvim/1LTtNur/T4bRhaKpRZ2OGH/LQk9uOB1PU+1XG1O1TxHDpUaiSZ4jJMyyrmEDpuTO4g9AQMV458XPG0l0LjSLa6trOzhnDXHk3O6Zlzxnpg55IHQY5PNefShKtUUpLzd+xzxTqyuzndV1a58f62k3iW9ksNOh3JAEtW8lT7nORn1JGcVvJp0lpMBaWlrayMAqxlCYbtR/cPZx1B6888Ve0A2sOnRQ2l9Dd3s4VVi34lbI+8rHhl571Uisore3eDy7XfBI5MkdwdxPsgOMjI5HWvYhGMdInoQSXurYvadqLaZ5l3A62rkFTxsRCOCX7emT9Ki0ya+mv7jzb+OOa4If7PcxCRLj3DZwfoKo63DcXeiS+fdCTTRI0bNFlTvPVT/dz7jGa4HVtUghg/snTWuJYQQsC4O+Jv5g02lq2ayUeVtW/r5HYeIrfxQmqR6Jp+BbXrqqpb8naTgEq3zIOfpXYaFp6+G54tA8Oxm4vBF52r6koLkAN/qlGMZJ/rTfCOiz+E9Ca+1aSW48TX0Z8hp5C5gXGBnPI69K1lu8WSRPO4tUJRbaMBQ7Y5cnqeTmuOpNzem35mMKbmr/0/uOdvtFuNN8NagukXTS3UjG4uJJXG2BS3O1xwPlzwB1ru9H8rRdH0+0tX1DUnvJv3csgLldwzlnAwkY9T61yypPqUttpQ0ua6srsGCa6HEMMR+8e24/h1Nd4jxaTprqn+j2NsgUy54jjUdz9B1rnrzbXKyMU9eVGPremyXkyzWdnZXOuW9uYRJOzmCHceQFHBODz3OBTvDuiahbCB73UYpoI4vKNvb2awqsh5ZhjpxwP1q3oeq3OoWt80VsLa2bLWV+JFmW4DDIl2joOnBPNWNBj1SOO6bW7q0LtNuge2QqfKwMbweN2c9B3rGU5Ri4nG5tKyIBYafbanPqi2ZF7PGIWuHLEiMHIUA8DnB4HNZ+rm81HW9G8xzZ2trM80ySgk3KhcAAg4AOSeas6Hq76lqF1BqcAs7yNmlW2aZZCkAOFkYjgbuePxrMHiuK71PXJfJQeGdOtEdb/DYupG/hRjwVz8vHU04pp7agmk/M5P46eIIrXSrDTrbYJpgZsY4Vegbpz3xXHaPZxjR1Sx1aK+hYb5LSeArJux93A5Psao62bjxh4tl1HUJY7fSWfykvFLNHFtHCZUcdhzVvS55LTVLu1uYN04QeReQuV57Nkc59iK9TDQ5I2O+nGy5Vuv6ZoWsZtYkEZQrINxib51VT0J7ggjJBHamXKW5kmi1GFdQiY7lmSHep7HnGePar9v5cl2JTafumRswwThcsB13E89MkH1rEu9YutLu5W0tzYRj5vs8rbwT64554/St/kdEry922v9djkvFLWDajDDpcSKdoXZsIOB9ecfWvoH4a6TNo3hO2k1ENHeXK+YUcf8e6fwoPTjk+pNeU/DG1bxt40e81fy3e1VZNyxgfdPC8etewSX73PjGKAyxSQBJFWF0+cyKQWKHONoHXI61w1m5XivU8+vKU9Om7NhvKW9iN3IpuArPFCOydNzev1p8cUVvHIY3lGSWJMhPJOf61DdtdPbXlxbLD9qVNsC3BxEzf7ZHOB3/Sq9xNdRi1eWS0CNGDJ5SEndjouf4Sc8muVK+hzpN6HO/Hg26/B22+1ykqddTbJGpzu+zydc9e9eBaefKQQ29zGZohnzGTblcZwD1xXvnxeI1f4RWe6MGOLxAgZJkK5At36Djn5hXh2jSx3V5L5PmsuQoSVcbR6f4UYZNc1+7O7Dxa3Oz+G+r6hd6ZqoghQTwRP9mlxxI+04z+OPzqHRdN1DTPA63WtebLfz3DYR8koG7N78MfxFXNB1vSjdx6Qjr9rkcIAmQCc9CRWjdp/YkWpWXijX1t7HUZiLF0Yh0z1HTgdOenvWr0ldnJOfJUve7/Md4K0/TdQ0oy3ehpayiTCvIADJ/tY7V06wJZvIu5Ui2ZZABwR0x9f5155o+l6r4YvJLC51drwXB/cRnkgE/eOema19UnuYCILO3kuZgBudVLBW9M9OtS1zO5SpSn10Z0tjYi4YyXEiJGwysQAHfjJqHV9LvG1izi0oRLbNk3ayOcYx2HUfUUaW0pjs49SMMTzLmRV4ZD1GPy5rohaQLEo38LwGZsnNRzcruc1SbhLcyi506eBNRYJBKREjMxP4bv8AGprO2m0u8lmln86xmHYZMXpz3FZviCwW/RI9SYTWcTb/AJOASOgNLFJ/aNw1pbXiAxKCsfaQY4yfTpTtdFct43e3U6NbyzuAYzLE4cbdpP3vwqi2k2tpiW3iEIY5MafcJ/vYq9EYXhh+0x28cvRkyDhvY1CNLtxerLbp5WFO4xsfmJPeovY54tRdrtGH4l0fTdSsJLK+lezhYbibQ7Q2OmQOv41xU3gKO2ggvNC1K6s75QXCuxJdexHb8K9QvNEtLiEoTJFJgjzEbDc+vrVa00pkaOO4W2uYlG0y5KuR7r0zVRnbZm8KsOXcxtMS5NtDb6qyvdRfvPMVSu49hgd61rq/a2O7VJmhhAyEQ43H0J61a1O4h0iFBFZh5Gwq4G0Z/wBogcVgza3ZtBdXE8Uc1yn/AC6x4dvqSaavJ3sXG9RXS0HaTZzarctfJdodLA+SONCjhs9z39atNd2NrqAtg28v94JuZt3bvjNZ/hfxhJq1zJDDppt4VIG7+nHeul00IbxiqKhI4VB8h9/r2zTldPUTco35xL4sYyIrMxyKBtdiq4Hv6CuC1ODxdf38tto62ltahh5s8w3bsY4Geg9v5V6lKwRS7YwByawbjxPpEumXVzFeRGGElZJOiqR79/wqYydnZGdOcrWSPOfEm3TLdVuJlec8M69z7DsM54rlbe8ckCUDn+LpxRrmu2+p+ZKj5TkjK8n3x6VyD6qJiSgfz16DnkAVs6ihuz3VUjTiuZ3PQrHWpYLgwbwYnXDKT1H+NdJBr0T2JsLjVUg3nPmzOCU9AP8AGvGo7i6/4+plKNG3A7/j/jXQaXcadfY+0oIpmU7mPT8auM1Pcyny1V7uj8z3231TS10/ziLeRVjKpOjKwkwMHDDv0zXn3hb4qXEvi1dG1Gyit9PdzEpUHdGc8Z9v8av+DtJ0nVNKWwspkQQx/M6kEEE5x6g+9de3g3TJLaFovL+1Qt8t1sVmyD3NZyUYy1PMnGnBcs3qZHjq51bT1zpAnj81WhYRAt82fl+nFYWta14k0mHRLOSFLm98oPcmaASbix4X6jj8a9MMrxBlvLfDqoJdeUY+3pWNezNvmvngAhjjDOCw3g9Ac9hx19KIy0sVRqp2Uo7ficuug6j408IXtp4gSC2vY2kW0jCeWA6/cJI52Z4IAziuF1PUrfw54Qk0TxL4f1Cz1K3TfZxyXDPbTyHZu2uvYbyxUEjA27gTXpGneLIPEUqW+iX8XnW5UMQhOQeDjgcD1rP+MPgHVvFz2NzaanaRpZoy/Z50KqCcl5A6gkk4QbcY4zn15cV7WKdSjozOTcZK73/A4zXfGNjren2V3p8T20CQiA2x/wCWLgfMAeh6ghu4I4ByBH4ZhsLUxzzyiSOeQGSRznnHA+mTya8+n0XVNGuvLVopFfhikmFPPT5sfnjv9RXr3g+1s4dKEUyRhtoQlgrAZGTn3+hxXVl9SpUhapFqS8t/Q73Nwp8sovRWOlt7twM2rckYIbDZHqDRXN3Gn2jKEsIZldT8zxysoP4CivS5W9kcqoQerZ9Hj2zRJEkibZFV1znDDpXnQ+IsqMBPZQIxBKqsjOXx6cc/StP/AIT2KODdJpd5JNkDbAysv13EgAY55+leE8JWXQylgq8Fex0N7oFleTRSy+erxO0iFJivzFdvI6EYPAORXnHxf8I6pc/2PqdjJ9pg0uJo7hXO1jHkndx1x3xXp+lapZ6pZJd2VwkkLDIOcfmDzV4FXXghgfbrUQr1KUtehEKs6Uk30PmbQdQ02a1kgubu3sojCZ0mnGyQk9Bk9vbNWNU8R6JpjW8NmqarHMWhlCn5lDDo2eDz0YdhXtniDwF4Z17zDqWk27yMmzzI8oQOvGOAfwqvonw48L6JcvcWOnHzHAG6WQvjA7A9K9D+0oW6nTLGqerujxZfAviDxlp9nMstuNNVStm9w22SNc8plRmTA/i6cCu58EfCLTtEMsmszvqjsx2o6bEUe/dvp0r0O98NW1zfLeQ3FzbTLD5ISKQiIruyCV9e2Rg4rCax8UO8MCNe20qy7mukvEkgZATxhhuGR/DisXX9trGSX4f18hKqpr3ZWNuyv7H7Nc29m3kw2b+TIY4tqxEAHAGOmO4qaDXbGaxjvbe9gOnshkWeVsIyDOWDHtgc96tQ216Y2Sae32tncvk7vlPY9M8Vkala/wBnaCyXun6d/ZVrGxaKOM7YU5yQvOeOfWuZKnN2/X/gIwspPVnNeI/FU+ieHdW8Sf2dYtcuqQ212hVvtMZ+6ysOdoByFbmvEfDOnXup+dfXSi4+2SmFXkjXLu3BUk9D9a9M1jRrm/8AD8em3c/mJfXZ2T2zZitI8ZjwpAIXAwcZwc561yttb3vhu8lt9V01r/SY8NHPFJuRu3IUcE9a9ehTjDY9GhFQd0bf2X7dpFuniS1ULaK3k722pI6ZGVKAcjHc8808RxlrspdWi3tokcjxzkS+awGWZHH8HQcd65248RSXehy2Vp4W1AXTszQSh2EcSluuD6A496m8MeHr7xWLa51q9s7bTbRMie2nAPynkZHLA91xkVq5qKfQqN1foYF9r2sa/rH2DRJJblr1QskaDcmOQCTjIxnqa9Z+Fngi30Scz61YS3OrRjm4nX92jDHEYb5mx/fwB2HSn+Hl0jT7O5uPDelSIbyBla5ceVOwyfur0jz26dRWhbarDaRafplsbuzeJFVJFga6wvUo0nJPJ6k9q5KzqVE0tETUU5fCrIg1bTtQn8VXcNlqAvbuRvtBt7hGiFvHwAFYjDDnsc1o3fhSSSxnBntL68IDC3lDxws2ejsnzYxnGOven6x400+306eLVxOLdQI5JXygbI6Lj5s/QVd029gi06FNMguDuQJGNxZvYtnnPqWrButyrS1v63/4BPPXUeTb7jR/tfTbS4hsbm8tYbhysQhRgDvxnbjqBjpmp5Zo50kgjCyRFdjoVDB89QwPasL/AIR9ZpGuLnRLQXDSi4kuZI0aVnAwCeOWHbNUpPEGpWU98p0+6hihK4jFs5luMnHyOMrj1yOP1rFUVL4Hd+pgqd9nc62zs1VVEaoqABQqDAUY6AdMfhWPrN9FpqR29/O8VxNJ5UDCAnex+6oA69Oelc/ruv6jqMC2ekwR2VzcF0a2vVlWYxZ2b18s8ZOcHOenrVSA3Vlby6XDpFxPc2cKSwTapumTA+XK4JYKDkZxmrhSlvIqFN35pHR+EkuTHctqmq6fqTo5iZbODakTDqhbJyefQVyPxu1eCy0C0s4HUTM+YLZMYJAxux0+UZwPU+wrrLK7ubi0srX+0I7HUYAs09vp8KvGwB+ZdrDO0/gQe9eNfESdfEHxMvY76CZrC3VYjDt2smR/Cxxznk1pRpynVClGTnzMq+FPM8P26rr13Pbi8PmW82Q6NkDKspzg9Occ962DEQJ3il8xULID5AVNpx0B5U/Xp2qtbeGLfz7O2gRjZTLkLfNHIVYZOVw2fzx+NX9TuRa28CBwloh+W42/ffPdvwPPSvViraHdSsnoW5LS2t951GbzHBy0sKqyoScKcH76k8exrm/FF2bRPLlgKW77kVoUOJGI7A9KrX3iK3tJriOWxtdRnmbMYeM7j7fL/wDWrqvhZ4Wh1eNdd8Q27yqjH7LBI7OvB/h3dAD+frUVKippszlUdO7nqzq/hd4afwp4U86aIHULlfMZQPmHdV59u3rXQ6Np1ppUE8sKSm7vHMkvmtuZGbqo/uqOuBUU15bR3hvLm7LEKEitlkLQqM9cKOWNUJNQ1LUdJml0WKY3E4PkzSwMqKc46HkDAPPWvOcZTu31/qxwcspNt6f1+h0YZcqp/cxRDPzN1rEYQ392JLmO7WOOQ+WsUjKJR/eYDqPbNRarp/iK8a3EEsMNuqDzIniEnmOO5YnhfbGfepn8O3UtrFD9qe3UDBETGPbg/wAO3pmlBRjq5DioqOsjI+McEF58JrRAkix/2+hGCd2RbvySf89K8as5LFYfNvQYwDwyMWyRxzjr3r3Px7Yzp8KbWC8OGj1oEMJN5dfJfBJ4ryrTNLs7aX7G9vhHVnKtyo9OtGHslJruzspStDQ3vDI8PTarZ3draL9plUiG42EbmH3hj+9jnPvVLxtoUGv+M7C51GdTZ2cWWt16yEMfl/E4zW54TtFs7GJDAqorsVOd2PXHoagu7cPqLzPgI2VJPJXvn8aJ2k2ccIr2j5jCt/Duov4m1LxHqUyTLLE32e2V++PlyewGO1ZHhrTtb0/xHcaz4ivpodLiDGeR3ITkcAKev0ArttNvJP30ACvIRtDheT+H9a5bTtJ8UXviLytVuY7rSN/zxTsGQqOmE9fSj1KlFxTVjN8U+NP7T0kp4fU20zSbBJcAK8ieqe+ccVqeAtb1A3txoOtSo9/Eu7Mg4kU9Qc4zgHr1rZ8TfD7T9X1OO7YiCSNFHkgfIVHTpwv0pNasNE0bU9Gubu626xGpSGRusqDIw3qMHGaS956EqaskmdLpzta6bFZypiEEoqs29vz71zeuzXmkC6vbKKOW5QM+xUIOB2rD8QXXiiTXbaHSHiNq67gQoxju2cHp7V0MesWqadDBqmrW0d+hw8igop/2c468U0rM15XG777mHZ3CeMdOW400y6Rq8bDcy/MrN2yO4rf8P6Z4tihll1vULQg/IgTncnrkEbT9M1n6DbanLrbLJFops5Q3zWkg3xnB2lvX3OKsXF49mnlGALCoxIFJG5vY1bveyYRg6lknt/Xc7PTY9Qe2WNbmPzkb5mkPmNj0OPUCpr/Q7C9uTczNcCdFwTBMU49wK42y0OeyuZZotRkMFwobZGWEnI9Rx3//AFVLpGhtp2oxajbajK8SSfMpB3t6o3OPbms+VX3IlSSblGdvRfgdXp19bQuLW2uJGjjyXaVtzLjsT3q61vYWnmvKkCLId53AcnvXGa7rOk6VqIutREtqJiN6CNhux/8AWNczrviLxEdVLaXo1vd6S7AW1yyyNlT3OG4P4UnT6mLotvS53P8AZ2pXOpXrrJZw6I0YWAQJtf1JJH41FrnjzRvDVzBY309xcXLIGWOGPcQOgPYDp061k6tN4nt7DTTpkdhLI7/6S5UrGqcHauTniuqXRtNS6j1G5jgM6DatzKF3KOvBI4/nTl5kyWlpfIj8W6rYL4Onubu4ms4bqHEe4bJckdADyDXm97oQXwRHF5jm3MqzuuMFx2z+dd9rlhpniS0kifyr6a2YSIGY4DVznxI1OLR9BtYJY4kuJFyVRuABwoAqoSsrLqb4aMU1GXc8a1GdZluYY7cQscYYdcen0qxbhLHQySELuxZWByVH+RRc3TXwEJjiRs/IxGN/pzVmHQTcWY+1RyYjclfLBK+4Y4wa1SerSuzv5HOXNF/oZNnp84ijuY4tzyk4iPdT3p4SHzoonuGtJYskqMryOgyf/wBVekeAfsxW++ztEb5GCYPGxAP4R6UnjeK3ubS3SS3El4xO0vhmC4POevJqlRSWhk5Ln9nEz/hvrKweJYUgcKGYJJn7pHpnvzXpd/qUhstT0zTgNP1Z96whDlXIz8yV8+XkdzpaiXzPKCMpxHkENXb22v2d74t8J63rEl4kjlYSEOxVbOPMY++eQOuKyl2e/wDVhV7S96S2X6mp8I/ET6hqUGmapqE9zcxGSVYGGE2jqM55bPOMY4NeneIBZ2MV1M0Mkz3Ns8KnaTFtPUORxj61iN4b07Q/FK63b2UM7vKF8xW27GJILHHfOa63VWgn065tYmDN5ZPlL1/KobbSbOKcv3kWtUzivhV4ftdBvtTS2iG6VEJY8lRk4UGtn4jeIrfQ9HWCT5ru/wAwW6DrnHLH0AH86n8KW72lrPNcMWOAp2+3eub+KUGnXmlR6zLIsz2BwjxNkfN1Hpnim17yXQrljPFeV16HjV1NDf3Gye1uQYsoDG2ePdcV0Si3igiWEvhQMBvvYHrVHwtbW99dfa7y8laIMQwZ9pJ6gZ5zx6V28x06JCtnaxspIGQhYj15/wAa7YQdr9z0411GTbV2/Qg0/VLHyEVLs2bjO4PEGB6dCc0VB9nt53bbFGuP4dn9KKtp3MXhqcnfU1fA0V5rN7dQeI55bOS5XbZyK29GfPfk7fYDrmur0nwvrdrNJDvWd4mKu4/d4HbjuMdxXf2Hh7S7N5TDYwqZJPM5XO0+3p61sgDr39a8ueOab5dvM5nmDjpDVef/AADwuXw7qS6omnW1o1vLvEKzxuwMS4yN5OSy5PQEdeor2GwtLzRfDVtbQML+7tYgpMhK+djrzzg/nWsOmOR7U4HnjpmuavinWtdbGFfFutZNbDICzxq7qEYgNtJzin44zz+NC9+KRyVUlRuIB+XPU1y9TjvcdzzgdPSoDeW4MgaeEGMZfMg+Uep9K841q513UfHunwfYb6zjtLZ590Tt5chPAXeOGP8Asnp71ydjqdvDcSX2o3wuzazH7ZEjmUnec/NhQSRyAVGB36V6FLAc6u5HbTwil8Uj2uHV7KVvkkYjGQ5jYKR9cYq9FKk0QeNg6nPPrXiUmranZC2bTdRnuFuJ2NrsDiMJngSD+Ehc5zxx+Fd/Y+LkgtYzrTKgzg3I4Qjt+Pb3pVsDKKvDUutgmlenr+Y+58HyR6qlzoupNZWctyJr2zeISxzLtwUXP3M+1ZN38MLb+yYLHS9Z1OyMBZkmJWU8nO1geo5rsdO1vT9Qt1mt7tMEZKyHYy/VTyKmu9Ts7S1a5nnQRL1Ktu59OKyVfERdtb+hkp11K2tzjdL+GtjZnzbi4+23QyTNcQhzn2BO0D2xWwvhC2WPYJ9o6gx20S4PqABW7Z3ttexLJazxyqwDfKwJHGeR1H41aJAGW4A5JPAFTLFVr6v8hvEVU9X+ByF/4CsL5ZDNcSiZlIWURxgoT3Axg/jV/R/CtpptjFbyT3V2yrtaSSTZuGc/dTAFbcM8M8rxxTRSSIAXVXBKg9MgdAccVg+J/Eb6MrtFp9xcxQlRNIqsQu44AAAJPUc9BRGtXqvkT/QaqVqj5U/0NOPRNMiAC6dafK4cbog2GHRue/vV85z26YrnLXxFN5d5/aNkIZIAWXy51cScEhevBx36Gsebx7maWCCyjWeMKzxySneqt0JUDjNH1etN23+ZX1atOVt/mv8AM7k8r+NAJA4PFec/8J7fJdIslnbtAfnZhlflzjaCT179K6iz8V6PdzNGl35cgGdsyFOOecnjse9FTCVYboVTCVqe6+7U3D1znkd/SjJHes+TV9OitHvJL+1W1Q4aVpQFB9M+vtVC28W6Hc3zWkWoxC4UA4fKhge6k9Rnj61mqU3smYezm72TNSaytpX8xoU8z++Plb8xzXkHjvwPrOi3cOueEPtOo3KxiC4gkVZXlQHK7g33sDjI54FesPrOnRzNFJewCReo3jA/HpmroIIBBBB545FbQq1KT8hqU6e/4nzTa61d3DPpkul6jBfSuf8AQ1tSMy9tzEdP0xWfdeE/Hk1wYf7ElQSMUGXUhT6nnGPevqRiSQxPPTNNIOcfh1rqeYSfQ6Pr87WWh414K+EC226fxKlo8zENshycHvyOMV6VpXh+2sbJLZ3mu0jyE+0Nu2L/AHQOwraA5z2ox9cDjmsJ4mpPRs5pV5yILe3ht12wRJEvogwKl9cnNOxSYGeaxbvqzK7b1G47jrSYyfSngc8/hRjn1ouBxvxws7u6+FUUWnSrFcDVVdcrndiCTj6mvHfB0OpXOg3MOtxzG8hG6HcAGMeeh7nn9BXuXxWt7ib4fWQtZREU1dGck4yvkvx+orxBPBk1v4wt9XS8cwI4kEZJ3HgDaD6VvhdIN36ndSb5U0dB4Juvswu4ZYZ4ZRkpExB4H8QrVuWi07T5tRvroggcbl6H0x3qLRbmR5zFfQyRGMhVkOBla2dUtNJ1G2EV7AJoY3EhBJAyO5x2reb94mU7VLy67mN4dujrFt9pSERSKcsNmNwPQ5963btGjurRrdfnjBEmOykd6u28IWECJ0iULwqqOBXK3finTLLUzp17dxIx7ytj8z/jUXu9DNv2k24rTsburXtvb6RdT3JdI0jJZl9PavHY7BfiPHJIZpIJbDcsJjTcHQ849j0/Wur8fm61jwpO2imW4ET7ZUQEq4/Lnr2pfg7p99aeHrltSiSHdJiGNFwQuPmzjrzTtZWsaRh7KDbHfDfw7c6FC5u7l5pSxA44VcdOeeak0zwDpST381/JJexTEkBskAk5HHt6+9dmWZWMfl/u1P8AF396zNU1CO3hdoLiIMoyQvGfbOMVSbBOU5e6ed2F14Cjv5LZhLbXkchTLB0GVPtXoxuLa8gtZo/3kK7TFMmHB9gf8a4RfEmja3ra2t5FpiyA7SbmAb2b2bGB+ddXp9pFp9hJb6ayWO99z7Rvjf6Z6CnZ21NXHuzto5oltxIHRUAB3E9B7muZ8Q+JbfTNRW1lt0Fm8DTzXJOAAP5n261nQa6kOpQ6PezQxSzqSrDLB8d8dMVfvrCD+zpzq93ZtYkHzPMwUUduT0FTy23OeFKNOT59SHwx4q0vxFD5cUsd6YvmMcigsB2JBrpnmjuXEU0HzfwKTx+NcBo/hzR7PTb3VfArWd3crG3Ik8wZH8OCeCfQ074c654h8TwSXN/FDBFBJs+4VZuPT2NFkwlCMveR3Go6hLZ284W2jWZYi4VXBBIzj/OKxtCvP+El8LxT+INOwGYlUkBALDoRXM3Os6N4q1q50i+njuJ7bckaR74mdl6lXHHGD164qx8P76ytfGGoeFbGDUvIgg83fdzeauQBkAYwo54PeqtFR8yXDkXN2Oy8LWdvZWoW1U7pmLuSc/QZ9AOK8V+K95Hq/iOdY5kBibZHGx4Kjt7HOT+Neu6lLLotlfJIGX9w728qjKkj+Ejtx+lfMt/NLc6nPNkNK7MW2nOaV9bvU66Ks5VHrfQ6DQ4o7aUGdCyIwMiSDGOuSpr1OHUFaOPbMJYUUBHhbBjH0+lcr4CsbOTRo5dSijvLpWwsLsQoTGfmx/nit6XwzZS7zbQGxuCCy7HbYOOnPUV3QVlsXWlTk1F3VjB1xrZdVS4tGUTsCZWi4IPbkVTiF9czySRJNcXHZjljn1NdhoscMOl232WKKK4ClJ5MBizDg5J7HjgYqTQnFtvhdnjLMWJjwM5Pp7VaT1aNfrKhCyjdrucFreja9MFNwot7VuCZE6kep5qnaXE9vMEsmguTbfMslxGJF3Do2Dnoa9Rub20skWR76GUPwySD5j68emK8g13ZYy3cmnu0VtJIdsZPJXPC4rOSUfeZNOrKonK2n9aH0D4E1GTxP4SjvJ4Da3b7op4yuELg9Rn8D+dbGmPDfQy21xAkV5APLlRD0HYqfQ1498GfFsluPK1KSFUQfO0jYKxg9cetesxae1lrlxrEMizQXqouxP0Pp+Nclk0n0a09Tgq0+RtX31RfeGOJZbaRpBFONocHnLcHn1964H4lWMWgeDrK2tPltopDv8wb9+VOS3rXYXur2kWt6dBdOsX2hmji8zgs4/hA7H3rnvioDd+H5YvKMgtpA8wHTYc4/wD1URumisJzKtFPr/wx49o95B5xgtYbdUYb2EYIYkdODn8xXcaV5nlqf7JkOeM7id3vjtXn3h+7s4rtVgjaCQsAGdt2R6Z7V6rpdtdSxZMWN2ChfGG44wc13w0je56Fadqa2I5JRMSv9nzGQY+VQMD6UU7UXltvLNzGYsjhm4DUUaM51GTV4r8z3Xd1ySPxqRcZGe9Rg8E88VItfOM8lMeMY56jmnZGOlNz7jigdgefqKgY76fjSIoDs4Jy2Op4H0pD7jilBP4UCHEleM4H9a5i98CeHLq9mvH02JLqWYzvMmQxY9SOwzjmum6gAHg06qhUlTd4uxUZuDvF6nCa/wCHDZxo+mxyNCCfMAbOwAEg4PJ54rmLrRpkkaPT9NA0pAstzdmUyF2PPCn0PNexLjAxxVOKxWC/kuYGCJID5sYX77cYOe2Oa7aWPlFWl0O6njpL4tWjwecTO941zaSGzs2WQSzcpIOxUA5444NNn1lNLurbT4IBdrPGZ98EhZRk5OS3IOex6V7pqkbxwr9i06C6aSQRyK5ChVPVjxyBxkVHL4c0m5uFubnT7Y3IwzMq4BYdyBwcVv8A2gt2jsWZxavKP5f8A8vsoLyytX1dNJuRASqyMsWHPbOD1Hv0xXeNp8EmkxC9W7iilPEMUrO0hPr2xznGMV1XI656UE85HU/hXLUxsqlnaxyVcfKo07W9DzKy8DvYRK2kh5IoI1Cx3DFGkZW3BjjqwPQn3GK9ESNrvTRHeqytJHtkBODz1+lWqQ56cYPvWNXESq2v0MKld1LXWx5xrnw9ebVGubAwywvCYHE7lX2EYKkj7w9M9MU7xD4M1jURbTJqzQtbxrmKBQDORwN7kZYAcYr0ToQR/KqWm6fBp0MkVp5u2WZ5z5khc7nOTgnoPQdBWscZUsrvbyNFjJ6N2uvI8Rv7K78OyXM2uR6lNKZfNiSNA4I9E5wV9RntWdDPd29vD/Zrz3Qnk8yV9Qy86qQMoirgA/XgV9DywxypiWOOQejKGA/Os++0XT75ALi1iwFCgqu0gdcAjpXVDME9Jo645lBu84/czw++VLmJvt9zGbeGfzkidVCohG0BierHrn2wKbYztNrhtTbTuNhcXQjAiAPRSRycHnPrXpN34B0/fJLKk94DIGjiYqQg9uOxyc8msp/AWsu8sEWpQ2lo0gcNGSzFQclTxnJHHpXVHFUmtzrjjaNm07HNzRSWuow/Z1R55QsZilk2qwXkuCc/MAScY5rT0TxB4h0y6tbW8u5L5VgKb5/ukgjG/HO/ngg4wOea6/wb4bu9M0+VNVuGuJTO7xhsHy48/Knv9T615D4m1eTR/iHf6FqQmlsZQIlltE2GPzFzn5j82M9eMEVPtadaTg1cweIo1G4z6HURfF+6XWrqCfR4GtYZpIAkNwN5ZPmL7mwAqrnOe5GO9dheeNYH0d7jTIg148W+FJ8mPcRxuK9R9K+a/iFJJod5p8Okpcwac9rujeUZMu45dtx6kkc+nTpXd/BXxK/iCS5tNWt45JrdFKzINnmZJG0gcAjtjHSsHDD+09m07o5YwoX95fcesWHjeK4uY45bGSNW2qzo+4Ix9R6Z710dtqthcytHbXttLIp27UkBOfSuHu9CubhnS2stqSAg5JUYIwRms2DwVe6Do8P9gWsELRy+bPFKGkZwT820gkk8DH0onh6LejsXWo4d25Xb53PV1PBx264oB4rxR72+iu5JL6aQSW0rXFtHasd5JG3BB+8SCfl6Cug8PeJtWmVZHhvEeQ8W99CUY+49PzrOWCktmRPL5x1TR6OJEaTyldDIOqBssB9OtOB7EY/pXmmueGdQv7m4vhb3H2y4TypE8zagXsRyOnH1rR8OavqFnJaWV+zXMMcOJJNuZGfjjHYKAT3Jz7VLw3u3i7mU8N7vNB3Oy8WwLc+Co4jjnUB+H7pq8l1/SruDU7C/gusW4zHNBj7+R/8Aqr1XxEV1DwNaywu4Q6iG5BU4EbDpXLXFkssbK7Pk87s9COhrLDScE15sw5+Rq5y91qUGnxRPfXVtbhztAds4PcZ7kVqxzwNZRTWrJNbvw0wbdu7cdjXPeIPCn9trs1CN4Zd25ZomyOOM4P6iui8KaBb6Jpgs1JlUsWJfoenP6ZrofLa/U0qSilcj1S8t9OhgF9MkRf5URELOwHYKO3PWuB8QeAoL/Xf7Vv5JWt2ZCEUAZXsD39q9Pu9O83UILpBGzRnpIucD29KFgSa8kWX94qtuCkZwe1JSQQrRivzJtPszbwR+WREm0fu1XAXj07VBckJcgCZSFHK8A57mq3jTWbjQtClu7O3E86kAKTgKvVmP0Arkdc8QrZeFRqtyyw3Vyivg88t3/LtTUXbmexnSg6ju3uO8Z+JoYtPUCaRSx4EPVv8AOK8b8R6vLdPBullETZO1s+vU+tWtVnvnulmI+1Q3MZeKWOX5SMYO30IPY96cvg/UbjSluWulhRQSI5fmI/wrVqTj+7Vz0m4wjyR2OdFw7XASS1hBHIZcgkevWty31u4m0s27T3O/hQiSFT7c96w7iCS1njikPnnGN0fJx7fStC3uzY6W0bBbpZXBJcbRHjPGev8ASs6d1dSYozlF2Og8I2wXWLG+e4k8+3kO2K6bOPqRyB0NelW7aZ4sGo+Hb5pobzlvJONnHI2nr1wa8PikuHu5Lqydba3iX55eu/H15JJ7V6P4Rv7XUtdtr+1KpfW3yKZSVEg/u+x9PyrSNpXVv+COUVODUNGJo2rH4cwCK60Z7WK8uHgmdmLOdoGG+mGzx+teqiaLRdPzYxIZ5fmAdtgIz2z35zXM/EixbxNpVlaXsOxPtAxInzPExGM47jnke9ZupeHVi1+/bUvEaQadfLHHBay5MnmIqjIXpgYIz7496mz7aHPy81ufRPexDJZX83ja3ufD1lY2momXzLw4G5043bSeOmc45Oa9WtLeMXk9xCsQlYlGbaNwAPCk9elc/pt/pukWf2+RxLaYEcd0BkkDAIPvmtj7XFDcfbsTJazR/vC6EAY+63txRK70SMq6cneK0OY+LGoRWuiC0u5lje4IEJAOSe/6Zr54t4Ypr5ZbeQB1fcV6bue3ofavb/jG1uutaHdXnly2MUcgaNj98t0II7YryWf+yrh1trG2W3TeW3tKS59OvH5U4Quk2dVBfu4qx1UFxDFAjwzmKXoQB2PYium0zXrrV3S2uHjSWJfkkY/eA7D3rmP7Pje2WRbn96oHGMkj/Ira06az+zLb3FnEl2jZ8/cV+mO2frXoNNvVHXWhTkr2uzfnsXsrV5rR/MZVMrJJ0J77T/j3rDuILzVL2CS7ZbSPy8goM4Q89upPJ5qXVp5jDFHHdl1D/NAw6jPqO1RXur3AxcRWQiiiBO0PuwPbjpQlbcyowqKPMrN669vvLf8Awi+nOxYXpLg4JmUjd9D0H/1q5jXtGti88MCNcyRk5ZFLqox1yPrWfP8AEI3VwtubXyreQ7JHAyxX6dK9E03WLO0tUWK4T7KkeFRSA3vnHPNQuWonyu9jONerDf3vI8YtbZVvHit5RK0imFnHQA9/pX0r4Ct7m18G2tpcPuliQhN7Zwo+7n8q+bZJYTrkptjmA3JfJGBjOePpXvnwx8QyahpF/bXsWZLCQRg9TJEwBUn9a55xXs9DHFa07pdSv4w1WOG78J6xdRRqzTkeXIM7SeMj3wDzWz4lCImswvlo720Nwnf5kABA/DBqTUPD9prtrp7SqcWknmRgnAB7A/pU3iq1kbT4LiIhntyScjPBGD9fpUXVkvX/AIBnCpHnjH5fjdHzha2tydTjSL9+5bISXAb8B1rvG0vUbWNYpr3yWxu8tZTx7Y7GuMF/bWXij+0YDK00b4aMDPPQ9etd/F4sj1CD7NHpb3bFt6eYm2RF9CR0x611QtbQ9CU6kZNRV1/Xcr2WliQk3N7KWAwMDdgenPaitAaXrE6+bbaZiFjkKJlYj60VrzQQ/bvpNL5o+gQBnIxTwOnqKcUAP41IsYKA85r5ls8BIYARn/CnD6/XmnKg2g89M04qMipuBGo5PHAox/Op0jDcknNIUHB5pXERgUo6e9SCMbgMnrRGgPcilcCM/pS+5p6oCSOeKURj5uTxRcCI9eMZpe4p6qCx+tJt5x70XAaetGcYz3qRYx1564pAgxRcYz17ijtxTyoHr0BpfLGCcnjBoGRE49qbk4561IRk4pNuBjJP1phcjIOe/wBKQEEkd8VIFGe9AXtk96dwKcVu8d5cTG4lkWbbtibG2PA/h781N261KVGG68CkIwxHvTvcbk2REA9qy9S0HTNSn86+sbaa42bFmeMM6DqMEjjnnitZRu29aTAI5qoycXdMm5852/ws8Ty61rP9tWkN3ZMrNbeXdBY5ZQV2nBJKgjOeM9QMVzPhPwxJ4c+K2k6fd26XbLqCxma28wBG2huVx0G4H8D2r6vcDaD3zVa3sra1nuGtoI4nuZDNMyjBkcgAsffAArr+tc3xLVbGqqvW4iRncCXzjsR1NSjII9qm2AY68VGoHHHrXM3czbZAbeEvvMMe8dCUGR+NSEbsDqAPyp684B6EUD7pPocU7sLsj71AbK33u5gi3Scu20ZJ9frVsqMD6ZpuPkz74pqTWw02til4pc2fguzWAKFGpKoQ88eU2QPf/CsE9xgjHcV0Pim2S68Naajs6hNXVwUbBJET9fasFoBll3vgEAdP8PeqoK8X6sqorqJVulDR5Y42nj69Kgh3SzsN21VAwoPf1qxcRAMV3MQGxzRZwL9pnGWxvwPYYrYSjaJFqt9b6XYy3N3KkUSD7zHAz2FNs54xZRTuyJ55GwyMBuJGQB6n2FcL8brcXUvhrTnkkFtc3qpIFIBIJA/kTWl4/wBFtZfEXhrLSiGwjmnhgDDZuj2lcjGew79qrlsl5jjBNJdzkfFPiz7L4y1PTtf+bSUjRWjQfeJxgD/PY1wnjDxLFqJmgtoswxOFhjbmNUAI6dzXZ+ILGLWNIttSvtz3TXRYsMDOUNePahEtvdyxoTtDY5NVWlKEfwPRS9ktDRtV1TVoUWKKea3tl2r5KfLECc9unNdx4ei1vU7Sa2vb5YIIht3OMscjjj6etHwe1K5trXUIYXCxhgSMZ3ZHQ/lXX66iWf2HUoEVZ5cxyLj5HX3FdWFg1FSb3IjPXl6nI3PhttOv7C3S7ZxLuO8ptA9+e30rQ8J2enq13BLFBPqsRYTecituQ427c9OKtapcSDV7OEH5Yo3ZOeQSOv6VygRr3xTDO8skUs7JG5iO3IOBW0ko2fmb8sqlNIf8S9L06wSwbTojDPJkTRqwIx1DYHT6VzQ1GWza0bTYzbiJtzSb/vn1JPSvQ/Hfhiw06y8yBpy8mFYu+c9fb2FeXO5zJBx5QG7HriuWqmm2upCXLG6Z70vjiO1g0KOa3MsOpSCGW4RsGOXIwT2wcg/nS+J/BkGu6taahfzzwtDKQHjO7IDHqD0GR1FcX8JYY9et9U0zU1EtokPmIvQoycqQR0I/rXq3h67kubBZZgrPJuzx9Tmp/vEVIqN5LY5z4k6NqOqeHf7M0RUZoZEuIY4sJvXncB2znBr0jQDcS+HtNN+qi6NtGJlHQPtGR+dUZIVRdNlQlXZ1UkejHkVzfw/8Sajq/jzxdpl7IrWdg+23QDG0B9vXvxUNXOSu+aKfY85+M99d3WvXmn+Sv2XTxEsSjhiCCSwPr/QVyGkwW9wkiGPfIDuBdSMV6h8bIIpNUtwyDMkQDHvnJwc+tec2OQdjMz/7RPPX2ropJaM9XDxuoPyN6xtXuNsS3AifuB3/AArorGG7sEaNraK9iI+5Jkf5+lchdzSLcxRqxAK5z3robS6uF05XWeQEuFPPUV2RasdVanJ7PQuWKrcaoVgtltXk4MIO4D6emfStbdFYMLDVFe3jGfnVTuc/3SecDn/9VSfC5f7U1q5a6J3RQ/KVwCctzmt34i2McdjBOGcuHKckHjH51m568pxVKv79UHtoedy2vhmylkaL7LuDHLE5xVGa5spUdrFUBUcsvP8ALpRqWhWEt4Xmh81ic5ZjV21sLayGLSJYQVB+Qd8Hv1rZRaOmCcH5HnE4umvpZHAVmOfMHAA9uwr2/wCHanUPDPlRY3NtikmDcsofrkc8AkV5d4p0u3M4ncyOwXOGbIPGa7j4J3LzWWoW7hfLMbMMDG3tgVy2cFJM5ay5U7ep65YKbffCqq0MZPkn1HbNcj4C8VXPiXTdasNZtfs2p6ezpJGM/MhyAfqDx+Vda7GPRDKuN+0EE84NLDaxG4S+K/6S6bGb+8CO/wCVcr3Z5aa1b7/kfLniGGe2125M8EIDSfJIMD8/U10/gTxKumXEqarEmH6M4xk9sYrK+I7+R4xmgVVa3bLGJh8oPPT0rn9G1Ka8vY4J0iaFQdq7fu46Y71tTqKLt3PalGNRuL2Z7hDdvrJMmm6fK7HLMF+XPqee1FcVaa5qELrAk52LGMeo9s0V3pP7OxzywlRO0bW+Z//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Low (left) and high (right) power views of a biopsy of a normal colon. Low power reveals straight crypts and mild lamina propria mononuclear cell infiltration. High power shows the surface enterocytes with interspersed goblet cells (arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Robert Odze, MD",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1119px;\">",
"  <div class=\"figure\" style=\"width: 481px\">",
"   <div class=\"ttl\">",
"    Collagenous colitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 461px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Light micrograph of a colonic biopsy from a patient with collagenous colitis. The characteristic change is thickened subepithelial collagenous band in the colonic mucosa that stains in bright blue (arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Prof Dr G Herrmann, Frankfurt.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 518px\">",
"   <div class=\"ttl\">",
"    Normal colon",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 518px; height: 172px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCACsAgYDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD3ECnDJ6Uwe3SnD1r22cKHjpnOQPWpAe3eowOeaeuB3496hjHcnpRn5R/jR+XWgVIwGcYxQPrzQcZ4/nQfccY/KgLi5Jzjg0g4FGBnimgdz0FAxwz2pePSmjpx+FPPPBNACDnHOemcUh69aUYznNIPQ0DEXBYA08rwCTnimEHPNBc42/qKBiseMgH/AAFNyOp59qQnPTjPakPNNIBQSOlJmim0xi5BOBR2pOAc88Uh6cUwDqPxpAfxFI3TnmkyeeaYCg54puRz1pG780h5NUkAuc45/Wkz1xmkJA6mkJ/CnYBe1BPP8qTP5mk3DNBIpODnpQD7VGcZ70oP51VhD9aP/FLJz/y+D/0A1yvbGTiup1nnwshxnN4P/RZrlONx46dq6ML8D9WYVviF4zuPU0pPB64pvHPal75/DrXUZWFz27U0knvx6UHBGOg9qO9AIdnH0xSZP40lApDHHsADxTc89eaXPU4z9ab70DHZ60dqbQDkfjigQ7cQDg/nQODzxUaFizblwM8c/rTwfwoGOB5OT2pc9ecjNN3dhQM8c85pAOzntxQffp/Omk578noaXpjAyTQOw7PocfpS5H4g8Ui4OeevrTjknkUAL+HvmlBGBTQDjk5pQc57UhD88CjI4/pTc4pSaAD1NND9u/8AOlz6VR1FJpECW+WLkK/z7QF7n1ppXY0rjZtYtI7sWwkDS43YXuO+KuqwZQVPGOKzotKhghCRFmOchpDuINXSrqiKm3jGeO3tVadCpKP2SRj1G79KQ89OnrQcn29Pek4GetCIaDI7mmk8/wA+aD09qa2cYFMVhaKb19qKBnZg04HI6muF8ZeNP7Isx/Ylt/aV4JNssag4jXB/NjjgVwkXxG8Y39nHNDYJBJJu/dLGv7tV7sSD74FckMDUmr7ep6VLB1aiulb7/wDI92BHbmn8E+pr550b4jeLNQ1VrW4kmgKDzC6wqECk9OQNx9x/9euqTxh4htmjkad7iHcBh1TdJ7ADkZ9a0/syq9mvx/yNPqE/5l/Xqj17rxj3pSeeveuFn8cDT4ka90+5aVxkIny8evNRXvxO0qykP2i3nSE4xIzKuenY/Wud4Gv0iYrC1mubl0PQCf1oyMVwN58VfC9paRXE89ysT/dPk9fpzz+FdEvibS1uzaXF0Le4VVZlnG0KSM7S3QMPSspYWrHeLIdCot4m5jnk9qaenv3xVaG+tJ4WnhuoHhBILrKCoPpmpnmRIxK8iLGcYdmAB/GseVrSxDTW5IBg8jn1oyARzyelUrjUrK1K/aLy2izyBJKFz+Bqude0lsY1Sy4P/PZeDVKlN6pMpQk9UjV74B5pAeMdKpxalZSxh4r21dMfeWZSP50x9V09CQ9/arxnmZR/Wj2cuw1F9i/3x29KQjpVI6nYhN/221C9j5y/41Edb0sAn+0LTGcf60GmqU+iYKMn0NHPakJH0rjdc+IGk2EvlW+68mxn5GCxgDuWNcjrvxcig0p5YVjs7mNir+crOCfROma6YYGtJXtZeZvHDVJa2t6nrxYZwaXIzjmvBbX4yX1w4jhi86YANs+yHdIMdua6GP4o3EE6G/sYjFIUCqu9WG4cc4IOOQfStHl9XpZ/Mp4Spa6t956wTkkUhPBGcVymn+N9Iu3Eczy2knOROMKD6bhxSTeO/D8cu06gZBzykLkZ/KsHhqqduVmfsKt7cr+46rI/SmnqOPeucHjTw+VU/wBpxqG6BkYH8sVHqHiG0vNOnTQ9b02O/dR5TyuCBzz8p9qaw9TrFr5MXsp3tJW9TpiaaT14NVbabbboJZ0klVQruSFywHJx257dqgm1WyicpLfWiFRlg0yg/qalU23ZGduxfJOe/vTdwyOK5XWPHvh3S4y1xqKSbeW8gGTaPUkcVw2s/FrzmddL8q1hG799IPMkOBnO3ov05rop4SpPpb1NqeGqTdkreuh7C0mxCTkgDPBpqSLIu4dDXjlt4t1HWUgibUGJJBUbFjUkcgvjnA64OM0/+29eFpqM0OpW80GSNxYfMQOSucbR/OuhZfK2rNJYRxdnJf18j115HEqrHFuGMlywAH+JqUEc+teS6F421KytCs9pHcA4dd8hRsH8/WugtviRpghdr+Ge2aMhZNuJAp98dv8AGs54OotlcmeCrR6XO91rnwouAT/po/8AQDXKk84PWsD4teIob74QR3ekXcqRf2ysMhXKMf3DNtPfuprxHSPEer2h8621OdQhztdtyn8DTwtK0Wno7slZfOquZOz7H0bS/SuT8P8Aipb7RUu7qIo6ukchAyMnAz9K1L3xHpNlKYZ71PNUBiiAucHp0BrdU5X0RwTozhLla1Ng8ikJ4qhZavZ3tuJYZMKTgbhjmrgYhcuVBz+ApOLTszNpx3H0MegP6U0HK5x9KI2Yrll2n0pCHdTQKWkP/wCukAooA9elGfekBPpQMX3oPAorJ1/XrXQv7N+1xzP9vvYrCLygDiR84LZI+Xg9Mn2qW1FXYJXNc9f/AK1H16UA9zSgDcBzg0wAd+M0oGMUe/Bpe4GOaQxAQcnmnGk6k8c0p+p56UWC4D6ClHU8UnUDjn0pPp0oAUnrigsaQnnA7UgwegBxwKBj84z7UduaaBxx9aUYwO9ABkkY7UHODyfrS9etN9hkZpiAZGOc0h6kfNx39aX6UAcHr6UwGt/u/rTOnJ5/pT+2elNz35oATp2ooHGaKYjzjxTdXmhqkkX2pFhjEcFyxBjZnfBaUIOgAHzc4zg9aHtMz2q3ckgsbBVkmS1tWgT7QzlUXjlxkFjnAA5PUCr+j67f6hd7b2TT7KGZd8Atb4yJdeX/AAxqw+7z8xA5Ix2zWZ4p1e+07wlpcF9q0ey+knnlcRM27L/IVJy2BznPPTAGK7U3KyPoIyk2rvcz7ZNS1bXb6RHaSIMyKTEsMYY84X+JjwcHgVc0hU0rV47q6Uh7dxKQPmwccZ7D6GsrwRc6ZBDI13HazRMSsVzHGTGTjBDDrn39624NXj0pr6O13TWrjcpxhW4xnk5wPxroXvJo6FKo04KOjX5+Zra3fS6lP9oEezAHkSRnlV6//Xrk9PuJ/EN5dNqaWh06KUW48wYk88HBBBP3uPTBDGrMN3qOrWlt4atYpBHes7R3cGMwOvQEjt+X6V0cunWVtNvdo5EtZ4pmuJbUiOWcoQvlsCDK5PAzhfr1rNyUPdQub2SUGtv6/rzK62kVvff2Lp8Fk/iMFZbaKVTMkS5y0jBchRgcZI5xWbrzaZq1zazT3uoQahNO0Xy2ksbFycOShGB/vZ4rTt7dLXQtf0eK1ltkunRA91MsDXKk7mUOMkoCecZ6Yz3rQ0fT7hvGl2mmy6hPpFkq29xZXBKNDOoGPKLE/Iw5z3H1rB1OVtt/1/XQzdZuT5v6/E5HWdLGk2Xm3WtG007iJA0WdzH+J25JOM4GPxNVm0zW7zTkaz1mC6gQl42cfum6fLjsAMnjqeOK6PUdN8Q2+o2bWsH9o/bkmto42gCW8Z2HDMqcMOuWduOw9H+CtOsLPThbW82lwmRni+wszhp5VAExVZOq9QAOMHOav2ytuV7dX/4JgnRtVe7eVtYsYlb5IYxhw4DAkg+uMjjpxzVa90awsbSP7brU84Cm2mEcRZ3O8MMBeSy8dunWupv9JstMsr4f2roNrZwyCKG1llRI7OUHMg+RXffjkr+FbGgX17b6NcW/he0gudQsrg2+69k8yNZCcs+9OTkEHb2BAJ4pOu+XmX/AJ+srVR1froctD4Os5hNf28l1pyzpHavKYWjOBz8gxuy3c9q1NZ8O2t5biC4unY248z92DF1BALEnLcHpXQ+LDqUC2eqF7wTmN1uL6InNtH1Ihgwd5PTJ5ArAsk0bVLoO+gT6hdG8Ek2IfKa3YqNskoLDGeuF6dxmojVbXMONbRtrQzdNsrCNLe2s7tZIkxD5zYckg85Oef51VTSJ766mkm1i2Nhc7hbQWrANIu3HUfMMHJrupZPDd9vtW0mZJoZ2d2giCIrkfPJuYYI+brznnFYUPhmaDXYprO00fTdFNq8EdxG6s0jlTtVc8sMYOAR0/Oo1rb6FvEqaSatY5Wz0bSdcF1bI94Dax+W5uMq21MDeV6kE45PXFa9zo9u0FvE1tBLHFGF3uo4OeMDnjocjntVzUtXsraO7ga50yC7d1huHhi3klBnbI/ABwDjnjHSm6jqT6JbeRLZmCKZFeCfzQ8jjrgIfmVQOcnrWibdvM1pzUtu5z+k6K9kslzeQLZCEgAG4DKyc8scdB2zW/HYm9hhkS8ieB5FkR1KusqqeVBPAyPfIrgZ/Fs1yAbWKKWKYMsgu1ZoSoPcHAJPpXa2kumajFZrr7TwR3flrbWVupNqk65YMjbQV4GSDwB17UTdloOpUaWmq7mP4mtJNC+03to6mQkxtDPJtjDM3zHPdjwM5wO1c7YeKLmC8El3Y7bZpWid2RiyqFyT9c/p+ddtDaZvbm3srF5NLUM8rvIJ/tT43AW+WKj0IPT9KyLC4nuYdQC3FlBfzSki1vreRFES8BcgbmbryARngUczsR7VX0djHuNEubp/t9vayQ3MmQjSOQIs8BwPTqT9eKntfDGsx2NzcT3E09w+S0cSK3zHAUrn0H9TWhpWsXbXNlb22tPqN2qHbby2TCO43Lldz7RsAA6jtVw38ltezyS20ssJEUC2s0ixxPI33gsjEZHUD+Ic0nLqg9pDV9f67FVtG1RDIimNcPG3muNzMgA8zIHcnI/OszUdNv821vNcAXzt57ssWFZAclQO3BHU5J4rRW+uE89NIltobGwSGWO1tVkumliYnIDY67gRnr64q9aaXfXN5dtJdMt4WDtaCYq1urKrIkisMI+M5HP0p87b1ZUa0Vuyn4V0Ca6aa31NZYLUsG+0yj5jknIwM8dBxUep+EtMtp0vIv3kUDZQc4Zs9SD24rVifWtNmtx5crZgeOS1jMYQPn5pmy2/YFPYdB2q3q4i07wTfajLc3ZN35XlNJFtCIF58pTyASc8/pUSk7iVaLlZ6/ccVoFvfyalcWaoJ5jukbDKodicnjsBwAOp610Mz6ZGYJYreKG7ikw9sVOWx1Dtzn2Nc14L0VJLqS2+3fZ3kdm82R8GQj06c9en612Uej2pszZQQxf2iGxK7buP+mm4881uttTKpNXSm3bsv1OX8QX1495HbWMRVLhZSsSMCOnClvxP51uaP4WtI4xA0q/abqJFkjkk/1hC88kjJH9OawQn9neK0iluAJywRkWTg7TncD+fPua6bTrfTbq1sVudbtL2Sa8lNvchmjmRjwpiyMKqpnJOeeR0FZyk1ojSc401zR/rYu+N9JdvglJaWc0TzL4kG9l7FbYrg++APwxXjegkXL3WnagDDeRcAAfeHb9cc+9e5+LRZ6J8EYG014prU64jyTq5cS7rYkuG/iJyOa+f5tSmugxTYLgkbZ1GHbbkgE9PyrhpLWUk+r+ZzOr73MjpPDXi86cklvMXg2uIZUb51x6kevWuuvrvT4Ar6ZdwpGSPNbG4A+/69a8WkW4mupZCxMkq+YxJ+8e/9a1oVmg0u5sghImCzEd29efx/Stqc3K6aJU5c3Md54z1y+tVsbvTrpgkTNHMqHhtw+Vj+RrWHxDmu9NaK9soFuHjKbkl+U8EA47c44z/9fjvDWiXF4f3yyyW1xZ8pnsGxx7jiodSiS38SPFOZVtXRW2kAr045+o7VvG19UY1KCm+Znofg/wAQRNeQ3MLXUVohaKeB3L5bb94Dt83pXWaV4rWa6aPUo47Tdkxnfkf7jH+9+leEy2c+mXWj3wcmJizM6ZOcHv8AhXT6ZLLc+I7u01G4RPMUqFZcgseQPfsaUoKd7kzw9OestGez6Vq0WoySLbxsVQ/eHb0rQZsKTjI56c187aNqT22q3tnfr9laM/JLHIUxg9CcjqO9bk97BaNIUnuYQqfNJ57dDx2P0rN0U9UYfUG9VJHte7KqegP609SK8LsbiWKQS6ZqF7AxTcrCYtke6kkY+orqNM8X63bII9RtoL9CPlaHMcp/Dof0qHQfQieBqRV46ryPTa+fPiT8UEvdXtLBNGnh/sbVo7pjNcKHdoshoyFDBfmJG4M3TPevbfDmpf2nYCcq6ksRscDcvscV4H8cfCrxeP7N9Ltv+Q3tCKCiq9zuCsAOMZyhJbqXJz1x5WYupCn7nfUypRSm1I9t8A+IX8U+G4NWFm1kJXZRG8gl4ViuVIwcZB6gHIPBGCelIyBz9M+tZui6Pa6No9np+mrshtYxGhwAXx1ZsAAknJJwMkk1owsTEpZVDY5AORXXC6iuZ6mMt9CQdFB5NDcZ5FBwRnmg4H0+tUIcOuMdKRWBYgfjTGdd4XIDt0FKSOATgnp9aAsSjnrScdO3WoJrqG3XdNLHEuersBTPtsBTzBNEYwMl/MBUD65p8rHYmY/MB0z3x0pVGB/UVSGsaaYhINRs/KxnJnXGPXrWZceL9HilEUN2lzOxwsUJ3k/j0A96pQk9kVGLk7JHQqwIyDSFuKw7nxHbW4ImgmJHXZgj6AkisZvFl7NIkdjZRszsRk7jtHYHpzimqUmaRw1WSuonak5xigMCeSCcdM84+lcQviq6kVLqa3WIoCPIil3CTnnkgdPxriL7ULv+111rU5SJJiELxOY/Lj6AKQeMfzq1R7s3pZfVne+h7cDwPSms5DAY6968jl8Y3OLiBNYWWC3ADN8u8knABOM1pSa1fyXzQw38kkEQ3MVXBXAyc8c1SoeYLL6vdHpe4nP8z3piklQDjd3xXmkXxAMcqW18ZI5jzwnBHbJz6Vu23i6K4jngVVkuwuUjQ/eU8Bvpmk8PNK6MJYecZcr3OtDEj5cMPY0Vg2OtadZWqRTTCMp8rknOX70VLpyT0JdCpfSLZzWl6uurapp9zrrWVtcyRfZDbNG0MySF2wqjONjYOFwDxzXO/EHRdQku5Vm1C21LALxBSP3UfVRtXIx/nNehacLWeEC2tRLPBMuZ0VCqgqRuLA5Q4PPfB75rjL7wxLf/ANoK3h2SKOIbLHyb9VjmVj867zyADltuOK6aclBvtt0Pai+R26Hn+n319Y5iktflg+WRQeFOM59QMe1bWmDUdckc28TyJ5ij90ynKEZO9jwigc7jXUp4csrl01OBtWubO3mSFbGOIxzx8YLbpPvw8cHG4E12lroGoa4b3TbnSodI8OkgpFbIQ90mfuyMeQcgcCnLEKC3+82+stQ3fzM3QLKwjbUdA8Nm5FxOhlub4RMIgduSqv8Awr0579q57w9AdFtru5067sZ9ZlmWzV47iSeJGzl2di2wOwX5VXkdCeufSdSttUsVGlaK2nWGirbGJJS482G56KpVmG/g565rBvfsml3mn2Mel6bqytJGELW8ZlS5AxJNJyOmPvHJ9DXNGo5p29f+H/yORz9pIreGpXufsWrto1/LrT209qdRA2rE4OHCjJQnJ4fGPlJzzVe4sdU1PQ7i119rq6ggWSS2iedknuQuOW4GFJO3HQ549a6Gw0N77XLjUGgu1mEa6d8oKRqi4ciMNwV55bnnIFUbnTovsr29lpn2qxVGZmtrozb33kmNOeT+OO3FVCUeZu+v9eZceVXT/wAzG0+GOCAJPqd8k+lzrcPYQ3UeISQDteNML5ajPHfn3ro4dSsruye/3Qrdyho7Ge4jXEIcdWAJEm4/MFXrkcVzF7b6odWsbIaml1r12dkulWGAn2RlGBMGyqED7zHJxgD1rd07Tby9vTptlC+m2Fkr+bqKoLcjA2kQN821euXOCR0ok48t2yXJNMt6Dc293F9p0+1VLyZAJ7s6eIJWx/FtxncfU9KbH9gurq98NWNtf2tokYeW9s5FVYnJzsJwfnJ5Pr71xurfEjTvDGzSPDT3GoQ28jfaby9Yzvct/eR8jKj6fQVzM3xT164lfCwW0T5kWJQF3KRjoe+Oc96UYN+X9f1YtR512R7dd2Fpocx1XTNLutW1ggwjy5sKGI6nLbYx3JUVpLpi2OnwWSxW1lZsMTBned2HU+WTnuTyfyry3wL4v1XXvEy6WdXVLSSzKs1vGN8T44MRx98dwcjmu9ublL21vW8M6kt3LbP9lkNxuKrIuBI24DJOOcDgk44FYTpyjK0n89fl5fgZTi4SszkLq/1WMS6eZdC1FJ2MEmni98pY0xgsgYAgkHcc7jkHHtb1iFL3RrWwFhb31xatEj2yyuiQIeBLvONwAGfXkZ61p6HoMY8ttYudHM894wsJ44gJS2wkjj5S3UnHy+tOTUmv7oQq8k+mWcAT7XLlzcuASzbQPnwAOVGCxAHSt+dX93oaRs3ZMxRDYa4+pahrFn9ns9IZojh94faNwkVQNpfkcYx0zmvPPEt4dV1ZQ95KzB/LlZ2jWZj0JJ4xkcHaK9L17UtKtzJbX1haSMlss+n206v9ocvgvJOn3V+YKQOTwK87fQp9f1W5vbC2uvIMpG+6Cjc/HMXGf6V0UdVzNaHRSdrt6J9/69CGLw3HMGhuprONbeIrFGsZCZ6gnJByO/50eHbvXfKurOyliuNQjVQHmueApJJyo44z26gc11Nhp0F5avaJay/2jGSkzTHhPVsfptFctp1hHp/jKWK7vjYRxAyvcRT+XtUEEqePunGOfWtZpdDWUlrbddP1/wAjuLqyvtHnvJ9CeyutTntzJ/Zsc6H96CB5oj4PPJbnAxiuUjtphqra5rMV5cSrMXiaBmKIr5yUDEMgUDPp6CptdV9O8W6hqkWrDTpYZhPJLPF521ZGwItyjKqDwVB/Crd5pja3Po93psaXAlQyCO7LxxwhjzIoJDEE8bSeeB71hHTWRzOPK9eg62vtP1e60m7i1i7v75hLFHE2baG4RDgCRcYCjcMuepPPSrlvd6jY+HdRbS9OgvTHLtgtlsPKNu55LbnzvCnJDgEn2FRalf6rNc2lkNOtkbVF8o2NwjLOoUnJOGOwEDIX1OSa3vC+lWeoi1uf7RlmtrZlmgjWfMqSZ+dJZFJDrjClegxxUS+G7Mm1Yo6FDfzWU+naVqN1qRd2tr7UUuVgNpJtBIhwoGA3XB/iyKp2ejW9wtxZXzjWbeNObtpU2/alG3ZJt+dmAIbLk4GPpXYrpGn2OtR3C/ZoFkb7OsIlI8+QZdvl4UufvZx2qqmm6NfXkWpwS2LQ28jCQWoUiTJ+ZGJPLdMnAbjGcVCkriuuhjS6bqbaY0t9DNLKIFBaKVYo5XLKT+/bDHAU5IwNvGDWT8X9WRX0X7FcN+9hMplUeYHQkABOox8vHqK7mDR5tW1X+0fEken3Eao8NlawxMAsT9AdxwTjIJA9s4FeParJJceLyNQtV+zWgMMEdoR5EMa/KoGec4x3z1xVUm5yV90aUE3O/Yv6DqttBdiO80+5mWaMEyEAmPGeOe/PQVavJ0ttVbzYrmzs5QN0SyfMRjv/AIVbsZ4NQeCwt4nleWQBA44UZ6/lWnJBDbaldiztpLuKNzE0pcFyQB0z2rtvrudM5Ri25RabXf0OL1ptOm8RaeNLhERKk5ZTtA44JPIzg13Ph6HTrXw3o9/qy29wk1w/2ZIYGVYxKNoXGM4AyCx555rm55tLHjzRWjt7wFpRG4CbfmLAdPUZyfYV6rLbPcaNImh3dvDPGDHFLMWdevKsRz6HiuWvJKxzVZ+6ottevmupy/xyihsfgpbW1q8cUMOvRxKkG3agFq/yYHQfWvnK8mS2gCRxssvyyB1PB46j/Cvon4m6U3h/4C6Zaz/Zbt01pXuGYHZKxt5MnJ56454NeFwadDfywAxGGFULrIhLggn7vPXuK4aKupKL6szhFyVolvSNNEqGWXY0cqAgAEMoOM49q6G106KCCF41DvFwHkALEdTz6cmrlrDG8cCphE4Q8cADAz9K27HTvNRxDFJOqNkPGAAR7Z/nXcmo7nc1GCKFnO8Cr5B2Hrk/w56j8apaw6NAFuIRJk+SHx90H3rf/s6Tn7RAy/wxSk4AbPQjnNTPolx5aIIN24ZKlhnjHIz7+lHtI3JlOmUbCNDpdjF5W2eGYruxkFOoqKC3jub/AO0TriUP5iOOMcnnPcAZrp7G1W2Mq3lpIjlcJIGxsP4VjSxfvViD4l3FQpypI9TnpmkppmalGba6HM+KdNm1HT0+zBQzygDI5K/WifRIodJERbMqxIjEdMjqf8+ldeLD7OIEkaM+cDsAk3EY7+3esS7jS6kcO3yIxCtnHyj275qoyV7jtGeqOW8GQTvrUuImkhUFd2MbeeOfwrodevhpEiXNzbb4GYBZVfleOmP85rP8RS3lrY26WBZGeXezxjBwOg4rHvpZGs7sXjMY775Y1fJG4c7l9AKpNrUxnGycDvtJ1rUbUxSaSmHuyMRTYZZcD73B+UY75rqb5f7RvtLn1vTbV73TpvPiELrINxQjgsM4zhscfMintXm+jawunWOn23LXMEGzcThCrdt3YjjrVv8A4SPT1u0iu4rr7X/HHvUknsBzUypxqayRxVqOuiPVf+EgtV1CKzZZVeXGxmUhc/3SexrY3Edq8gu/EK2sguruJorUJ5SiY7nOTnkD6cY/OlbW7x7P7VZ312tuV8zbFM3T6HNZSop7CWBlJaaep6zdXltaRh7yeK3Q/wAUrhB+tU28RaKr+WdX0/fjOPtC/wCNeVz27XC+ZLJJOWXcXlkLkg9+a528hu1vIktbOFrLjjaM9e1L2CNf7OSV5S/A9n17xfpWlRP/AKRFdXmzMdtC29nPYEjOAfU15fL4k8RXd3LJdah5fmPuFuI1CKOyg9QPfNJaRxzPItp5QkGN0a4Uj0JFcp4t1VrSWMWxIkBIbAwQffNWoxpas6IYSjQjzS946bUN9/As2oytsQkBS+1F/H0+tVLi0t4ljkAj2scKE5B+gBwa56G8D6QyqVmuLlgZIGyQw6hgOxqxHpb3uiwiGZobhJMhC33D/TOP0rXm6nRCcbWhFDpL6xj1K4tJ4CsiZKtsHzkDOAPetHQtctA0V5bxyQuHETxKg5Yjg7vSrGm2Mo8qS+CT3UYB88rznp+PFbFtBbxqI4YIkAOfkjAyfXApJvqaclR6t2+Rm6xqWvSwI9vCrEPyQQx28cY96vy3N5/acMS48u4AdmJ4XIxg+vNXvJj+ZsA87lwcCptOsjdX6mJ40YttUuwVRjpk/wBKLi5FFXucdbaZqupX1hc3sjILG6O/JIypPUAdeRikv9CutRgSAX01xHPeead5yIY1zk9fw9OlemPpRtmZXZJJ9uf3LbgSTzk46+1UIbEwRDCYjjXa7Lgc5zjP1/pUXUkYx9m07HAa/oEWmQR39g8jhZ2laBlByecOx9j2oS+lfQra0kuXhubv97cTs2CIieB9T1rf1YfZyI5oslgW2sPvk9MA9qivNNjlMJuArTAhlAH3f88Y9K1g0vQ1eHvqnucHeSTa14kd4g8dtGFhQHnai8DI7k9ee9bDa1DpkywaWg3rxPPjcWA/hH8ia6WGBYXZreCIH5icICPc/wA+a43xQkFk+2wBimmfLNnp/h68Vmv3a01JlSdNN3NwX0+oWcdzcXDoS7DZHhNtFUdAuptFUxyJFN8gCho84HUnnuTRXTG1t7EpzSty3+aPoa10Qw3Vnqek6bBp85yZPtjsuUbGcxoQvmYAALZwBWpb2OqT20Q1eeyV2ZhJHahgpGfl2k88jqPWq6axd3+qX9kdMktZrMKVubhP3JVj1VjwWA5wPpmqV34tsNFa0stZuY77UZi4LW8W1Dt5JILHYAMd/pXkfvJPRa/ecPvN7a/eXRoOmaO9/qt1qGrXVssBBtPNZ44lA5McagHdgdQeO1c/ZeJoX0K4uLhJ9H0fyn+zJLMZLm+QfxRhm345Hv2rG/4WdqH2u6tk06zN/btvNuk5IePjDoxGM+xrX1GabxT9g1JB5N9tAst1qJZInYjJweOMEc5A61rCjNO9T+vl+poqU170jN8HeG7S50F7PxBZXeoW90PtZZ95ghBBCIoJ3BgCOCM5PWuj8M6GttBPqb6GYdWUfZo5JVHmyRp8qkkk7eOMeg5qW51eO61q+s7u5MQ0PYZpPtAgiZ5FwoYA4b1AOOTVh42sNP0XS7vXVubrmadpELNKnJYjYcDBICg8YHcipnKUnr19X5kuTdkYt5qviVNdlsrTULoTS+XNG7abmzjhXO6ISk8ueu7GBUWm6Te6JaXSnUbrVoQpW3skjRJGdmyz5BGWOSCxIAA710P9kXdzqtpJb3E0dmqES2sknyMOoYhRkt0GCcYHTNU/FvjDSvAFsqzwS3OpSrvESYXg5+Z2Jwo9B19u9Lmt7sFd+X6hdLRLUp22haP4T8M6nEgl0qxuV2zzeeZpEJGDHC2AQeeMfWvNfG/xEj1mOLRtAlk0zR48IGd/mmwMAMPSpft+p/EK4m1TU59ukQzBJLWMFJI0IzuUDqOgJ6nqPStxPCug2kF1ClnE0siF7eUsXZTwNo7HnHPvXZSpctnLV/1/X5G8HGLV9zhdE8JxT3KpqF08Edxhopim1AwHTJ4yeead4i063hiWG4YXSRJ5MNxyFaMcADHXv19K7u/knuvDTQzx2sL2xEZiHzOSjY4AHH696yvHuyXQ4JJ7iG9R9ypFbxqrZwPmPOSox04rpWu6OqMrOzXdd/ne3Uxvg1FJ/wALDtZ4Ink+zpIZUwcwjHDc9OMCvZ7y9ijtHW0toIbuVmhs4AcRy3ABblgvQdS2MDvXE/DTwpqNj4envTcLZ3WsW5itIwvz4Awrtk/KoPzADrx9K7ttA/tWSx0vUInu7W2gSW5vN+1JZRwECg5JJyxzlRgDkmvOrzhzczf9L+rHHWmrv+v6/wAyhFYalrIitpESxv4LfyWvbUD9wWA80Rk8Lkgc9eM1yOsePG055tB8KSS3N2C6zam4DmNhk7VAGAo9fXmnfF/xXNFfQ6DoF2sWnxfubtYD8zMeuWGeFHbuc+grH0XTbXQtQgudMlfUonBWbcmGI9uOR36VvRpc6UprTov8/wDI1p0+bVr5f5+pl6DDc3eoG+1WKfVVhy0kifMy7hySe9dTpmpWkN5dW2nXXlW7hJY4WX/loTtPXke/Pb2q3bT2y6pcvp8kcPnoreWI8hpBnqG6H9M1XV7VNbjkil2tcqRK86YHmememDzzXW9ehq/eupJrQr39jfLqRltriS4vJEZyYSFGBjkY/Adq5zwLbPqOqavfTrpv2mzicudTjcwpgjmZe4GCR7jntW/4h1ObwxcLMFVjdx7UWPKkEHr9PocGqOjuljoWoTatOEh1cpczNdwsYo4dwBR/Qu3CKM8LnvWdV+5buZyqylDW1rf19x0k1rpMuoLdWbOLa4uGe72FJIbiR03EybiSo7r3A7Gs/RYbmXxgptNSlexubNJVjnjCvcR5KrFGrfMqJ1zjknPpSeJv7HsoodTstOWe4ndLeKSF/JlV2HEqkjkBRjgd+tdhfaXHqGjB72zf7Q9sCTDdeXOzZ4XzF4UNzz2rmlLlRnL3dDE0670WXxRfTQafJNqFlE1k8iw5Mrnl4lJ5aTA/ADGeeblrocr2VxBN4ihttLOUia2gjieGXeCpJzj5fu7cc5Oa29Gt5LrTrLzbafTvLUia1aYO+/G075B99sYO7vWbpHiG2uJlsItEgtNOkcxwubdwJZFOXJQqNqjjDE5LdKxcm9FuYuTbLniBpINMstDtb23kv7tSk91K7JN5QT95MpQHa+OnI4rF0fSrqx0GwRrfTtTluxIbnVLZtsaKBhGCEZeQ4AzgH1Oa6rQre+toLsaveRyyT3ckiRbQFhhP3UPHJA7HNS3kMCWH+kXCrasGEkkb7Dt/2CP4u/ArJS5dv+HIi+VnE+MNRfSdPOtCy1G31ra1tDBLIoUDbjeUU5IXsCepyRXBeFW0Kewlk1yZjf3DE7kQgADpjnr61D4n1WDXtRg06wiltdMtF227Tu29VPO9myTuY8nd60mmWAs5xbXhkusfdeMh930969GjTfLqejSpe7q3fy/rodh4Yso7WS6vrGdZreJPJjJ4HmN23fT+dU3ttXtJPtFjMWeQ5cqysrH0wR9RVvV4ns9HtNLiVQyASyI3DknkAgcVy2p+KNU06xKCN9gO0eZHu2n0Ddq0TunL+rCipyTmmnfv2/rU0/Bwk1vxDqN/qJRrK2jGVT92EYcYJ/P9c126Pc6npyi1nXR7+5dHVEZZ2jB5zgEAllHXrz7Vy/wqsrhrMsFW5jvpXWYSsCUUDJBGMNksOvauvtrnwv4eEsyX9nAZpZDJO025pJABvwe+3gfLwBxXLVlrbqc9aWtjkviTMH+B0LR3F1d2tx4rKwm4TaUQwSYC46jIOM+pryrRpoIIIImKtK0hVABkEnnP4V7v8aNTsrn4MWd5ZSpNGdbQwylMgt9nc559s814HoV7DaSIpiZvtD7N2OFz1+n4Vz4Zu8m+7KovW53lpZCa0W5uZXijGJEdMfvNvO3HYHvWJoGh6/Z67aaveXpj+0EupEmEcEHA9OtdDe69bafJZpc6YbnTpFWMzw8snbIwM9a63wr4bg03SrpZtQN/BcSGVDLjaikcDHY45PStZvqyK2JUJe8iaxQtawyzRk3CqCNx+VyP5HNVNctdUudR+3w6fiaG2ZUcPkDIzxzz+VW7eaOCWeG3ljnijUHeANyMP4c9+Mc1Q1vxDc2WlzvFau12o3LHu4PfpUJtO6Oe0nK6VzI0zU7+00G6/tZme8hVpIi68kduKd4Y1O28TaMb14THLCwiuApx15B/GmLevqlhZau1lJbzMGE0DcgfgegNV9LtYNBN3Po8/leeRI9pKNyrjJGPpk1pJ36G8YNpOBN4rvINIsBfyaddw2M0ixh0X/Vpzk49T2zSyQW89taXdvcLLDIqiKNU2SsD7Dqfeur0DxXpOuW0tvNcW8lzGuJ4SNwI6Zx3FVmttFXUDrWlahFD9nQo6RSDyjxjoOhGO1ZqTvZoiGJnB2ktv63OZuYo5AyxKuSceVuyRjHGDVHV7GDU1MV3HgLgopO0g4/hI6HtSav4rU+NTpV/AYYePKnyTuYjIPupyK2ptKmt4kNzEqiZNzfMCATwMY6VrzaHZTqxktTltV8P+bFFNZP8wVcxMMIQOMZ+lUr/AES4/tibWVXzC6hwsSltrYAyPYV3EUMy2ixT20rKTkSdCje3qOlMs44LaCaC4Fx57sCs8WQgX6Yzinz38xOMXqcJe2F7dRfZ5Ij5EaLKj5/eSseox2x/SnTvqMF3YWdufLhhVNwXADdzkdx2ruX0+GREn+yv5xyVlUscjPXH9ajksGI3MjjHR2j7Gn7VdRxjF9TjZdX1vR9Y/wBIZpYZH+SIAEbOgI4pmoT6l/bdhb20Ey27hXKgZA55BPbFdwLVJX3GNgBk7+Ov9Kt/2ZNK6DySFC4wE5x13D1oVS3UTjFXTZ5rqGk3+kXd7qWnyzySSMRtaPJwT+tVrvTbrXLO3u7u136hG3lu+cZQdCR616VPppjlV5/MQAkDIwKkfSmPyrC3pkgjPak3Fqz2Hy0++jOBvdGfdbXkMUT6gu0yMG2gkYx7HAFa1jYJaCV4YX8yXlyCSOvOM+9djH4duI4mP7sp0xvySfWtTTPDwkiee9heQkElVcrv9OKXtEloN16NP3kc9omg3l/IRGQEB/1pGAB711Nn4KihXdLcGU4+6qYB9s5qtrt02lacrW8YtLWE+ZIi5BKjrjPWuE8JaZq3jPXH16PW5I7CGbAtS5LDuF25wBjv+lTdy1vZHJWxFWa5lKyOk1jXPDXh7UTbalCFnYfIsgLEehI/rWX4q8Qafoptbh7ETCc4SGJDtIx2xjvXR3Om6TP4ji1DVLa3klt1AEiEOc9BkHkkfStWTX9D+0R28kUiIQSWkiI2Y7Y6ik27aLUSnNbJvQwdHtjc2UNze26WD3Ee5IbiQq4HPJTrmp9K1DQblZLWO6hnuEPSGT51XPVgOBVxrnSNbkntLe3kDTI0YkkXbkEdAeoyK8q8aXkPhKAaT4d05raKRQ89wSS+4/wk+39aHJL4h3nP4tD0y30K3niN6ZI0bcQr3B3Mec5z347VXsNFjluXmtcXTwSfvA6YQsOcfjV/4c6mmseDbQxgPexIA4lXo3rVjUk8QT6tFb26Qw6aq5uZz8pb/ZXHsBk1V2pWuR9ZqJuLdjl/FWoXF1JsuAltbwAkRpt2n3yO1eU6rch9aSaKCS8I+55g2xRr247+uTXsPi/SoYNGS6gvvtQSQBsAYKk5HTrjpXll/tt9Ta4aW3vrwKPJsWyFTI79if8AZqotW00sdsXGVFcv9feaGn3Ul2Gad1C/wmNDj88YoqzoGvzfYgNQVYHH/LMIePoB0FFdtubVMmNSSXwMl1Dxb44S3V71UFlKxRBvyCRjK5z3z6VyN19puIbrUL2T95KFwkkRWKXB2kkg8NznnHQ/SvUJtKe6RRmUzAkx2xiwqqG5Kk8AfjXmniApPrMVvZNMnSJpIY2L7gecc/NjuK56kFCLaY5JKOjJtA0HVNRuDJp8fnTW4zvtZcYJUlTu6fNz1/HFfTXw/wBHuLTSIpb6WR7iVB+6PWI45Ga5D4W/DttIikvtTnbzbgDgZzIAfldgTwa9K1H7TZ6cWtopLqdsKqLiNfqx/hQdyOcVwVq3MvZxZzV6qS5IvXr/AF+ZzWnaPpup6Xqcp0Z/KurySa6hmZZjK8YwrYz0yOB+NXNHjW71N4dNeJ7KEg3N2pUl5evkqAMBR7VBZeHxq9jHC15YwaKxaa4tdIDIlxKTksZyQzDrnAGeM9K5n4g+P9J8H6fHoHhuJI5gCgW3G1Y/YN6n15oTc24w/wCG9fMzg224r/hvUteO/HK+Eftmm6bcpd6rw5RbYlbVOAXfBy7Y9wB6V5auk33jXUVvHnE19F82ZkKi8G7lsZIAPA9Ks+DoL60u5tZima9iJZbqC4wZGDdWB5wenPQ4NdaZrOJj/Zm20+7PbggqQH++uDwQcZ616NKj7PZa9zqhS5dErvv/AJlWPxE9zJFLp1lNBrEJMF1atH8u1R8ysRwQOqkc4NJYXE1xZm5ja+bUIiWiQANDGhPAw3Y8/lTpmIuxeeWI+vy8SAnGDn+8KVr/AFnTrN7m1iS8s0gMJ8k5bywSRx3x0rXl00N/ZqnFWtfz/If4d1tnmuYrq+gspXcvvkTazsevzdvoa5+30eLXPGN3aWQvNT03z1a4W0HMj4yWDE4Uc4zUOv6rpPiTTNLtdP06+ub2V9jNCCPl9M9zk9K9x8F+HLTwho8VrZbZLiVgHcj7xIycHvXPia6orTdmFScY3mla/T+ug2Hwxb6jZ26a5aIJbe4WaNbaRh5W37iBs5IC4B7E5xXP+P8AxLNc6k/hrwzeJb6juK3EzEIiDafkU9SfoOuB611fjjxHB4V8M3V9dXHl3LKUg+UMfMPAIXPO3Oa+efCs9i+pT3HiBJdUhucPHe4zIGzk7lzlfqK5MJF1X7Sey2OejGVR89rgvhLVtN1C4SeSQzOcIzDCS55+8fU+9dv4J0261G3YSZWwib5pmJV0YdVX1IGc+lS6PBPrF8thp+sT3OmSjc0dxHuESA8lW6k9BXU+INQiSNNHhuDaQlDG8gTCKMf6vd0XIPJ/qa7p1JJqEd/nojtnWlGKp21/LzOR1Ga1N87vv0mMHMFz5ZcM3pJ6ZrnNe1rUBYzWF1p8ctyvzQzRvlWGe34/zrrtXivNIs5P3huo4gA6zbZE24/vDkH65rznRo7nxF4xhax0e4ns45VJgh+bHPJUk4QcdTgY9eK15klzX0KhKLXN2/r1/Q1Phx4XvfFEw1XVrtlson8pIkHMjqRwOwX1Nd5d3Nrqms6zpYkvbucqsrgKVWIoANkGRtxnrnk0nie+t9JgiNqY0trmXZPb6ZB5hZc42hwcKeME1ujw7aXt8NQivNTM8siTzqr+Wsuxdqow9ADzjGSO9cc6j0nJ/wBf1/XbnlJ6SZzGg2djf+JLvS7nSHe4hYXu/VQ0jShjjdEo+VRxjGRnvW5DDa6f4sKado99JeNPF9tuB+7hji5wQW4cJx8i/XrXV3jS29u00t1DZWcYJ3tjAGOhJ7DrWL4bhtpraa7h1aXV0uJTIrvOJY4ug2oV4VeM7RXN7RyTfQwcuZGJpuo32lPqV74lNtp+mtO32WxRkV2Y9DJJnBLk5wT9a6Xw/qv9tQT3Y+zkwzfZnit5BKIWXqGbHLcjPb0qW/bT7XR7ufWRD/ZijzJFljWVWA6EDGSc9OOtS217FqPh2DUtKhksrd2EvlTW/lM4zjJXtngg9+Kick+nlciTu7Fqfc0sYeNTjOAwx9OfWvNvi3qNhp72rSEy6miPFAw4ECsAGCDpux3612Gt67HodsbzUDPPbyb5vmCgQHA2RjHXJzjPOMk9K+cb/VpvEmvm81RryK1kyqywqQVGewJxmtsPTbak9jbDQ97msdH4LeW0tpvsjwSJP80sdwCCTjpn/wDX0rr9D0+wkv5NWitW0/TrLDS72DEyY/hA4A7/AI1xVto9pYzxytqA1ODdmMlmimAPZl6dveut1XVbCDTLDRROYtPx5k8yDLO5ORkdwD/SvQldpW0O2VPS8E9d/Tr8yiqWWr3Us0t9NDdPIWwCFzzwOevGODWXq+ranPqS+GLeTT3+0Msa3EMX7wHsMdFPuBU+pTaZDpxjttZ027RssFcbZkI5wO9U/h94am12Z52/dQ3jiEOW2OsfWRlwM5xhfT5qUmkvIym4yXOnov0+49L8JabrukPDYLbwXEEqM02obgiJg8BUHzMW7k49ai0nRtMhunNxBp17cHfC0EapIIFLHKrxgAkktxnOa3tThsY9bgW3hhW+ESQ71J3iPPC59OKt2WgWmn3c1xZ29vayS5LNHGB1OefXqT+Nee6nV9Ti59Ly6mF8arNLr4R2sUqoA2sqVVV2jIt5AB+lfPWmxTGWzge0BS1cMu4ZDY6gnpXvfxwtZLf4QWyW91tb+3lfzJJDkgwScZ/p7V88S35sLqO2sYB9oYL5kmCy5OOVX05qMO0oyfmzopOKjd7fmd7Hpeo6g8Js76O0ihm8yeEBsrk/Ljjt6V2RjnsyDKYZbeZt0rru8z8B69Pyqp4Rlkvp3a8bbPJAsYZV+UcdfaujtryCLS5obqFI3th5bR7hhvQg9s1rOTvYxr1GptWOMvdWtU1DVm07VbeR4bdmEaRnz45On0x/Wl+GZmuNGfWdZcSRNIY4yzDLY65z71J4Z0bwnba5c3IEIvMOpPnMUOeuc9+taPiXRdG1Tw4un2yTrZscwtA2AjZ+8Qe31FS5O1miJN/BrcwvEMWsajrVs9gzWltu2oirgOM9iKveBtai8RRX2ny6dm5tHaO4kGPnwSAc468dPatHwzoUHhq1sLaO7e72lt3mkcBuoGOgB5ra8P6Zoug/aXsWEZuJN0ju5bJ+vpSlK60FVq2ilFHEL4at/C2sy31rab2eNkwMhNjcMp9CaxPCWiHw/wCM5reGU/2ddowMc7BQUKkgEf3gcc16ZKTd61E8qzC2t2J2GLcGJ/l9ap+LPAen+I9YsdX+1TW9xBtBWPBSVQc4x2PuKXMk1dFSrRSXOtTiLw6raWr/AGqxGorbSqLYmIM0S5ydrYJwPbI5FZ+o674j0ayvJNQjikty6C3hkBPlr15/Dg57mu38U+Er628PyPol5Kt1EMjM2DjPXd+P0qhpml6ywSHVY4bmBohJJISJFlbAzz/Me1a8yaumbKcJ6p/8Oa+i6nPeeHdL1F1eNSnzQg9Segweuax9U1eB9YisrbUTbahK+PsrAck/dBP5UvhzU7m88c/2Y8TfY7Fd80vSNTtz9AOcfga6jUtG0LULya/tbKzuNVUAxzbsjcO5Ge3rUt2dzJzVOXKtSkPDMusiDfqkkMcJ2tHGASxHXk+tZfi3wffy3Vpa6RqF5bGZyjMy5jUAEhnIOQCRjgHmrUnh+8v9Mjh1l1tFkOWSJjjIyQVYc9KisPDmoRXsdra6jq7RsQzGWTCKOSMA89vWk239orXVqehseH/Dd5oWnKmqXkeoPnBfbgY9Ofatu41WK3iKPZzpJ0GQMfUEHpWXY208l0lq+oTvLGxSQE7hnHVc9a17PQkFxK94pmbd+6kZiXA9/epb/mZhNxX8R3ObuPEVpqc5ijtYZ47bmYt1Vhxnj0rQa9lhkWW7lhgtcExxFgu7jvk5NacXh/SYJdiW6LKcPyfvHPU+tcf478Cadqtyb++ubqN1G3EbArgd8Hp+FVzx2RSnTl7sUbkVwjzYWYKsjfK6cgn0PvT5L+7SCZDIY5Y8uGB+V1Hpnp9K4uWUWWjrplk0sMKx4VmAPHsPX3p/h/ULO3h8i6d5ABjccnIz3FXynX9W05mijF4v1hbqddf03ybNs4uXcFRz/DuxnI7CvQdMtdMsbG3msoQsEq5AaArnuSAO/vXJ/EXw5B4ru7DUVvlWKBAojX1Jz0/Ku20O0cW1m2pXMcl3bKVG0Dayn2PQ0r3jd6HNUdop7L+vI4jTtd0zW/Ec1loekXUNyAytI6EAY4JB/h/Guht/DkUe+ecS3B3Ayuke4vt4wc9frWnrevzabrOnWlppzzQ3x2tdoQUjI7MoGTWlp82o3MZa7t4oYz0YMVY++OcUudpIh16ijdaL8TCOpWdjqkj3E6WsJVY0kuhtA46YP4c1oxaZJIz3sl5GzPg7lVSrL2PPWvK/F3gLVLrXbxo5xqQuWBVWlyIlz0J7Yz1rY8S6CW8Mabph1h7G9tHV0l+YhsDGFwenOadk1puaTg9HTe6Nnw/HqHhyG6tX1KHUxM7TR3DgiSJOcjGPn561tQ6gdT0O1hkkld72IhhGAZQD3x2FWIbuys/D9vNq8sSRBFD3LlUEhxjceeMmnWWt6JZ6cbyKSK1s9wQTEYV/TBHUU+j0vY5pTW/LqcB41ae8jtJ9JvreLRrItaT2aMN5k7ggcDHH+TXmF7bm1vWe1KRqTuluHAYgntz0r1TxHpnh7TvD9xd6BcSOuoXZuMBt6uwyG2gjgc/nXl0dpc3bFFtUWzZ90vmP83Xr65q46rVanq4f3qKsuv8AX/BOos9Hje3E1tdKY3I5CnBOKKhs7C6itES2t7jyF+7tBx/LNFdfPFHRHnS1miHxB4pc26wWct1HcKMRfMxADHkL6HpkGvRfgp4KltWl1nxDcAknzIYGAA9S7gjIx6H+VS+GvhA+nWyXUsscOpb8yiIiRtoJBCM3ALDBJIOK9AtrZLi0mt2jvdNmDlUt7qRWEqjoVIOMH65rhrV1UVlL7v6/E86daMlaMvu6GxBq9nqM8kOl6hZzyxqGkMUqybAenAPesvVZzq6zWFnqawwKxju7uzlVpYmHVB1CHsSe1cpqFhFqVtfaMka6PGSPt729qCXxggE8bgQCCRjBxgmqnxSvH0TwxpujaGgS91PEUZQKpSJcf99E8A5OcZrGNBRkkv68zGNJJpMo/Evx55kZ0LwxNCqiMq8juQ0qAYKxnpn3PftXD+EtEEMz38xa6uLYCZJZxu3ISeD6+me1bFpoNvo+nxWF5Es0xYSNao4kAcggvFJjKnPVW6VoRS6fotnEdUzekrtW3BKxRHI64+9njPbNenSpRpxSSO+lCMY3iv6/rqbFppCX1xFdWExttMkUSm5Hy7ecMg6dcZOeAapa1AEYHw8kb+U4PlXGWadCOq8dD64qjL4r36vZwahbp9kjYoLTYNnlsuA69mI560abqmjWVnpkN/qUYERktke4cqyfMSrZz02kDPtiqSlG7kxN1Kestv6+8pXGq6lpNtNdyL9p0qCRJ4gseDDnORnvnBFUv+E/utT1UWHgfT5p3vgQ0c6DAk/vgDgcdT0rT0m71nXb+70nR7Vks7vfHJc3MY8p0PV1I+7kDnqPTBr1Twn4Lh0FLJNIKWsandeSLCC90NpATJ5VcnJxycVz4msqXUxrVVrf+vvKnw48IxeEbAtcvHc65dNvuJUTCqcYIUDj6txnNbvim/1LTtNur/T4bRhaKpRZ2OGH/LQk9uOB1PU+1XG1O1TxHDpUaiSZ4jJMyyrmEDpuTO4g9AQMV458XPG0l0LjSLa6trOzhnDXHk3O6Zlzxnpg55IHQY5PNefShKtUUpLzd+xzxTqyuzndV1a58f62k3iW9ksNOh3JAEtW8lT7nORn1JGcVvJp0lpMBaWlrayMAqxlCYbtR/cPZx1B6888Ve0A2sOnRQ2l9Dd3s4VVi34lbI+8rHhl571Uisore3eDy7XfBI5MkdwdxPsgOMjI5HWvYhGMdInoQSXurYvadqLaZ5l3A62rkFTxsRCOCX7emT9Ki0ya+mv7jzb+OOa4If7PcxCRLj3DZwfoKo63DcXeiS+fdCTTRI0bNFlTvPVT/dz7jGa4HVtUghg/snTWuJYQQsC4O+Jv5g02lq2ayUeVtW/r5HYeIrfxQmqR6Jp+BbXrqqpb8naTgEq3zIOfpXYaFp6+G54tA8Oxm4vBF52r6koLkAN/qlGMZJ/rTfCOiz+E9Ca+1aSW48TX0Z8hp5C5gXGBnPI69K1lu8WSRPO4tUJRbaMBQ7Y5cnqeTmuOpNzem35mMKbmr/0/uOdvtFuNN8NagukXTS3UjG4uJJXG2BS3O1xwPlzwB1ru9H8rRdH0+0tX1DUnvJv3csgLldwzlnAwkY9T61yypPqUttpQ0ua6srsGCa6HEMMR+8e24/h1Nd4jxaTprqn+j2NsgUy54jjUdz9B1rnrzbXKyMU9eVGPremyXkyzWdnZXOuW9uYRJOzmCHceQFHBODz3OBTvDuiahbCB73UYpoI4vKNvb2awqsh5ZhjpxwP1q3oeq3OoWt80VsLa2bLWV+JFmW4DDIl2joOnBPNWNBj1SOO6bW7q0LtNuge2QqfKwMbweN2c9B3rGU5Ri4nG5tKyIBYafbanPqi2ZF7PGIWuHLEiMHIUA8DnB4HNZ+rm81HW9G8xzZ2trM80ySgk3KhcAAg4AOSeas6Hq76lqF1BqcAs7yNmlW2aZZCkAOFkYjgbuePxrMHiuK71PXJfJQeGdOtEdb/DYupG/hRjwVz8vHU04pp7agmk/M5P46eIIrXSrDTrbYJpgZsY4Vegbpz3xXHaPZxjR1Sx1aK+hYb5LSeArJux93A5Psao62bjxh4tl1HUJY7fSWfykvFLNHFtHCZUcdhzVvS55LTVLu1uYN04QeReQuV57Nkc59iK9TDQ5I2O+nGy5Vuv6ZoWsZtYkEZQrINxib51VT0J7ggjJBHamXKW5kmi1GFdQiY7lmSHep7HnGePar9v5cl2JTafumRswwThcsB13E89MkH1rEu9YutLu5W0tzYRj5vs8rbwT64554/St/kdEry922v9djkvFLWDajDDpcSKdoXZsIOB9ecfWvoH4a6TNo3hO2k1ENHeXK+YUcf8e6fwoPTjk+pNeU/DG1bxt40e81fy3e1VZNyxgfdPC8etewSX73PjGKAyxSQBJFWF0+cyKQWKHONoHXI61w1m5XivU8+vKU9Om7NhvKW9iN3IpuArPFCOydNzev1p8cUVvHIY3lGSWJMhPJOf61DdtdPbXlxbLD9qVNsC3BxEzf7ZHOB3/Sq9xNdRi1eWS0CNGDJ5SEndjouf4Sc8muVK+hzpN6HO/Hg26/B22+1ykqddTbJGpzu+zydc9e9eBaefKQQ29zGZohnzGTblcZwD1xXvnxeI1f4RWe6MGOLxAgZJkK5At36Djn5hXh2jSx3V5L5PmsuQoSVcbR6f4UYZNc1+7O7Dxa3Oz+G+r6hd6ZqoghQTwRP9mlxxI+04z+OPzqHRdN1DTPA63WtebLfz3DYR8koG7N78MfxFXNB1vSjdx6Qjr9rkcIAmQCc9CRWjdp/YkWpWXijX1t7HUZiLF0Yh0z1HTgdOenvWr0ldnJOfJUve7/Md4K0/TdQ0oy3ehpayiTCvIADJ/tY7V06wJZvIu5Ui2ZZABwR0x9f5155o+l6r4YvJLC51drwXB/cRnkgE/eOema19UnuYCILO3kuZgBudVLBW9M9OtS1zO5SpSn10Z0tjYi4YyXEiJGwysQAHfjJqHV9LvG1izi0oRLbNk3ayOcYx2HUfUUaW0pjs49SMMTzLmRV4ZD1GPy5rohaQLEo38LwGZsnNRzcruc1SbhLcyi506eBNRYJBKREjMxP4bv8AGprO2m0u8lmln86xmHYZMXpz3FZviCwW/RI9SYTWcTb/AJOASOgNLFJ/aNw1pbXiAxKCsfaQY4yfTpTtdFct43e3U6NbyzuAYzLE4cbdpP3vwqi2k2tpiW3iEIY5MafcJ/vYq9EYXhh+0x28cvRkyDhvY1CNLtxerLbp5WFO4xsfmJPeovY54tRdrtGH4l0fTdSsJLK+lezhYbibQ7Q2OmQOv41xU3gKO2ggvNC1K6s75QXCuxJdexHb8K9QvNEtLiEoTJFJgjzEbDc+vrVa00pkaOO4W2uYlG0y5KuR7r0zVRnbZm8KsOXcxtMS5NtDb6qyvdRfvPMVSu49hgd61rq/a2O7VJmhhAyEQ43H0J61a1O4h0iFBFZh5Gwq4G0Z/wBogcVgza3ZtBdXE8Uc1yn/AC6x4dvqSaavJ3sXG9RXS0HaTZzarctfJdodLA+SONCjhs9z39atNd2NrqAtg28v94JuZt3bvjNZ/hfxhJq1zJDDppt4VIG7+nHeul00IbxiqKhI4VB8h9/r2zTldPUTco35xL4sYyIrMxyKBtdiq4Hv6CuC1ODxdf38tto62ltahh5s8w3bsY4Geg9v5V6lKwRS7YwByawbjxPpEumXVzFeRGGElZJOiqR79/wqYydnZGdOcrWSPOfEm3TLdVuJlec8M69z7DsM54rlbe8ckCUDn+LpxRrmu2+p+ZKj5TkjK8n3x6VyD6qJiSgfz16DnkAVs6ihuz3VUjTiuZ3PQrHWpYLgwbwYnXDKT1H+NdJBr0T2JsLjVUg3nPmzOCU9AP8AGvGo7i6/4+plKNG3A7/j/jXQaXcadfY+0oIpmU7mPT8auM1Pcyny1V7uj8z3231TS10/ziLeRVjKpOjKwkwMHDDv0zXn3hb4qXEvi1dG1Gyit9PdzEpUHdGc8Z9v8av+DtJ0nVNKWwspkQQx/M6kEEE5x6g+9de3g3TJLaFovL+1Qt8t1sVmyD3NZyUYy1PMnGnBcs3qZHjq51bT1zpAnj81WhYRAt82fl+nFYWta14k0mHRLOSFLm98oPcmaASbix4X6jj8a9MMrxBlvLfDqoJdeUY+3pWNezNvmvngAhjjDOCw3g9Ac9hx19KIy0sVRqp2Uo7ficuug6j408IXtp4gSC2vY2kW0jCeWA6/cJI52Z4IAziuF1PUrfw54Qk0TxL4f1Cz1K3TfZxyXDPbTyHZu2uvYbyxUEjA27gTXpGneLIPEUqW+iX8XnW5UMQhOQeDjgcD1rP+MPgHVvFz2NzaanaRpZoy/Z50KqCcl5A6gkk4QbcY4zn15cV7WKdSjozOTcZK73/A4zXfGNjren2V3p8T20CQiA2x/wCWLgfMAeh6ghu4I4ByBH4ZhsLUxzzyiSOeQGSRznnHA+mTya8+n0XVNGuvLVopFfhikmFPPT5sfnjv9RXr3g+1s4dKEUyRhtoQlgrAZGTn3+hxXVl9SpUhapFqS8t/Q73Nwp8sovRWOlt7twM2rckYIbDZHqDRXN3Gn2jKEsIZldT8zxysoP4CivS5W9kcqoQerZ9Hj2zRJEkibZFV1znDDpXnQ+IsqMBPZQIxBKqsjOXx6cc/StP/AIT2KODdJpd5JNkDbAysv13EgAY55+leE8JWXQylgq8Fex0N7oFleTRSy+erxO0iFJivzFdvI6EYPAORXnHxf8I6pc/2PqdjJ9pg0uJo7hXO1jHkndx1x3xXp+lapZ6pZJd2VwkkLDIOcfmDzV4FXXghgfbrUQr1KUtehEKs6Uk30PmbQdQ02a1kgubu3sojCZ0mnGyQk9Bk9vbNWNU8R6JpjW8NmqarHMWhlCn5lDDo2eDz0YdhXtniDwF4Z17zDqWk27yMmzzI8oQOvGOAfwqvonw48L6JcvcWOnHzHAG6WQvjA7A9K9D+0oW6nTLGqerujxZfAviDxlp9nMstuNNVStm9w22SNc8plRmTA/i6cCu58EfCLTtEMsmszvqjsx2o6bEUe/dvp0r0O98NW1zfLeQ3FzbTLD5ISKQiIruyCV9e2Rg4rCax8UO8MCNe20qy7mukvEkgZATxhhuGR/DisXX9trGSX4f18hKqpr3ZWNuyv7H7Nc29m3kw2b+TIY4tqxEAHAGOmO4qaDXbGaxjvbe9gOnshkWeVsIyDOWDHtgc96tQ216Y2Sae32tncvk7vlPY9M8Vkala/wBnaCyXun6d/ZVrGxaKOM7YU5yQvOeOfWuZKnN2/X/gIwspPVnNeI/FU+ieHdW8Sf2dYtcuqQ212hVvtMZ+6ysOdoByFbmvEfDOnXup+dfXSi4+2SmFXkjXLu3BUk9D9a9M1jRrm/8AD8em3c/mJfXZ2T2zZitI8ZjwpAIXAwcZwc561yttb3vhu8lt9V01r/SY8NHPFJuRu3IUcE9a9ehTjDY9GhFQd0bf2X7dpFuniS1ULaK3k722pI6ZGVKAcjHc8808RxlrspdWi3tokcjxzkS+awGWZHH8HQcd65248RSXehy2Vp4W1AXTszQSh2EcSluuD6A496m8MeHr7xWLa51q9s7bTbRMie2nAPynkZHLA91xkVq5qKfQqN1foYF9r2sa/rH2DRJJblr1QskaDcmOQCTjIxnqa9Z+Fngi30Scz61YS3OrRjm4nX92jDHEYb5mx/fwB2HSn+Hl0jT7O5uPDelSIbyBla5ceVOwyfur0jz26dRWhbarDaRafplsbuzeJFVJFga6wvUo0nJPJ6k9q5KzqVE0tETUU5fCrIg1bTtQn8VXcNlqAvbuRvtBt7hGiFvHwAFYjDDnsc1o3fhSSSxnBntL68IDC3lDxws2ejsnzYxnGOven6x400+306eLVxOLdQI5JXygbI6Lj5s/QVd029gi06FNMguDuQJGNxZvYtnnPqWrButyrS1v63/4BPPXUeTb7jR/tfTbS4hsbm8tYbhysQhRgDvxnbjqBjpmp5Zo50kgjCyRFdjoVDB89QwPasL/AIR9ZpGuLnRLQXDSi4kuZI0aVnAwCeOWHbNUpPEGpWU98p0+6hihK4jFs5luMnHyOMrj1yOP1rFUVL4Hd+pgqd9nc62zs1VVEaoqABQqDAUY6AdMfhWPrN9FpqR29/O8VxNJ5UDCAnex+6oA69Oelc/ruv6jqMC2ekwR2VzcF0a2vVlWYxZ2b18s8ZOcHOenrVSA3Vlby6XDpFxPc2cKSwTapumTA+XK4JYKDkZxmrhSlvIqFN35pHR+EkuTHctqmq6fqTo5iZbODakTDqhbJyefQVyPxu1eCy0C0s4HUTM+YLZMYJAxux0+UZwPU+wrrLK7ubi0srX+0I7HUYAs09vp8KvGwB+ZdrDO0/gQe9eNfESdfEHxMvY76CZrC3VYjDt2smR/Cxxznk1pRpynVClGTnzMq+FPM8P26rr13Pbi8PmW82Q6NkDKspzg9Occ962DEQJ3il8xULID5AVNpx0B5U/Xp2qtbeGLfz7O2gRjZTLkLfNHIVYZOVw2fzx+NX9TuRa28CBwloh+W42/ffPdvwPPSvViraHdSsnoW5LS2t951GbzHBy0sKqyoScKcH76k8exrm/FF2bRPLlgKW77kVoUOJGI7A9KrX3iK3tJriOWxtdRnmbMYeM7j7fL/wDWrqvhZ4Wh1eNdd8Q27yqjH7LBI7OvB/h3dAD+frUVKippszlUdO7nqzq/hd4afwp4U86aIHULlfMZQPmHdV59u3rXQ6Np1ppUE8sKSm7vHMkvmtuZGbqo/uqOuBUU15bR3hvLm7LEKEitlkLQqM9cKOWNUJNQ1LUdJml0WKY3E4PkzSwMqKc46HkDAPPWvOcZTu31/qxwcspNt6f1+h0YZcqp/cxRDPzN1rEYQ392JLmO7WOOQ+WsUjKJR/eYDqPbNRarp/iK8a3EEsMNuqDzIniEnmOO5YnhfbGfepn8O3UtrFD9qe3UDBETGPbg/wAO3pmlBRjq5DioqOsjI+McEF58JrRAkix/2+hGCd2RbvySf89K8as5LFYfNvQYwDwyMWyRxzjr3r3Px7Yzp8KbWC8OGj1oEMJN5dfJfBJ4ryrTNLs7aX7G9vhHVnKtyo9OtGHslJruzspStDQ3vDI8PTarZ3draL9plUiG42EbmH3hj+9jnPvVLxtoUGv+M7C51GdTZ2cWWt16yEMfl/E4zW54TtFs7GJDAqorsVOd2PXHoagu7cPqLzPgI2VJPJXvn8aJ2k2ccIr2j5jCt/Duov4m1LxHqUyTLLE32e2V++PlyewGO1ZHhrTtb0/xHcaz4ivpodLiDGeR3ITkcAKev0ArttNvJP30ACvIRtDheT+H9a5bTtJ8UXviLytVuY7rSN/zxTsGQqOmE9fSj1KlFxTVjN8U+NP7T0kp4fU20zSbBJcAK8ieqe+ccVqeAtb1A3txoOtSo9/Eu7Mg4kU9Qc4zgHr1rZ8TfD7T9X1OO7YiCSNFHkgfIVHTpwv0pNasNE0bU9Gubu626xGpSGRusqDIw3qMHGaS956EqaskmdLpzta6bFZypiEEoqs29vz71zeuzXmkC6vbKKOW5QM+xUIOB2rD8QXXiiTXbaHSHiNq67gQoxju2cHp7V0MesWqadDBqmrW0d+hw8igop/2c468U0rM15XG777mHZ3CeMdOW400y6Rq8bDcy/MrN2yO4rf8P6Z4tihll1vULQg/IgTncnrkEbT9M1n6DbanLrbLJFops5Q3zWkg3xnB2lvX3OKsXF49mnlGALCoxIFJG5vY1bveyYRg6lknt/Xc7PTY9Qe2WNbmPzkb5mkPmNj0OPUCpr/Q7C9uTczNcCdFwTBMU49wK42y0OeyuZZotRkMFwobZGWEnI9Rx3//AFVLpGhtp2oxajbajK8SSfMpB3t6o3OPbms+VX3IlSSblGdvRfgdXp19bQuLW2uJGjjyXaVtzLjsT3q61vYWnmvKkCLId53AcnvXGa7rOk6VqIutREtqJiN6CNhux/8AWNczrviLxEdVLaXo1vd6S7AW1yyyNlT3OG4P4UnT6mLotvS53P8AZ2pXOpXrrJZw6I0YWAQJtf1JJH41FrnjzRvDVzBY309xcXLIGWOGPcQOgPYDp061k6tN4nt7DTTpkdhLI7/6S5UrGqcHauTniuqXRtNS6j1G5jgM6DatzKF3KOvBI4/nTl5kyWlpfIj8W6rYL4Onubu4ms4bqHEe4bJckdADyDXm97oQXwRHF5jm3MqzuuMFx2z+dd9rlhpniS0kifyr6a2YSIGY4DVznxI1OLR9BtYJY4kuJFyVRuABwoAqoSsrLqb4aMU1GXc8a1GdZluYY7cQscYYdcen0qxbhLHQySELuxZWByVH+RRc3TXwEJjiRs/IxGN/pzVmHQTcWY+1RyYjclfLBK+4Y4wa1SerSuzv5HOXNF/oZNnp84ijuY4tzyk4iPdT3p4SHzoonuGtJYskqMryOgyf/wBVekeAfsxW++ztEb5GCYPGxAP4R6UnjeK3ubS3SS3El4xO0vhmC4POevJqlRSWhk5Ln9nEz/hvrKweJYUgcKGYJJn7pHpnvzXpd/qUhstT0zTgNP1Z96whDlXIz8yV8+XkdzpaiXzPKCMpxHkENXb22v2d74t8J63rEl4kjlYSEOxVbOPMY++eQOuKyl2e/wDVhV7S96S2X6mp8I/ET6hqUGmapqE9zcxGSVYGGE2jqM55bPOMY4NeneIBZ2MV1M0Mkz3Ns8KnaTFtPUORxj61iN4b07Q/FK63b2UM7vKF8xW27GJILHHfOa63VWgn065tYmDN5ZPlL1/KobbSbOKcv3kWtUzivhV4ftdBvtTS2iG6VEJY8lRk4UGtn4jeIrfQ9HWCT5ru/wAwW6DrnHLH0AH86n8KW72lrPNcMWOAp2+3eub+KUGnXmlR6zLIsz2BwjxNkfN1Hpnim17yXQrljPFeV16HjV1NDf3Gye1uQYsoDG2ePdcV0Si3igiWEvhQMBvvYHrVHwtbW99dfa7y8laIMQwZ9pJ6gZ5zx6V28x06JCtnaxspIGQhYj15/wAa7YQdr9z0411GTbV2/Qg0/VLHyEVLs2bjO4PEGB6dCc0VB9nt53bbFGuP4dn9KKtp3MXhqcnfU1fA0V5rN7dQeI55bOS5XbZyK29GfPfk7fYDrmur0nwvrdrNJDvWd4mKu4/d4HbjuMdxXf2Hh7S7N5TDYwqZJPM5XO0+3p61sgDr39a8ueOab5dvM5nmDjpDVef/AADwuXw7qS6omnW1o1vLvEKzxuwMS4yN5OSy5PQEdeor2GwtLzRfDVtbQML+7tYgpMhK+djrzzg/nWsOmOR7U4HnjpmuavinWtdbGFfFutZNbDICzxq7qEYgNtJzin44zz+NC9+KRyVUlRuIB+XPU1y9TjvcdzzgdPSoDeW4MgaeEGMZfMg+Uep9K841q513UfHunwfYb6zjtLZ590Tt5chPAXeOGP8Asnp71ydjqdvDcSX2o3wuzazH7ZEjmUnec/NhQSRyAVGB36V6FLAc6u5HbTwil8Uj2uHV7KVvkkYjGQ5jYKR9cYq9FKk0QeNg6nPPrXiUmranZC2bTdRnuFuJ2NrsDiMJngSD+Ehc5zxx+Fd/Y+LkgtYzrTKgzg3I4Qjt+Pb3pVsDKKvDUutgmlenr+Y+58HyR6qlzoupNZWctyJr2zeISxzLtwUXP3M+1ZN38MLb+yYLHS9Z1OyMBZkmJWU8nO1geo5rsdO1vT9Qt1mt7tMEZKyHYy/VTyKmu9Ts7S1a5nnQRL1Ktu59OKyVfERdtb+hkp11K2tzjdL+GtjZnzbi4+23QyTNcQhzn2BO0D2xWwvhC2WPYJ9o6gx20S4PqABW7Z3ttexLJazxyqwDfKwJHGeR1H41aJAGW4A5JPAFTLFVr6v8hvEVU9X+ByF/4CsL5ZDNcSiZlIWURxgoT3Axg/jV/R/CtpptjFbyT3V2yrtaSSTZuGc/dTAFbcM8M8rxxTRSSIAXVXBKg9MgdAccVg+J/Eb6MrtFp9xcxQlRNIqsQu44AAAJPUc9BRGtXqvkT/QaqVqj5U/0NOPRNMiAC6dafK4cbog2GHRue/vV85z26YrnLXxFN5d5/aNkIZIAWXy51cScEhevBx36Gsebx7maWCCyjWeMKzxySneqt0JUDjNH1etN23+ZX1atOVt/mv8AM7k8r+NAJA4PFec/8J7fJdIslnbtAfnZhlflzjaCT179K6iz8V6PdzNGl35cgGdsyFOOecnjse9FTCVYboVTCVqe6+7U3D1znkd/SjJHes+TV9OitHvJL+1W1Q4aVpQFB9M+vtVC28W6Hc3zWkWoxC4UA4fKhge6k9Rnj61mqU3smYezm72TNSaytpX8xoU8z++Plb8xzXkHjvwPrOi3cOueEPtOo3KxiC4gkVZXlQHK7g33sDjI54FesPrOnRzNFJewCReo3jA/HpmroIIBBBB545FbQq1KT8hqU6e/4nzTa61d3DPpkul6jBfSuf8AQ1tSMy9tzEdP0xWfdeE/Hk1wYf7ElQSMUGXUhT6nnGPevqRiSQxPPTNNIOcfh1rqeYSfQ6Pr87WWh414K+EC226fxKlo8zENshycHvyOMV6VpXh+2sbJLZ3mu0jyE+0Nu2L/AHQOwraA5z2ox9cDjmsJ4mpPRs5pV5yILe3ht12wRJEvogwKl9cnNOxSYGeaxbvqzK7b1G47jrSYyfSngc8/hRjn1ouBxvxws7u6+FUUWnSrFcDVVdcrndiCTj6mvHfB0OpXOg3MOtxzG8hG6HcAGMeeh7nn9BXuXxWt7ib4fWQtZREU1dGck4yvkvx+orxBPBk1v4wt9XS8cwI4kEZJ3HgDaD6VvhdIN36ndSb5U0dB4Juvswu4ZYZ4ZRkpExB4H8QrVuWi07T5tRvroggcbl6H0x3qLRbmR5zFfQyRGMhVkOBla2dUtNJ1G2EV7AJoY3EhBJAyO5x2reb94mU7VLy67mN4dujrFt9pSERSKcsNmNwPQ5963btGjurRrdfnjBEmOykd6u28IWECJ0iULwqqOBXK3finTLLUzp17dxIx7ytj8z/jUXu9DNv2k24rTsburXtvb6RdT3JdI0jJZl9PavHY7BfiPHJIZpIJbDcsJjTcHQ849j0/Wur8fm61jwpO2imW4ET7ZUQEq4/Lnr2pfg7p99aeHrltSiSHdJiGNFwQuPmzjrzTtZWsaRh7KDbHfDfw7c6FC5u7l5pSxA44VcdOeeak0zwDpST381/JJexTEkBskAk5HHt6+9dmWZWMfl/u1P8AF396zNU1CO3hdoLiIMoyQvGfbOMVSbBOU5e6ed2F14Cjv5LZhLbXkchTLB0GVPtXoxuLa8gtZo/3kK7TFMmHB9gf8a4RfEmja3ra2t5FpiyA7SbmAb2b2bGB+ddXp9pFp9hJb6ayWO99z7Rvjf6Z6CnZ21NXHuzto5oltxIHRUAB3E9B7muZ8Q+JbfTNRW1lt0Fm8DTzXJOAAP5n261nQa6kOpQ6PezQxSzqSrDLB8d8dMVfvrCD+zpzq93ZtYkHzPMwUUduT0FTy23OeFKNOT59SHwx4q0vxFD5cUsd6YvmMcigsB2JBrpnmjuXEU0HzfwKTx+NcBo/hzR7PTb3VfArWd3crG3Ik8wZH8OCeCfQ074c654h8TwSXN/FDBFBJs+4VZuPT2NFkwlCMveR3Go6hLZ284W2jWZYi4VXBBIzj/OKxtCvP+El8LxT+INOwGYlUkBALDoRXM3Os6N4q1q50i+njuJ7bckaR74mdl6lXHHGD164qx8P76ytfGGoeFbGDUvIgg83fdzeauQBkAYwo54PeqtFR8yXDkXN2Oy8LWdvZWoW1U7pmLuSc/QZ9AOK8V+K95Hq/iOdY5kBibZHGx4Kjt7HOT+Neu6lLLotlfJIGX9w728qjKkj+Ejtx+lfMt/NLc6nPNkNK7MW2nOaV9bvU66Ks5VHrfQ6DQ4o7aUGdCyIwMiSDGOuSpr1OHUFaOPbMJYUUBHhbBjH0+lcr4CsbOTRo5dSijvLpWwsLsQoTGfmx/nit6XwzZS7zbQGxuCCy7HbYOOnPUV3QVlsXWlTk1F3VjB1xrZdVS4tGUTsCZWi4IPbkVTiF9czySRJNcXHZjljn1NdhoscMOl232WKKK4ClJ5MBizDg5J7HjgYqTQnFtvhdnjLMWJjwM5Pp7VaT1aNfrKhCyjdrucFreja9MFNwot7VuCZE6kep5qnaXE9vMEsmguTbfMslxGJF3Do2Dnoa9Rub20skWR76GUPwySD5j68emK8g13ZYy3cmnu0VtJIdsZPJXPC4rOSUfeZNOrKonK2n9aH0D4E1GTxP4SjvJ4Da3b7op4yuELg9Rn8D+dbGmPDfQy21xAkV5APLlRD0HYqfQ1498GfFsluPK1KSFUQfO0jYKxg9cetesxae1lrlxrEMizQXqouxP0Pp+Nclk0n0a09Tgq0+RtX31RfeGOJZbaRpBFONocHnLcHn1964H4lWMWgeDrK2tPltopDv8wb9+VOS3rXYXur2kWt6dBdOsX2hmji8zgs4/hA7H3rnvioDd+H5YvKMgtpA8wHTYc4/wD1URumisJzKtFPr/wx49o95B5xgtYbdUYb2EYIYkdODn8xXcaV5nlqf7JkOeM7id3vjtXn3h+7s4rtVgjaCQsAGdt2R6Z7V6rpdtdSxZMWN2ChfGG44wc13w0je56Fadqa2I5JRMSv9nzGQY+VQMD6UU7UXltvLNzGYsjhm4DUUaM51GTV4r8z3Xd1ySPxqRcZGe9Rg8E88VItfOM8lMeMY56jmnZGOlNz7jigdgefqKgY76fjSIoDs4Jy2Op4H0pD7jilBP4UCHEleM4H9a5i98CeHLq9mvH02JLqWYzvMmQxY9SOwzjmum6gAHg06qhUlTd4uxUZuDvF6nCa/wCHDZxo+mxyNCCfMAbOwAEg4PJ54rmLrRpkkaPT9NA0pAstzdmUyF2PPCn0PNexLjAxxVOKxWC/kuYGCJID5sYX77cYOe2Oa7aWPlFWl0O6njpL4tWjwecTO941zaSGzs2WQSzcpIOxUA5444NNn1lNLurbT4IBdrPGZ98EhZRk5OS3IOex6V7pqkbxwr9i06C6aSQRyK5ChVPVjxyBxkVHL4c0m5uFubnT7Y3IwzMq4BYdyBwcVv8A2gt2jsWZxavKP5f8A8vsoLyytX1dNJuRASqyMsWHPbOD1Hv0xXeNp8EmkxC9W7iilPEMUrO0hPr2xznGMV1XI656UE85HU/hXLUxsqlnaxyVcfKo07W9DzKy8DvYRK2kh5IoI1Cx3DFGkZW3BjjqwPQn3GK9ESNrvTRHeqytJHtkBODz1+lWqQ56cYPvWNXESq2v0MKld1LXWx5xrnw9ebVGubAwywvCYHE7lX2EYKkj7w9M9MU7xD4M1jURbTJqzQtbxrmKBQDORwN7kZYAcYr0ToQR/KqWm6fBp0MkVp5u2WZ5z5khc7nOTgnoPQdBWscZUsrvbyNFjJ6N2uvI8Rv7K78OyXM2uR6lNKZfNiSNA4I9E5wV9RntWdDPd29vD/Zrz3Qnk8yV9Qy86qQMoirgA/XgV9DywxypiWOOQejKGA/Os++0XT75ALi1iwFCgqu0gdcAjpXVDME9Jo645lBu84/czw++VLmJvt9zGbeGfzkidVCohG0BierHrn2wKbYztNrhtTbTuNhcXQjAiAPRSRycHnPrXpN34B0/fJLKk94DIGjiYqQg9uOxyc8msp/AWsu8sEWpQ2lo0gcNGSzFQclTxnJHHpXVHFUmtzrjjaNm07HNzRSWuow/Z1R55QsZilk2qwXkuCc/MAScY5rT0TxB4h0y6tbW8u5L5VgKb5/ukgjG/HO/ngg4wOea6/wb4bu9M0+VNVuGuJTO7xhsHy48/Knv9T615D4m1eTR/iHf6FqQmlsZQIlltE2GPzFzn5j82M9eMEVPtadaTg1cweIo1G4z6HURfF+6XWrqCfR4GtYZpIAkNwN5ZPmL7mwAqrnOe5GO9dheeNYH0d7jTIg148W+FJ8mPcRxuK9R9K+a/iFJJod5p8Okpcwac9rujeUZMu45dtx6kkc+nTpXd/BXxK/iCS5tNWt45JrdFKzINnmZJG0gcAjtjHSsHDD+09m07o5YwoX95fcesWHjeK4uY45bGSNW2qzo+4Ix9R6Z710dtqthcytHbXttLIp27UkBOfSuHu9CubhnS2stqSAg5JUYIwRms2DwVe6Do8P9gWsELRy+bPFKGkZwT820gkk8DH0onh6LejsXWo4d25Xb53PV1PBx264oB4rxR72+iu5JL6aQSW0rXFtHasd5JG3BB+8SCfl6Cug8PeJtWmVZHhvEeQ8W99CUY+49PzrOWCktmRPL5x1TR6OJEaTyldDIOqBssB9OtOB7EY/pXmmueGdQv7m4vhb3H2y4TypE8zagXsRyOnH1rR8OavqFnJaWV+zXMMcOJJNuZGfjjHYKAT3Jz7VLw3u3i7mU8N7vNB3Oy8WwLc+Co4jjnUB+H7pq8l1/SruDU7C/gusW4zHNBj7+R/8Aqr1XxEV1DwNaywu4Q6iG5BU4EbDpXLXFkssbK7Pk87s9COhrLDScE15sw5+Rq5y91qUGnxRPfXVtbhztAds4PcZ7kVqxzwNZRTWrJNbvw0wbdu7cdjXPeIPCn9trs1CN4Zd25ZomyOOM4P6iui8KaBb6Jpgs1JlUsWJfoenP6ZrofLa/U0qSilcj1S8t9OhgF9MkRf5URELOwHYKO3PWuB8QeAoL/Xf7Vv5JWt2ZCEUAZXsD39q9Pu9O83UILpBGzRnpIucD29KFgSa8kWX94qtuCkZwe1JSQQrRivzJtPszbwR+WREm0fu1XAXj07VBckJcgCZSFHK8A57mq3jTWbjQtClu7O3E86kAKTgKvVmP0Arkdc8QrZeFRqtyyw3Vyivg88t3/LtTUXbmexnSg6ju3uO8Z+JoYtPUCaRSx4EPVv8AOK8b8R6vLdPBullETZO1s+vU+tWtVnvnulmI+1Q3MZeKWOX5SMYO30IPY96cvg/UbjSluWulhRQSI5fmI/wrVqTj+7Vz0m4wjyR2OdFw7XASS1hBHIZcgkevWty31u4m0s27T3O/hQiSFT7c96w7iCS1njikPnnGN0fJx7fStC3uzY6W0bBbpZXBJcbRHjPGev8ASs6d1dSYozlF2Og8I2wXWLG+e4k8+3kO2K6bOPqRyB0NelW7aZ4sGo+Hb5pobzlvJONnHI2nr1wa8PikuHu5Lqydba3iX55eu/H15JJ7V6P4Rv7XUtdtr+1KpfW3yKZSVEg/u+x9PyrSNpXVv+COUVODUNGJo2rH4cwCK60Z7WK8uHgmdmLOdoGG+mGzx+teqiaLRdPzYxIZ5fmAdtgIz2z35zXM/EixbxNpVlaXsOxPtAxInzPExGM47jnke9ZupeHVi1+/bUvEaQadfLHHBay5MnmIqjIXpgYIz7496mz7aHPy81ufRPexDJZX83ja3ufD1lY2momXzLw4G5043bSeOmc45Oa9WtLeMXk9xCsQlYlGbaNwAPCk9elc/pt/pukWf2+RxLaYEcd0BkkDAIPvmtj7XFDcfbsTJazR/vC6EAY+63txRK70SMq6cneK0OY+LGoRWuiC0u5lje4IEJAOSe/6Zr54t4Ypr5ZbeQB1fcV6bue3ofavb/jG1uutaHdXnly2MUcgaNj98t0II7YryWf+yrh1trG2W3TeW3tKS59OvH5U4Quk2dVBfu4qx1UFxDFAjwzmKXoQB2PYium0zXrrV3S2uHjSWJfkkY/eA7D3rmP7Pje2WRbn96oHGMkj/Ira06az+zLb3FnEl2jZ8/cV+mO2frXoNNvVHXWhTkr2uzfnsXsrV5rR/MZVMrJJ0J77T/j3rDuILzVL2CS7ZbSPy8goM4Q89upPJ5qXVp5jDFHHdl1D/NAw6jPqO1RXur3AxcRWQiiiBO0PuwPbjpQlbcyowqKPMrN669vvLf8Awi+nOxYXpLg4JmUjd9D0H/1q5jXtGti88MCNcyRk5ZFLqox1yPrWfP8AEI3VwtubXyreQ7JHAyxX6dK9E03WLO0tUWK4T7KkeFRSA3vnHPNQuWonyu9jONerDf3vI8YtbZVvHit5RK0imFnHQA9/pX0r4Ct7m18G2tpcPuliQhN7Zwo+7n8q+bZJYTrkptjmA3JfJGBjOePpXvnwx8QyahpF/bXsWZLCQRg9TJEwBUn9a55xXs9DHFa07pdSv4w1WOG78J6xdRRqzTkeXIM7SeMj3wDzWz4lCImswvlo720Nwnf5kABA/DBqTUPD9prtrp7SqcWknmRgnAB7A/pU3iq1kbT4LiIhntyScjPBGD9fpUXVkvX/AIBnCpHnjH5fjdHzha2tydTjSL9+5bISXAb8B1rvG0vUbWNYpr3yWxu8tZTx7Y7GuMF/bWXij+0YDK00b4aMDPPQ9etd/F4sj1CD7NHpb3bFt6eYm2RF9CR0x611QtbQ9CU6kZNRV1/Xcr2WliQk3N7KWAwMDdgenPaitAaXrE6+bbaZiFjkKJlYj60VrzQQ/bvpNL5o+gQBnIxTwOnqKcUAP41IsYKA85r5ls8BIYARn/CnD6/XmnKg2g89M04qMipuBGo5PHAox/Op0jDcknNIUHB5pXERgUo6e9SCMbgMnrRGgPcilcCM/pS+5p6oCSOeKURj5uTxRcCI9eMZpe4p6qCx+tJt5x70XAaetGcYz3qRYx1564pAgxRcYz17ijtxTyoHr0BpfLGCcnjBoGRE49qbk4561IRk4pNuBjJP1phcjIOe/wBKQEEkd8VIFGe9AXtk96dwKcVu8d5cTG4lkWbbtibG2PA/h781N261KVGG68CkIwxHvTvcbk2REA9qy9S0HTNSn86+sbaa42bFmeMM6DqMEjjnnitZRu29aTAI5qoycXdMm5852/ws8Ty61rP9tWkN3ZMrNbeXdBY5ZQV2nBJKgjOeM9QMVzPhPwxJ4c+K2k6fd26XbLqCxma28wBG2huVx0G4H8D2r6vcDaD3zVa3sra1nuGtoI4nuZDNMyjBkcgAsffAArr+tc3xLVbGqqvW4iRncCXzjsR1NSjII9qm2AY68VGoHHHrXM3czbZAbeEvvMMe8dCUGR+NSEbsDqAPyp684B6EUD7pPocU7sLsj71AbK33u5gi3Scu20ZJ9frVsqMD6ZpuPkz74pqTWw02til4pc2fguzWAKFGpKoQ88eU2QPf/CsE9xgjHcV0Pim2S68Naajs6hNXVwUbBJET9fasFoBll3vgEAdP8PeqoK8X6sqorqJVulDR5Y42nj69Kgh3SzsN21VAwoPf1qxcRAMV3MQGxzRZwL9pnGWxvwPYYrYSjaJFqt9b6XYy3N3KkUSD7zHAz2FNs54xZRTuyJ55GwyMBuJGQB6n2FcL8brcXUvhrTnkkFtc3qpIFIBIJA/kTWl4/wBFtZfEXhrLSiGwjmnhgDDZuj2lcjGew79qrlsl5jjBNJdzkfFPiz7L4y1PTtf+bSUjRWjQfeJxgD/PY1wnjDxLFqJmgtoswxOFhjbmNUAI6dzXZ+ILGLWNIttSvtz3TXRYsMDOUNePahEtvdyxoTtDY5NVWlKEfwPRS9ktDRtV1TVoUWKKea3tl2r5KfLECc9unNdx4ei1vU7Sa2vb5YIIht3OMscjjj6etHwe1K5trXUIYXCxhgSMZ3ZHQ/lXX66iWf2HUoEVZ5cxyLj5HX3FdWFg1FSb3IjPXl6nI3PhttOv7C3S7ZxLuO8ptA9+e30rQ8J2enq13BLFBPqsRYTecituQ427c9OKtapcSDV7OEH5Yo3ZOeQSOv6VygRr3xTDO8skUs7JG5iO3IOBW0ko2fmb8sqlNIf8S9L06wSwbTojDPJkTRqwIx1DYHT6VzQ1GWza0bTYzbiJtzSb/vn1JPSvQ/Hfhiw06y8yBpy8mFYu+c9fb2FeXO5zJBx5QG7HriuWqmm2upCXLG6Z70vjiO1g0KOa3MsOpSCGW4RsGOXIwT2wcg/nS+J/BkGu6taahfzzwtDKQHjO7IDHqD0GR1FcX8JYY9et9U0zU1EtokPmIvQoycqQR0I/rXq3h67kubBZZgrPJuzx9Tmp/vEVIqN5LY5z4k6NqOqeHf7M0RUZoZEuIY4sJvXncB2znBr0jQDcS+HtNN+qi6NtGJlHQPtGR+dUZIVRdNlQlXZ1UkejHkVzfw/8Sajq/jzxdpl7IrWdg+23QDG0B9vXvxUNXOSu+aKfY85+M99d3WvXmn+Sv2XTxEsSjhiCCSwPr/QVyGkwW9wkiGPfIDuBdSMV6h8bIIpNUtwyDMkQDHvnJwc+tec2OQdjMz/7RPPX2ropJaM9XDxuoPyN6xtXuNsS3AifuB3/AArorGG7sEaNraK9iI+5Jkf5+lchdzSLcxRqxAK5z3robS6uF05XWeQEuFPPUV2RasdVanJ7PQuWKrcaoVgtltXk4MIO4D6emfStbdFYMLDVFe3jGfnVTuc/3SecDn/9VSfC5f7U1q5a6J3RQ/KVwCctzmt34i2McdjBOGcuHKckHjH51m568pxVKv79UHtoedy2vhmylkaL7LuDHLE5xVGa5spUdrFUBUcsvP8ALpRqWhWEt4Xmh81ic5ZjV21sLayGLSJYQVB+Qd8Hv1rZRaOmCcH5HnE4umvpZHAVmOfMHAA9uwr2/wCHanUPDPlRY3NtikmDcsofrkc8AkV5d4p0u3M4ncyOwXOGbIPGa7j4J3LzWWoW7hfLMbMMDG3tgVy2cFJM5ay5U7ep65YKbffCqq0MZPkn1HbNcj4C8VXPiXTdasNZtfs2p6ezpJGM/MhyAfqDx+Vda7GPRDKuN+0EE84NLDaxG4S+K/6S6bGb+8CO/wCVcr3Z5aa1b7/kfLniGGe2125M8EIDSfJIMD8/U10/gTxKumXEqarEmH6M4xk9sYrK+I7+R4xmgVVa3bLGJh8oPPT0rn9G1Ka8vY4J0iaFQdq7fu46Y71tTqKLt3PalGNRuL2Z7hDdvrJMmm6fK7HLMF+XPqee1FcVaa5qELrAk52LGMeo9s0V3pP7OxzywlRO0bW+Z//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Low (left) and high (right) power views of a biopsy of a normal colon. Low power reveals straight crypts and mild lamina propria mononuclear cell infiltration. High power shows the surface enterocytes with interspersed goblet cells (arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Robert Odze, MD",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_2_41002=[""].join("\n");
var outline_f40_2_41002=null;
var title_f40_2_41003="The law of Laplace";
var content_f40_2_41003=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F58408&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F58408&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Law of Laplace",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 342px; height: 97px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    According to the law of Laplace, left ventricular (LV) wall stress is directly proportional to the product of cavity pressure and radius and inversely proportional to wall thickness. An elevation in LV cavity pressure (as with aortic stenosis or hypertension) causes an increase in wall stress. If a hypertrophic response occurs, increasing thickness can return wall stress to normal. With LV chamber enlargement (as with mitral regurgitation, dilated cardiomyopathy, or infarct expansion) wall stress increases, unless there is an appropriate hypertrophic response.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_2_41003=[""].join("\n");
var outline_f40_2_41003=null;
var title_f40_2_41004="Immunogenic drugs";
var content_f40_2_41004=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F54199&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F54199&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Drugs as immunogens",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Mechanism",
"      </td>",
"      <td class=\"subtitle1\">",
"       Examples",
"      </td>",
"      <td class=\"subtitle1\">",
"       Type of reaction generated",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"3\">",
"       Complete allergens",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\" rowspan=\"5\">",
"       Foreign macromolecules",
"      </td>",
"      <td>",
"       Insulin and other hormones",
"      </td>",
"      <td rowspan=\"7\">",
"       Type I",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Enzymes and protamine",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Antisera",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Recombinant proteins (eg, cetuximab, rituximab)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Vaccines",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\" rowspan=\"2\">",
"       Functionally multivalent chemicals",
"      </td>",
"      <td>",
"       Quaternary ammonium compounds (eg, neuromuscular blocking agents such as succinylcholine)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Carboxymethyl cellulose",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"3\">",
"       Direct haptenation",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"3\">",
"       &nbsp;",
"      </td>",
"      <td>",
"       <sub>",
"        &beta;",
"       </sub>",
"       -lactam antibiotics",
"      </td>",
"      <td rowspan=\"3\">",
"       <p>",
"        Type I",
"       </p>",
"       <p>",
"        Type II",
"       </p>",
"       <p>",
"        Type III",
"       </p>",
"       <p>",
"        Type IV",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Penicillamine",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Heavy metals (gold, cisplatinum)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"3\">",
"       Metabolism to haptenic form*",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"8\">",
"       &nbsp;",
"      </td>",
"      <td>",
"       Sulfonamides&bull;",
"      </td>",
"      <td rowspan=\"8\">",
"       <p>",
"        Type I",
"       </p>",
"       <p>",
"        Type II",
"       </p>",
"       <p>",
"        Type III",
"       </p>",
"       <p>",
"        Type IV",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Acetaminophen&Delta;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Phenacetin&bull;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Phenytoin&loz;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Lamotrigine",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Carbamazepine",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Procainamide&bull;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Halothane&sect;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"3\">",
"       Direct stimulation of immune receptors (the p-i concept)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\" rowspan=\"4\">",
"       &nbsp;",
"      </td>",
"      <td>",
"       Sulfamethoxazole",
"      </td>",
"      <td rowspan=\"4\">",
"       Type IV",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Lidocaine, mepivacaine",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Carbamazepine",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Lamotrigine",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Postulated intermediates:",
"     <br>",
"      &bull; Hydroxylamine;",
"      <br>",
"       &Delta; Quinone imine;",
"       <br>",
"        &loz; Arene oxide;",
"        <br>",
"         &sect; Radicals, acylhalides.",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Celik, G, Pichler, WJ, Adkinson, NF Jr. Drug Allergy. In: Middleton's Allergy Principles &amp; Practice, 7th ed, Adkinson, NF, et al (Ed), Mosby Elsevier, Philadelphia 2009. p. 1205-1226. Illustration used with the permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_2_41004=[""].join("\n");
var outline_f40_2_41004=null;
var title_f40_2_41005="Contents: Drug eruptions";
var content_f40_2_41005=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"mobipreview.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"mobipreview.htm?2/59/3006\">",
"       Dermatology",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Drug eruptions",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"mobipreview.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Drug eruptions",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/6/9322\">",
"           Acneiform eruption secondary to epidermal growth factor (EGFR) inhibitors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/60/42951\">",
"           Acute generalized exanthematous pustulosis (AGEP)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/7/36986\">",
"           Cutaneous complications of conventional chemotherapy agents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/63/35834\">",
"           Cutaneous complications of molecularly targeted therapy and other biologic agents used for cancer therapy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/17/41241\">",
"           Drug eruptions",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/57/43929\">",
"           Drug reaction with eosinophilia and systemic symptoms (DRESS)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/50/24360\">",
"           Exanthematous (morbilliform) drug eruption",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/50/9000\">",
"           Fixed drug eruption",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/48/3848\">",
"           Lichenoid drug eruption (drug-induced lichen planus)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/29/17882\">",
"           Stevens-Johnson syndrome and toxic epidermal necrolysis: Clinical manifestations; pathogenesis; and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/0/33801\">",
"           Stevens-Johnson syndrome and toxic epidermal necrolysis: Management, prognosis, and long-term sequelae",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-EE334AB09F-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f40_2_41005=[""].join("\n");
var outline_f40_2_41005=null;
var title_f40_2_41006="Correction of myopia";
var content_f40_2_41006=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"videoplayer\" h264=\"./images/CARD/80691/myop_ref_conv.mp4?title=Correction+of+myopia\" style=\"width:338px;height:228px\">",
"  </div>",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Myopia corrected with refractive divergent lens",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 336px; height: 210px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Myopia is corrected with divergent (concave) lenses which move the focus onto the retina from a point of focus in front of the retina.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: the University of Michigan Kellogg Eye Center, file://www.kellogg.umich.edu.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_2_41006=[""].join("\n");
var outline_f40_2_41006=null;
var title_f40_2_41007="MPS I chest radiograph";
var content_f40_2_41007=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F50673&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F50673&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Chest radiograph in a patient with mucopolysaccharidosis type I (MPS I)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 288px; height: 370px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The ribs are broadened distally and narrowed at the takeoff from the vertebral bodies, resulting in the oar shape. The clavicle is also abnormally curved.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Emil Kakkis, MD, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_2_41007=[""].join("\n");
var outline_f40_2_41007=null;
     